1
|
Rossi M, Terreri S, Battafarano G, Rana I, Buonuomo PS, Di Giuseppe L, D'Agostini M, Porzio O, Di Gregorio J, Cipriani C, Jenkner A, Gonfiantini MV, Bartuli A, Del Fattore A. Analysis of circulating osteoclast and osteogenic precursors in patients with Gorham-Stout disease. J Endocrinol Invest 2024:10.1007/s40618-024-02365-8. [PMID: 38556572 DOI: 10.1007/s40618-024-02365-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/05/2023] [Accepted: 03/14/2024] [Indexed: 04/02/2024]
Abstract
PURPOSE Gorham-Stout disease is a very rare disorder characterized by progressive bone erosion and angiomatous proliferation; its etiopathogenesis is still unknown, and diagnosis is still performed by exclusion criteria. The alteration of bone remodeling activity has been reported in patients; in this study, we characterized circulating osteoclast and osteogenic precursors that could be important to better understand the osteolysis observed in patients. METHODS Flow cytometry analysis of PBMC (Peripheral Blood Mononuclear Cells) was performed to characterize circulating osteoclast and osteogenic precursors in GSD patients (n = 9) compared to healthy donors (n = 55). Moreover, ELISA assays were assessed to evaluate serum levels of bone markers including RANK-L (Receptor activator of NF-κB ligand), OPG (Osteoprotegerin), BALP (Bone Alkaline Phosphatase) and OCN (Osteocalcin). RESULTS We found an increase of CD16-/CD14+CD11b+ and CD115+/CD14+CD11b+ osteoclast precursors in GSD patients, with high levels of serum RANK-L that could reflect the increase of bone resorption activity observed in patients. Moreover, no significant alterations were found regarding osteogenic precursors and serum levels of BALP and OCN. CONCLUSION The analysis of circulating bone cell precursors, as well as of RANK-L, could be relevant as an additional diagnostic tool for these patients and could be exploited for therapeutic purposes.
Collapse
Affiliation(s)
- M Rossi
- Bone Physiopathology Research Unit, Translational Pediatrics and Clinical Genetics Research Division, Bambino Gesù Children's Hospital, IRCCS, Viale San Paolo 15, 00146, Rome, Italy
| | - S Terreri
- Bone Physiopathology Research Unit, Translational Pediatrics and Clinical Genetics Research Division, Bambino Gesù Children's Hospital, IRCCS, Viale San Paolo 15, 00146, Rome, Italy
| | - G Battafarano
- Bone Physiopathology Research Unit, Translational Pediatrics and Clinical Genetics Research Division, Bambino Gesù Children's Hospital, IRCCS, Viale San Paolo 15, 00146, Rome, Italy
| | - I Rana
- Rare Diseases and Medical Genetic Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
| | - P S Buonuomo
- Rare Diseases and Medical Genetic Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
| | - L Di Giuseppe
- Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University, Rome, Italy
| | - M D'Agostini
- Clinical Laboratory, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
| | - O Porzio
- Clinical Laboratory, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
- Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy
| | - J Di Gregorio
- Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy
| | - Cristiana Cipriani
- Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University, Rome, Italy
| | - A Jenkner
- Pediatric Palliative Care Center, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
| | - M V Gonfiantini
- Rare Diseases and Medical Genetic Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
| | - A Bartuli
- Rare Diseases and Medical Genetic Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
| | - A Del Fattore
- Bone Physiopathology Research Unit, Translational Pediatrics and Clinical Genetics Research Division, Bambino Gesù Children's Hospital, IRCCS, Viale San Paolo 15, 00146, Rome, Italy.
| |
Collapse
|
2
|
Eccher A, Becker JU, Pagni F, Cazzaniga G, Rossi M, Gambaro G, L’Imperio V, Marletta S. The Puzzle of Preimplantation Kidney Biopsy Decision-Making Process: The Pathologist Perspective. Life (Basel) 2024; 14:254. [PMID: 38398762 PMCID: PMC10890315 DOI: 10.3390/life14020254] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2024] [Revised: 02/11/2024] [Accepted: 02/13/2024] [Indexed: 02/25/2024] Open
Abstract
Kidney transplantation is the best treatment for end-stage renal disease since it offers the greatest survival benefit compared to dialysis. The gap between the number of renal transplants performed and the number of patients awaiting renal transplants leads to a steadily increasing pressure on the scientific community. Kidney preimplantation biopsy is used as a component of the evaluation of organ quality before acceptance for transplantation. However, the reliability and predictive value of biopsy data are controversial. Most of the previously proposed predictive models were not associated with graft survival, but what has to be reaffirmed is that histologic examination of kidney tissue can provide an objective window on the state of the organ that cannot be deduced from clinical records and renal functional studies. The balance of evidence indicates that reliable decisions about donor suitability must be made based on the overall picture. This work discusses recent trends that can reduce diagnostic timing and variability among players in the decision-making process that lead to kidney transplants, from the pathologist's perspective.
Collapse
Affiliation(s)
- Albino Eccher
- Department of Medical and Sciences for Children and Adults, University of Modena and Reggio Emilia, University Hospital of Modena, 41100 Modena, Italy
| | - Jan Ulrich Becker
- Institute of Pathology, University Hospital of Cologne, 50923 Cologne, Germany;
| | - Fabio Pagni
- Department of Medicine and Surgery, Pathology, IRCCS Fondazione San Gerardo dei Tintori, University of Milano-Bicocca, 20126 Milano, Italy; (F.P.); (G.C.); (V.L.)
| | - Giorgio Cazzaniga
- Department of Medicine and Surgery, Pathology, IRCCS Fondazione San Gerardo dei Tintori, University of Milano-Bicocca, 20126 Milano, Italy; (F.P.); (G.C.); (V.L.)
| | - Mattia Rossi
- Division of Nephrology, Department of Medicine, University of Verona, 37129 Verona, Italy; (M.R.); (G.G.)
| | - Giovanni Gambaro
- Division of Nephrology, Department of Medicine, University of Verona, 37129 Verona, Italy; (M.R.); (G.G.)
| | - Vincenzo L’Imperio
- Department of Medicine and Surgery, Pathology, IRCCS Fondazione San Gerardo dei Tintori, University of Milano-Bicocca, 20126 Milano, Italy; (F.P.); (G.C.); (V.L.)
| | - Stefano Marletta
- Department of Diagnostics and Public Health, Section of Pathology, University of Verona, 37129 Verona, Italy;
- Division of Pathology, Humanitas Istituto Clinico Catanese, 95045 Catania, Italy
| |
Collapse
|
3
|
Masè M, Rossi M, Setti M, Barbati G, Teso MV, Ribichini FL, Koni M, Stolfo D, Merlo M, Sinagra G. Applicability and performance of heart failure prognostic scores in dilated cardiomyopathy: the real-world experience of an Italian referral center for cardiomyopathies. Int J Cardiol 2024; 396:131562. [PMID: 37907097 DOI: 10.1016/j.ijcard.2023.131562] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/18/2023] [Revised: 09/26/2023] [Accepted: 10/27/2023] [Indexed: 11/02/2023]
Abstract
BACKGROUND The performance of heart failure (HF) risk models is validated in the general population with HF but in specific aetiological settings, and specifically in dilated cardiomyopathy (DCM), has scarcely been explored. We tested eight of the main prognostic scores used in HF in a large real-world population of patients with DCM. METHODS We included 784 consecutive DCM patients enrolled, both inpatients and outpatients, enrolled between January 2000 and December 2017. The risk of 1 and/or 3-year all-cause mortality/heart transplantation/durable left ventricular assist device (LVAD) implantation (D/HTx/LVAD) was estimated in our cohort according to the following risk scores SHFM, 3-CHF, CHARM, MAGGIC, GISSI-HF, MECKI, Barcelona Bio-HF, Krakow score and their accuracy calculated through the receiver operator characteristic (ROC) curve analysis. RESULTS During a median follow-up of 5.8 years (Interquartile Range 3.2-7.6 years), 191 patients (20%) died or underwent HTx/LVAD (158 deaths, 30 heart transplantations, and 3 LVAD implantations). The high missing rate allowed to calculated only four prognostic models (MAGGIC, CHARM, 3-CHF and SHFM). All the scores overestimated the rate of D/HTx/LVAD. The prognostic accuracy was suboptimal for MAGGIC (AUC 0.754) and CHARM (AUC 0.720) scores and only modest for 3-CHF (AUC 0.677) and SHFM (AUC 0.667). CONCLUSIONS Main prognostic scores for the risk stratification of HF are only partially applicable to real-world patients with DCM. MAGGIC and CHARM scores showed the best accuracy, despite the overestimation of risk. Our findings corroborate the need of specific risk scores for the prognostic stratification of DCM. CLINICAL PERSPECTIVE What is new? The present study is the largest analysis in literature which investigate how the main existing heart failure prognostic risk scores performed in a real-world of dilated cardiomyopathy population, both in- and outpatients. What are the clinical implications? DCM is a stand-alone model of heart failure, where the performance of multiple heart failure prognostic scores for the risk stratification is quite limited. The need for contemporary, dedicated prognostic scores in this disease is increasingly evident.
Collapse
Affiliation(s)
- M Masè
- Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) and University of Trieste, Via P. Valdoni 7, 34100 Trieste, Italy
| | - M Rossi
- Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) and University of Trieste, Via P. Valdoni 7, 34100 Trieste, Italy
| | - M Setti
- Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) and University of Trieste, Via P. Valdoni 7, 34100 Trieste, Italy; Division of Cardiology, Department of Medicine, University of Verona, Italy
| | - G Barbati
- Biostatistics Unit, Department of Medical Sciences, University of Trieste, Trieste, Italy
| | | | - F L Ribichini
- Division of Cardiology, Department of Medicine, University of Verona, Italy
| | - M Koni
- Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) and University of Trieste, Via P. Valdoni 7, 34100 Trieste, Italy
| | - D Stolfo
- Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) and University of Trieste, Via P. Valdoni 7, 34100 Trieste, Italy
| | - M Merlo
- Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) and University of Trieste, Via P. Valdoni 7, 34100 Trieste, Italy.
| | - G Sinagra
- Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) and University of Trieste, Via P. Valdoni 7, 34100 Trieste, Italy
| |
Collapse
|
4
|
Cazzaniga G, Rossi M, Eccher A, Girolami I, L'Imperio V, Van Nguyen H, Becker JU, Bueno García MG, Sbaraglia M, Dei Tos AP, Gambaro G, Pagni F. Time for a full digital approach in nephropathology: a systematic review of current artificial intelligence applications and future directions. J Nephrol 2024; 37:65-76. [PMID: 37768550 PMCID: PMC10920416 DOI: 10.1007/s40620-023-01775-w] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2023] [Accepted: 08/22/2023] [Indexed: 09/29/2023]
Abstract
INTRODUCTION Artificial intelligence (AI) integration in nephropathology has been growing rapidly in recent years, facing several challenges including the wide range of histological techniques used, the low occurrence of certain diseases, and the need for data sharing. This narrative review retraces the history of AI in nephropathology and provides insights into potential future developments. METHODS Electronic searches in PubMed-MEDLINE and Embase were made to extract pertinent articles from the literature. Works about automated image analysis or the application of an AI algorithm on non-neoplastic kidney histological samples were included and analyzed to extract information such as publication year, AI task, and learning type. Prepublication servers and reviews were not included. RESULTS Seventy-six (76) original research articles were selected. Most of the studies were conducted in the United States in the last 7 years. To date, research has been mainly conducted on relatively easy tasks, like single-stain glomerular segmentation. However, there is a trend towards developing more complex tasks such as glomerular multi-stain classification. CONCLUSION Deep learning has been used to identify patterns in complex histopathology data and looks promising for the comprehensive assessment of renal biopsy, through the use of multiple stains and virtual staining techniques. Hybrid and collaborative learning approaches have also been explored to utilize large amounts of unlabeled data. A diverse team of experts, including nephropathologists, computer scientists, and clinicians, is crucial for the development of AI systems for nephropathology. Collaborative efforts among multidisciplinary experts result in clinically relevant and effective AI tools.
Collapse
Affiliation(s)
- Giorgio Cazzaniga
- Department of Medicine and Surgery, Pathology, Fondazione IRCCS San Gerardo dei Tintori, Università di Milano-Bicocca, Monza, Italy.
| | - Mattia Rossi
- Division of Nephrology, Department of Medicine, University of Verona, Piazzale Aristide Stefani, 1, 37126, Verona, Italy
| | - Albino Eccher
- Department of Pathology and Diagnostics, University and Hospital Trust of Verona, P.le Stefani n. 1, 37126, Verona, Italy
- Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, University Hospital of Modena, Modena, Italy
| | - Ilaria Girolami
- Department of Pathology and Diagnostics, University and Hospital Trust of Verona, P.le Stefani n. 1, 37126, Verona, Italy
| | - Vincenzo L'Imperio
- Department of Medicine and Surgery, Pathology, Fondazione IRCCS San Gerardo dei Tintori, Università di Milano-Bicocca, Monza, Italy
| | - Hien Van Nguyen
- Department of Electrical and Computer Engineering, University of Houston, Houston, TX, 77004, USA
| | - Jan Ulrich Becker
- Institute of Pathology, University Hospital of Cologne, Cologne, Germany
| | - María Gloria Bueno García
- VISILAB Research Group, E.T.S. Ingenieros Industriales, University of Castilla-La Mancha, Ciudad Real, Spain
| | - Marta Sbaraglia
- Department of Pathology, Azienda Ospedale-Università Padova, Padua, Italy
- Department of Medicine, University of Padua School of Medicine, Padua, Italy
| | - Angelo Paolo Dei Tos
- Department of Pathology, Azienda Ospedale-Università Padova, Padua, Italy
- Department of Medicine, University of Padua School of Medicine, Padua, Italy
| | - Giovanni Gambaro
- Division of Nephrology, Department of Medicine, University of Verona, Piazzale Aristide Stefani, 1, 37126, Verona, Italy
| | - Fabio Pagni
- Department of Medicine and Surgery, Pathology, Fondazione IRCCS San Gerardo dei Tintori, Università di Milano-Bicocca, Monza, Italy
| |
Collapse
|
5
|
Egalini F, Rossi M, Massussi M, Gaggero G, Beccuti G, Benso A, Piepoli MF, Broglio F. Eicosapentaenoic Acid: between Cardiovascular Benefits and the Risk of Atrial Fibrillation. Endocr Metab Immune Disord Drug Targets 2024; 24:651-663. [PMID: 38083891 DOI: 10.2174/0118715303280825231122153024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/07/2023] [Revised: 10/19/2023] [Accepted: 10/23/2023] [Indexed: 01/31/2024]
Abstract
In recent years, scientific research has increasingly focused on the cardiovascular benefits of omega-3 polyunsaturated fatty acids (n-3 PUFAs) supplements. The most promising results emerged from the new trials on a high-dose eicosapentaenoic acid (EPA)-only approach, instead of the previously prescribed therapy with EPA + docosahexaenoic acid (DHA). The evidence of the reduction of cardiovascular events in patients at high cardiovascular risk with EPA is intriguing. However, physicians have expressed concern about the potential high risk of atrial fibrillation (AF) occurrence due to such an approach. This study aims to investigate the current evidence on the cardiovascular benefits of EPA and its association with atrial arrhythmogenesis. Current guidelines consider EPA (as IPE) treatment for selected patients but with no specific indication regarding AF risk evaluation. We propose a flowchart that could be a starting point for the future development of an algorithm to help clinicians to prescribe EPA safely and effectively, especially in patients at high risk of incipient AF.
Collapse
Affiliation(s)
- Filippo Egalini
- Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Corso Dogliotti 14, Turin, 10126, Italy
| | - Mattia Rossi
- Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Corso Dogliotti 14, Turin, 10126, Italy
| | - Mauro Massussi
- Cardiac Catheterization Laboratory and Cardiology, ASST Spedali Civili di Brescia, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy
| | - Giulia Gaggero
- Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Corso Dogliotti 14, Turin, 10126, Italy
| | - Guglielmo Beccuti
- Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Corso Dogliotti 14, Turin, 10126, Italy
| | - Andrea Benso
- Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Corso Dogliotti 14, Turin, 10126, Italy
| | - Massimo F Piepoli
- Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Corso Dogliotti 14, Turin, 10126, Italy
- Department of Biomedical Science for the Health, University of Milan, Via Festa del Perdono, 7, 20122, Milan, Italy
| | - Fabio Broglio
- Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Corso Dogliotti 14, Turin, 10126, Italy
| |
Collapse
|
6
|
Turati F, Rossi M, Spinazzè A, Pira E, Cavallo DM, Patel L, Mensi C, La Vecchia C, Negri E. Occupational asbestos exposure and ovarian cancer: updated systematic review. Occup Med (Lond) 2023; 73:532-540. [PMID: 38072464 DOI: 10.1093/occmed/kqad122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2024] Open
Abstract
BACKGROUND The association between asbestos exposure and ovarian cancer has been questioned given the possible misdiagnosis of peritoneal mesothelioma as ovarian cancer. AIMS To update a systematic review on ovarian cancer risk in women occupationally exposed to asbestos, exploring the association with the time since first exposure and the duration of exposure. METHODS We searched PubMed from 2008 onwards, screened previous systematic reviews, combined standardized mortality ratios (SMR) using random effect models and quantified heterogeneity using the I2 statistic. To assess tumour misclassification, we compared the distribution of observed excess ovarian cancers (OEOC) to that expected (EEOC) from the distribution of peritoneal cancers in strata of latency and exposure duration. RESULTS Eighteen publications (20 populations), including a pooled analysis of 21 cohorts, were included. The pooled SMR was 1.79 (95% confidence interval 1.38-2.31), with moderate heterogeneity between studies (I2 = 42%), based on 144 ovarian cancer deaths/cases. The risk was increased for women with indirect indicators of higher exposure, longer duration and latency, and lower for chrysotile than for crocidolite exposure. The effect of duration and latency could not be completely disentangled, since no multivariate analysis was available for time-related variables. The dissimilarity index between OEOC and EEOC for the time since first exposure was small suggesting a similar pattern of risk. CONCLUSIONS While some misclassification between ovarian and peritoneal cancers cannot be excluded, the observed excess risk of ovarian cancer should be added to the overall disease burden of asbestos.
Collapse
Affiliation(s)
- F Turati
- Department of Clinical Sciences and Community Health, University of Milan, 20133 Milan, Italy
| | - M Rossi
- Department of Clinical Sciences and Community Health, University of Milan, 20133 Milan, Italy
| | - A Spinazzè
- Department of Science and High Technology, University of Insubria, 22100 Como, Italy
| | - E Pira
- Department of Sciences of Public Health and Pediatrics, University of Turin, 10126 Turin, Italy
| | - D M Cavallo
- Department of Science and High Technology, University of Insubria, 22100 Como, Italy
| | - L Patel
- Department of Clinical Sciences and Community Health, University of Milan, 20133 Milan, Italy
| | - C Mensi
- Occupational Health Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy
| | - C La Vecchia
- Department of Clinical Sciences and Community Health, University of Milan, 20133 Milan, Italy
| | - E Negri
- Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy
| |
Collapse
|
7
|
Altini N, Rossini M, Turkevi-Nagy S, Pesce F, Pontrelli P, Prencipe B, Berloco F, Seshan S, Gibier JB, Pedraza Dorado A, Bueno G, Peruzzi L, Rossi M, Eccher A, Li F, Koumpis A, Beyan O, Barratt J, Vo HQ, Mohan C, Nguyen HV, Cicalese PA, Ernst A, Gesualdo L, Bevilacqua V, Becker JU. Performance and limitations of a supervised deep learning approach for the histopathological Oxford Classification of glomeruli with IgA nephropathy. Comput Methods Programs Biomed 2023; 242:107814. [PMID: 37722311 DOI: 10.1016/j.cmpb.2023.107814] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/31/2023] [Revised: 09/11/2023] [Accepted: 09/12/2023] [Indexed: 09/20/2023]
Abstract
BACKGROUND AND OBJECTIVE The Oxford Classification for IgA nephropathy is the most successful example of an evidence-based nephropathology classification system. The aim of our study was to replicate the glomerular components of Oxford scoring with an end-to-end deep learning pipeline that involves automatic glomerular segmentation followed by classification for mesangial hypercellularity (M), endocapillary hypercellularity (E), segmental sclerosis (S) and active crescents (C). METHODS A total number of 1056 periodic acid-Schiff (PAS) whole slide images (WSIs), coming from 386 kidney biopsies, were annotated. Several detection models for glomeruli, based on the Mask R-CNN architecture, were trained on 587 WSIs, validated on 161 WSIs, and tested on 127 WSIs. For the development of segmentation models, 20,529 glomeruli were annotated, of which 16,571 as training and 3958 as validation set. The test set of the segmentation module comprised of 2948 glomeruli. For the Oxford classification, 6206 expert-annotated glomeruli from 308 PAS WSIs were labelled for M, E, S, C and split into a training set of 4298 glomeruli from 207 WSIs, and a test set of 1908 glomeruli. We chose the best-performing models to construct an end-to-end pipeline, which we named MESCnn (MESC classification by neural network), for the glomerular Oxford classification of WSIs. RESULTS Instance segmentation yielded excellent results with an AP50 ranging between 78.2-80.1 % (79.4 ± 0.7 %) on the validation and 75.1-77.7 % (76.5 ± 0.9 %) on the test set. The aggregated Jaccard Index was between 73.4-75.9 % (75.0 ± 0.8 %) on the validation and 69.1-73.4 % (72.2 ± 1.4 %) on the test set. At granular glomerular level, Oxford Classification was best replicated for M with EfficientNetV2-L with a mean ROC-AUC of 90.2 % and a mean precision/recall area under the curve (PR-AUC) of 81.8 %, best for E with MobileNetV2 (ROC-AUC 94.7 %) and ResNet50 (PR-AUC 75.8 %), best for S with EfficientNetV2-M (mean ROC-AUC 92.7 %, mean PR-AUC 87.7 %), best for C with EfficientNetV2-L (ROC-AUC 92.3 %) and EfficientNetV2-S (PR-AUC 54.7 %). At biopsy-level, correlation between expert and deep learning labels fulfilled the demands of the Oxford Classification. CONCLUSION We designed an end-to-end pipeline for glomerular Oxford Classification on both a granular glomerular and an entire biopsy level. Both the glomerular segmentation and the classification modules are freely available for further development to the renal medicine community.
Collapse
Affiliation(s)
- Nicola Altini
- Department of Electrical and Information Engineering (DEI), Polytechnic University of Bari, Via Edoardo Orabona n.4, Bari 70126, Italy
| | - Michele Rossini
- Nephrology Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy
| | - Sándor Turkevi-Nagy
- Department of Pathology, Albert Szent-Györgyi Health Center, University of Szeged, Szeged, Hungary
| | - Francesco Pesce
- Nephrology Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy; Division of Renal Medicine, "Fatebenefratelli Isola Tiberina - Gemelli Isola", Rome, Italy
| | - Paola Pontrelli
- Nephrology Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy
| | - Berardino Prencipe
- Department of Electrical and Information Engineering (DEI), Polytechnic University of Bari, Via Edoardo Orabona n.4, Bari 70126, Italy
| | - Francesco Berloco
- Department of Electrical and Information Engineering (DEI), Polytechnic University of Bari, Via Edoardo Orabona n.4, Bari 70126, Italy
| | - Surya Seshan
- Department of Pathology, Weill-Cornell Medical Center/New York Presbyterian Hospital, New York, NY, USA
| | - Jean-Baptiste Gibier
- Department of Pathology, Pathology Institute, Lille University Hospital (CHU), Lille, France
| | | | - Gloria Bueno
- VISILAB Research Group, University of Castilla-La Mancha, Ciudad Real, Spain
| | - Licia Peruzzi
- AOU Città della Salute e della Scienza di Torino, Regina Margherita Children's Hospital, Turin, Italy
| | - Mattia Rossi
- Division of Nephrology, Department of Medicine, University of Verona, Verona, Italy
| | - Albino Eccher
- Section of Pathology, Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, University Hospital of Modena, Modena, Italy
| | - Feifei Li
- Faculty of Medicine, University Hospital Cologne, University of Cologne, Institute for Medical Informatics, Cologne, Germany
| | - Adamantios Koumpis
- Faculty of Medicine, University Hospital Cologne, University of Cologne, Institute for Medical Informatics, Cologne, Germany
| | - Oya Beyan
- Faculty of Medicine, University Hospital Cologne, University of Cologne, Institute for Medical Informatics, Cologne, Germany
| | - Jonathan Barratt
- Department of Cardiovascular Sciences, University of Leicester, Leicester, UK
| | - Huy Quoc Vo
- Department of Biomedical Engineering, University of Houston, Houston, USA
| | - Chandra Mohan
- Department of Biomedical Engineering, University of Houston, Houston, USA
| | - Hien Van Nguyen
- Department of Biomedical Engineering, University of Houston, Houston, USA
| | | | - Angela Ernst
- Institute of Medical Statistics and Computational Biology, University of Cologne, Cologne, Germany
| | - Loreto Gesualdo
- Nephrology Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy
| | - Vitoantonio Bevilacqua
- Department of Electrical and Information Engineering (DEI), Polytechnic University of Bari, Via Edoardo Orabona n.4, Bari 70126, Italy; Apulian Bioengineering s.r.l., Via delle Violette n.14, Modugno 70026, Italy.
| | - Jan Ulrich Becker
- Institute of Pathology, University Hospital of Cologne, Cologne, Germany
| |
Collapse
|
8
|
Guglielmini PF, Massone C, Grasso C, Francese A, Vincenti M, Chiodi S, Rossi M, Maconi A. A rare and severe lichenoid skin eruption after apalutamide treatment for prostate cancer. Ann Dermatol Venereol 2023; 150:310-311. [PMID: 37903707 DOI: 10.1016/j.annder.2023.09.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2023] [Revised: 06/14/2023] [Accepted: 09/05/2023] [Indexed: 11/01/2023]
Affiliation(s)
- P-F Guglielmini
- Oncology Unit, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo Hospital, Alessandria, Italy
| | - C Massone
- Dermatology Unit & Scientific Directorate, Galliera Hospital, Genoa, Italy
| | - C Grasso
- Infrastruttura Ricerca Formazione Innovazione, Dipartimento Attività Integrate Ricerca Innovazione, Azienda Ospedaliera "SS Antonio e Biagio e Cesare Arrigo", Alessandria, Italy
| | - A Francese
- Infrastruttura Ricerca Formazione Innovazione, Dipartimento Attività Integrate Ricerca Innovazione, Azienda Ospedaliera "SS Antonio e Biagio e Cesare Arrigo", Alessandria, Italy.
| | - M Vincenti
- Oncology Unit, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo Hospital, Alessandria, Italy
| | - S Chiodi
- Plastic Surgery, Galliera Hospital, 16128 Genoa, Italy
| | - M Rossi
- Oncology Unit, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo Hospital, Alessandria, Italy
| | - A Maconi
- Infrastruttura Ricerca Formazione Innovazione, Dipartimento Attività Integrate Ricerca Innovazione, Azienda Ospedaliera "SS Antonio e Biagio e Cesare Arrigo", Alessandria, Italy
| |
Collapse
|
9
|
Cazzaniga G, Bolognesi MM, Stefania MD, Mascadri F, Eccher A, Alberici F, Mescia F, Smith A, Fraggetta F, Rossi M, Gambaro G, Pagni F, L'Imperio V. Congo Red Staining in Digital Pathology: The Streamlined Pipeline for Amyloid Detection Through Congo Red Fluorescence Digital Analysis. J Transl Med 2023; 103:100243. [PMID: 37634845 DOI: 10.1016/j.labinv.2023.100243] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2023] [Revised: 08/04/2023] [Accepted: 08/21/2023] [Indexed: 08/29/2023] Open
Abstract
Renal amyloidosis is a rare condition caused by the progressive accumulation of misfolded proteins within glomeruli, vessels, and interstitium, causing functional decline and requiring prompt treatment due to its significant morbidity and mortality. Congo red (CR) stain on renal biopsy samples is the gold standard for diagnosis, but the need for polarized light is limiting the digitization of this nephropathology field. This study explores the feasibility and reliability of CR fluorescence on virtual slides (CRFvs) in evaluating the diagnostic accuracy and proposing an automated digital pipeline for its assessment. Whole-slide images from 154 renal biopsies with CR were scanned through a Texas red fluorescence filter (NanoZoomer S60, Hamamatsu) at the digital Nephropathology Center of the Istituto di Ricovero e Cura a Carattere Scientifico San Gerardo, Monza, Italy, and evaluated double-blinded for the detection and quantification through the amyloid score and a custom ImageJ pipeline was built to automatically detect amyloid-containing regions. Interobserver agreement for CRFvs was optimal (k = 0.90; 95% CI, 0.81-0.98), with even better concordance when consensus-based CRFvs evaluation was compared to the standard CR birefringence (BR) (k = 0.98; 95% CI, 0.93-1). Excellent performance was achieved in the assessment of amyloid score overall by CRFvs (weighted k = 0.70; 95% CI, 0.08-1), especially within the interstitium (weighted k = 0.60; 95% CI, 0.35-0.84), overcoming the misinterpretation of interstitial and capsular collagen BR. The application of an automated digital pathology pipeline (Streamlined Pipeline for Amyloid detection through CR fluorescence Digital Analysis, SPADA) further increased the performance of pathologists, leading to a complete concordance with the standard BR. This study represents an initial step in the validation of CRFvs, demonstrating its general reliability in a digital nephropathology center. The computational method used in this study has the potential to facilitate the integration of spatial omics and artificial intelligence tools for the diagnosis of amyloidosis, streamlining its detection process.
Collapse
Affiliation(s)
- Giorgio Cazzaniga
- Department of Medicine and Surgery, Pathology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione San Gerardo dei Tintori, University of Milano-Bicocca, Monza, Italy
| | - Maddalena Maria Bolognesi
- Department of Medicine and Surgery, Pathology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione San Gerardo dei Tintori, University of Milano-Bicocca, Monza, Italy
| | - Matteo Davide Stefania
- Department of Medicine and Surgery, Pathology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione San Gerardo dei Tintori, University of Milano-Bicocca, Monza, Italy
| | - Francesco Mascadri
- Department of Medicine and Surgery, Pathology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione San Gerardo dei Tintori, University of Milano-Bicocca, Monza, Italy
| | - Albino Eccher
- Department of Pathology and Diagnostics, University and Hospital Trust of Verona, Verona, Italy; Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, University Hospital of Modena, Modena, Italy
| | - Federico Alberici
- Nephrology Unit, Spedali Civili Hospital, Azienda Socio Sanitaria Territoriale (ASST) Spedali Civili di Brescia, Brescia, Italy; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy
| | - Federica Mescia
- Nephrology Unit, Spedali Civili Hospital, Azienda Socio Sanitaria Territoriale (ASST) Spedali Civili di Brescia, Brescia, Italy; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy
| | - Andrew Smith
- Department of Medicine and Surgery, Proteomics and Metabolomics Unit, University of Milano-Bicocca, Monza, Italy
| | - Filippo Fraggetta
- Pathology Unit, Azienda Sanitaria Provinciale (ASP) Catania, "Gravina" Hospital, Caltagirone, Italy
| | - Mattia Rossi
- Division of Nephrology, Department of Medicine, University of Verona, Verona, Italy
| | - Giovanni Gambaro
- Division of Nephrology, Department of Medicine, University of Verona, Verona, Italy
| | - Fabio Pagni
- Department of Medicine and Surgery, Pathology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione San Gerardo dei Tintori, University of Milano-Bicocca, Monza, Italy
| | - Vincenzo L'Imperio
- Department of Medicine and Surgery, Pathology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione San Gerardo dei Tintori, University of Milano-Bicocca, Monza, Italy.
| |
Collapse
|
10
|
De Leo S, D'Elia S, Grani G, Dondi F, Bertagna F, Puxeddu E, Morelli S, Piovesan A, Nervo A, Zatelli MC, Gagliardi I, Samà MT, Aimaretti G, Crocetti U, Massa M, Deandrea M, Retta F, Pagano L, Rossi M, Solaroli E, Pezzullo L, Chiofalo MG, Pontecorvi A, Lombardi CP, Antonelli A, Patrizio A, Messuti I, Magri F, Spiazzi G, Ceresini G, Bruno R, Sparano C, Centanni M, Crescenzi A, Tallini G, Marotta V, Madeo B, Mian C, Filetti S, Durante C, Fugazzola L. A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis. Thyroid 2023; 33:1318-1326. [PMID: 37725571 DOI: 10.1089/thy.2023.0052] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 09/21/2023]
Abstract
Background: There is some controversy on the potential relationship between autoimmune processes and clinicopathologic features as well as prognosis of differentiated thyroid cancer (DTC), and the evidence is limited by its largely retrospective nature. We examined the relationship between the presence of autoimmune thyroiditis (AT) and 1-year thyroid cancer treatment outcomes in a large multicenter study using prospectively collected data. Methods: We included data from consecutive DTC patients enrolled in the Italian Thyroid Cancer Observatory (ITCO) database (NCT04031339). We divided the groups according to the presence (AT) or absence (no autoimmune thyroiditis [noAT]) of associated AT. We used propensity score matching to compare the clinical features and outcomes between the two groups at 1-year follow-up. Results: We included data from 4233 DTC patients, including 3172 (75%) females. The American Thyroid Association (ATA) risk levels were as follows: 51% (2160/4233) low risk, 41.3% (1750/4233) intermediate risk, and 7.6% (323/4233) high risk. There were 1552 patients (36.7%) who had AT. Before propensity score matching, AT patients were significantly younger and had a smaller and bilateral tumor (p < 0.0001). Patients with AT more frequently fell into the low- and intermediate-risk categories, while the ATA high risk was more frequent among noAT patients (p = 0.004). After propensity score matching, patients with AT more frequently showed evidence of disease (structural/biochemical incomplete response) versus excellent/indeterminate response, compared with patients without AT (7.3% vs. 4.5%, p = 0.001), with an odds ratio of 1.86 ([confidence interval: 1.3-2.6], p = 0.0001). However, when considering only structural persistence as the outcome, no statistically significant differences were observed between patients with or without AT (3.4% vs. 2.7%, p = 0.35). The elevated risk associated with the ATA intermediate and high risk at diagnosis remained consistently statistically significant. Conclusions: In this large prospective series, biochemical persistence was more frequent, at 1-year follow-up, in AT patients. However, there was no significant association between the presence of AT and structural persistence of disease. These findings may be explained by the presence of a residual thyroid tissue.
Collapse
Affiliation(s)
- Simone De Leo
- Endocrine Oncology Unit, Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy
| | - Silvia D'Elia
- Department of Statistical Sciences and Sapienza University of Rome, Rome, Italy
| | - Giorgio Grani
- Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy
| | - Francesco Dondi
- Nuclear Medicine Department, University of Brescia and ASST-Spedali Civili, Brescia, Italy
| | - Francesco Bertagna
- Nuclear Medicine Department, University of Brescia and ASST-Spedali Civili, Brescia, Italy
| | - Efisio Puxeddu
- Department of Medicine and Surgery, University of Perugia, Perugia, Italy
| | - Silvia Morelli
- Department of Medicine and Surgery, University of Perugia, Perugia, Italy
| | - Alessandro Piovesan
- Oncological Endocrinology Unit, Città della Salute e della Scienza Hospital, Turin, Italy
| | - Alice Nervo
- Oncological Endocrinology Unit, Città della Salute e della Scienza Hospital, Turin, Italy
| | - Maria Chiara Zatelli
- Section of Endocrinology, Geriatrics and Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy
| | - Irene Gagliardi
- Section of Endocrinology, Geriatrics and Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy
| | - Maria Teresa Samà
- Division of Endocrinology, Department of Translational Medicine, University of Piemonte Orientale, Maggiore della Carità University Hospital, Novara, Italy
| | - Gianluca Aimaretti
- Division of Endocrinology, Department of Translational Medicine, University of Piemonte Orientale, Maggiore della Carità University Hospital, Novara, Italy
| | - Umberto Crocetti
- Department of Medical Sciences, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
| | - Michela Massa
- Department of Medical Sciences, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
| | - Maurilio Deandrea
- UO Endocrinologia, Diabetologia e Malattie del metabolismo, AO Ordine Mauriziano Torino, Torino, Italy
| | - Francesca Retta
- UO Endocrinologia, Diabetologia e Malattie del metabolismo, AO Ordine Mauriziano Torino, Torino, Italy
| | - Loredana Pagano
- Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, AOU Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy
| | - Mattia Rossi
- Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, AOU Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy
| | - Erica Solaroli
- Unit of Endocrinology, Department of Medicine, AUSL Bologna, Bologna, Italy
| | - Luciano Pezzullo
- Thyroid Oncological Surgery Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy
| | - Maria Grazia Chiofalo
- Thyroid Oncological Surgery Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy
| | - Alfredo Pontecorvi
- Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore and Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
| | - Celestino Pio Lombardi
- Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore and Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
- Division of Endocrine Surgery, Unicamillus-Saint Camillus International University of Health Sciences, Rome, Italy
| | - Alessandro Antonelli
- Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy
| | - Armando Patrizio
- Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy
| | - Ilaria Messuti
- Department of Endocrinology and Andrology, Humanitas Gradenigo, Turin, Italy
| | - Flavia Magri
- Unit of Internal Medicine and Endocrinology, Department of Internal Medicine and Therapeutics, University of Pavia and Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy
| | - Giovanna Spiazzi
- Endocrinology and Diabetology Unit, Department of Medicine, Azienda Ospedaliera-Universitaria di Verona, Verona, Italy
| | - Graziano Ceresini
- Department of Medicine and Surgery, University Hospital of Parma, Parma, Italy
| | - Rocco Bruno
- Endocrine Unit, Tinchi Hospital-ASM, Matera, Italy
| | - Clotilde Sparano
- Endocrinology Unit, Department of Experimental and Clinical Biomedical Sciences "Mario Serio," University of Florence, Florence, Italy
| | - Marco Centanni
- Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy
- UOC Endocrinologia, AUSL Latina, Latina, Italy
| | - Anna Crescenzi
- Unit of Endocrine Organs and Neuromuscolar Pathology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy
| | - Giovanni Tallini
- Department of Medical and Surgical Sciences (DIMEC), University of Bologna Medical Center, Bologna, Italy
- IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
| | - Vincenzo Marotta
- UOC Clinica Endocrinologica e Diabetologica, AOU San Giovanni di Dio e Ruggi d'Aragona, Salerno, Italy
| | - Bruno Madeo
- Unit of Endocrinology, Department of Medical Specialties, Azienda Ospedaliero-Universitaria Policlinico di Modena, Ospedale Civile di Baggiovara, Modena, Italy
| | - Caterina Mian
- Unit of Endocrinology, Department of Medicine-DIMED, University of Padua, Padua, Italy
| | | | - Cosimo Durante
- Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy
| | - Laura Fugazzola
- Endocrine Oncology Unit, Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy
- Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
| |
Collapse
|
11
|
Wollenberg A, Kinberger M, Arents B, Aszodi N, Barbarot S, Bieber T, Brough HA, Pinton PC, Christen-Zaech S, Deleuran M, Dittmann M, Fosse N, Gáspár K, Gerbens LAA, Gieler U, Girolomoni G, Gregoriou S, Mortz CG, Nast A, Nygaard U, Rehbinder EM, Ring J, Rossi M, Roxburgh C, Serra-Baldrich E, Simon D, Szalai ZZ, Szepietowski JC, Torrelo A, Werfel T, Flohr C. First update of the living European guideline (EuroGuiDerm) on atopic eczema. J Eur Acad Dermatol Venereol 2023; 37:e1283-e1287. [PMID: 37328919 DOI: 10.1111/jdv.19269] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2022] [Accepted: 06/13/2023] [Indexed: 06/18/2023]
Affiliation(s)
- A Wollenberg
- Department of Dermatology and Allergy, LMU Munich, Munich, Germany
- Department of Dermatology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium
| | - M Kinberger
- Division of Evidence-Based Medicine (dEBM), Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - B Arents
- European Federation of Allergy and Airways Diseases Patients' Associations (EFA), Brussels, Belgium
| | - N Aszodi
- Department of Dermatology and Allergy, LMU Munich, Munich, Germany
| | - S Barbarot
- Department of Dermatology, Nantes Université, CHU Nantes, UMR 1280 PhAN, INRAE, Nantes, France
| | - T Bieber
- Department of Dermatology and Allergy, University Hospital of Bonn, Bonn, Germany
| | - H A Brough
- Children's Allergy Service, Evelina London Children's Hospital, Guy's and St. Thomas' NHS Foundation Trust, London, UK
- Department of Women and Children's Health, School of Life Course Sciences, Paediatric Allergy Group, King's College London, London, UK
| | - P C Pinton
- Dermatology Department, University of Brescia, Brescia, Italy
| | | | - M Deleuran
- Department of Dermatology, Aarhus University Hospital and Aarhus University, Aarhus, Denmark
| | - M Dittmann
- Division of Evidence-Based Medicine (dEBM), Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - N Fosse
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
| | - K Gáspár
- Department of Dermatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
| | - L A A Gerbens
- Department of Dermatology, Amsterdam UMC (University Medical Centers), Amsterdam, The Netherlands
| | - U Gieler
- Department of Dermatology, Univ. Giessen, Giessen, Germany
| | - G Girolomoni
- Dermatology and Venereology Section, Department of Medicine, University of Verona, Verona, Italy
| | - S Gregoriou
- Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece
| | - C G Mortz
- Department of Dermatology and Allergy Centre, Odense University Hospital, University of Southern Denmark, Odense, Denmark
| | - A Nast
- Division of Evidence-Based Medicine (dEBM), Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - U Nygaard
- Department of Dermato-Venerology, Aarhus University Hospital, Aarhus, Denmark
| | - E M Rehbinder
- Dermatology Department, Oslo University Hospital, Oslo, Norway
| | - J Ring
- Department of Dermatology Allergology Biederstein, Technical University Munich, Munich, Germany
| | - M Rossi
- Dermatology Department, University of Brescia, Brescia, Italy
| | - C Roxburgh
- Eczema Outreach Support (UK), Linlithgow, UK
| | | | - D Simon
- Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
| | - Z Z Szalai
- Pediatric Dermatology Unit, Heim Pál National Children's Institute Budapest, Budapest, Hungary
| | - J C Szepietowski
- Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland
| | - A Torrelo
- Hospital Infantil Niño Jesús, Madrid, Spain
| | - T Werfel
- Hannover Medical School, Hannover, Germany
| | - C Flohr
- St John's Institute of Dermatology, King's College London, London, UK
- Guy's & St Thomas' NHS Foundation Trust, London, UK
| |
Collapse
|
12
|
Del Prete D, Ferrone G, Riso C, Piersanti A, Antonicelli F, Russo A, Modoni A, Rossi M. Effect of electroacupuncture on brachial plexus post-traumatic neuralgia: A case report. Clin Ter 2023; 174:473-477. [PMID: 38048107 DOI: 10.7417/ct.2023.5011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/05/2023]
Abstract
Background Brachial plexus injury is a serious peripheral nerve injury that severely disables upper limbs and affects patients' daily life and work Acupuncture and Electroacupuncture have traditionally been used to treat neuropathic pain. However, there is still lacking evidence as regard to their effects on pain following traumatic nerve and plexus lesions. Neurotmesis after brachial plexus injury also causes movement disorders of the denervated muscles and loss of sensory function in the skin. Case report We report a case of a brachial plexus injury due to humeral fracture, predominantly involving the lower trunk and the medial cord, treated with electroacupuncture. Results. We documented a positive significant response, based on clinical examination, pain scores and neurophysiologic findings. Conclusions Repeated Electroacupuncture can relieve neuropathic pain due to brachial plexus injury. However, additional studies are needed to verify the efficacy and effectiveness of this approach.
Collapse
Affiliation(s)
- D Del Prete
- Department of Emergency, Intensive Care Medicine and Anesthesia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
| | - G Ferrone
- Department of Emergency, Intensive Care Medicine and Anesthesia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
| | - C Riso
- Department of Emergency, Intensive Care Medicine and Anesthesia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
| | - A Piersanti
- Department of Emergency, Intensive Care Medicine and Anesthesia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
| | - F Antonicelli
- Department of Emergency, Intensive Care Medicine and Anesthesia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
| | - A Russo
- Department of Emergency, Intensive Care Medicine and Anesthesia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
| | - A Modoni
- Insitute of Neurology, Fondazio-ne Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
| | - M Rossi
- Department of Emergency, Intensive Care Medicine and Anesthesia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
- Istituto di Anestesiologia e Rianimazione, Università Cattolica del Sacro Cuore, Rome, Italy
| |
Collapse
|
13
|
Vergari A, Console E, Nestorini R, Frassanito L, Piersanti A, Sbaraglia F, Della Sala F, De Padova D, Ferrone G, Rossi M. PENG block associated with dexmedetomidine sedation for intramedullary femoral fixation in high-risk elderly patients: a case series and review of the literature. Eur Rev Med Pharmacol Sci 2023; 27:10061-10068. [PMID: 37916376 DOI: 10.26355/eurrev_202310_34186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 11/03/2023]
Abstract
BACKGROUND Hip fracture is a major cause of hospitalization among the elderly population. The standard surgical treatment involves early repair to reduce mortality and morbidity. One type of treatment in the case of intertrochanteric and subtrochanteric fractures is intramedullary nailing, as it decreases soft tissue damage and permits early weight bearing. The most common anesthesia technique combines spinal anesthesia with a peripheral block. In cases where spinal anesthesia is contraindicated, general anesthesia is preferred. However, both techniques can lead to significant complications, especially in patients with multiple comorbidities. Pain management after hip surgery, particularly in elderly and frail individuals, poses a challenge. The pericapsular nerve group block (PENG) targets the innervation of the anterior portion of the hip joint and is increasingly used for pain management related to hip surgery. CASE SERIES This paper presents a case series of three elderly patients who underwent pericapsular nerve group block (PENG) block combined with dexmedetomidine sedation for intramedullary femoral fixation. CONCLUSIONS The PENG block can be effectively used as the sole anesthetic technique for managing elderly patients undergoing intramedullary femoral fixation while on antiplatelet drugs. This procedure effectively controlled pain during both the surgical and postoperative periods. The addition of dexmedetomidine for sedation enables comfortable and safe procedures, minimizing the risk of perioperative neurocognitive dysfunctions and without adverse effects on cardiorespiratory function.
Collapse
Affiliation(s)
- A Vergari
- Department of Emergency, Intensive Care Medicine and Anesthesia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Platamone G, Procacci S, Maccioni O, Borromeo I, Rossi M, Bacchetta L, Forni C. Arthrobacter sp. Inoculation Improves Cactus Pear Growth, Quality of Fruits, and Nutraceutical Properties of Cladodes. Curr Microbiol 2023; 80:266. [PMID: 37400738 DOI: 10.1007/s00284-023-03368-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2023] [Accepted: 06/06/2023] [Indexed: 07/05/2023]
Abstract
A study was undertaken to determine the effects of a strain of Arthrobacter sp., a Plant Growth-Promoting Bacteria (PGPB), on plant phenology and qualitative composition of Opuntia ficus-indica (L.) Mill. fruits and cladodes. The strain was inoculated in soil, and its effects on cactus pear plants were detected and compared to nontreated plants. Compared to the latter, the treatment with bacteria promoted an earlier plant sprouting (2 months before the control) and fruitification, ameliorating fruit quality (i.e., improved fresh and dry weight: + 24% and + 26%, respectively, increased total solid content by 30% and polyphenols concentrations by 22%). The quality and quantity of monosaccharides of cladodes were also increased by Arthrobacter sp. with a positive effect on their nutraceutical value. In summer, the mean values of xylose, arabinose, and mannose were significantly higher in treated compared to not treated plants (+ 3.54; + 7.04; + 4.76 mg/kg d.w. respectively). A similar trend was observed in autumn, when the cladodes of inoculated plants had higher contents, i.e., 33% xylose, 65% arabinose, and 40% mannose, respect to the controls. In conclusion, Arthrobacter sp. plays a role in the improvement of nutritional and nutraceutical properties of cactus pear plants due to its capabilities to promote plant growth. Therefore, these results open new perspectives in PGPB application in the agro-farming system as alternative strategy to improve cactus pear growth, yield, and cladodes quality, being the latter the main by-product to be utilized for additional industrial uses.
Collapse
Affiliation(s)
- G Platamone
- PhD School in Evolutionary Biology and Ecology, University of Rome "Tor Vergata", Rome, Italy
- Department of Biology, University of Rome "Tor Vergata", Via della Ricerca Scientifica, Rome, Italy
| | - S Procacci
- Bioproducts and Bioprocesses Laboratory, BIOAG Division, SSPT Department, ENEA Casaccia, Via Anguillarese 301, Rome, Italy
| | - O Maccioni
- Bioproducts and Bioprocesses Laboratory, BIOAG Division, SSPT Department, ENEA Casaccia, Via Anguillarese 301, Rome, Italy
| | - I Borromeo
- PhD School in Evolutionary Biology and Ecology, University of Rome "Tor Vergata", Rome, Italy
- Department of Biology, University of Rome "Tor Vergata", Via della Ricerca Scientifica, Rome, Italy
| | - M Rossi
- Department of Biology, University of Rome "Tor Vergata", Via della Ricerca Scientifica, Rome, Italy
| | - Loretta Bacchetta
- Bioproducts and Bioprocesses Laboratory, BIOAG Division, SSPT Department, ENEA Casaccia, Via Anguillarese 301, Rome, Italy.
| | - C Forni
- Department of Biology, University of Rome "Tor Vergata", Via della Ricerca Scientifica, Rome, Italy
| |
Collapse
|
15
|
Brauneis S, Araimo F, Rossi M, Russo D, Mammucari M, Maggiori E, di Marzo R, Vellucci R, Gori F, Bifarini B, Chiné E, Carpenedo R, Paolucci T, Giorgio C, Ritarossi R, Calò A, Luongo L, Natoli S. The role of mesotherapy in the management of spinal pain. A randomized controlled study. Clin Ter 2023; 174:336-342. [PMID: 37378503 DOI: 10.7417/ct.2023.2447] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/29/2023]
Abstract
Background Mesotherapy is a technique through which active ingredients are administered into the thickness of the skin in order to increase the local analgesic effect. Methods 141 patients with spinal pain not responding to systemic therapy with NSAIDs were randomized to receive one or more intra-cutaneous drugs on a weekly basis. Results All patients achieved a pain reduction of at least 50% compared to baseline, and all tolerated the therapy without having to resort to systemic drug dose increases. Conclusions The data from our study show that the active ingredients infiltrated into the skin induce a mesodermal modulation between the infiltrated liquid and the cutaneous nervous and cellular structures from which the typical drug-saving effect of mesotherapy arises. Although further studies are needed to establish how to integrate mesotherapy in various clinical settings, it appears to be a useful technique available to the practicing physician. This research is also useful in guiding future clinical research.
Collapse
Affiliation(s)
- S Brauneis
- Department of Anesthesiology, Critical Care and Pain Medicine, La Sapienza University of Rome, Rome, Italy
| | - F Araimo
- Department of Anesthesiology, Critical Care and Pain Medicine, La Sapienza University of Rome, Rome, Italy
| | - M Rossi
- Section Of Anesthesia in Specialty Surgeries, Department of Emergency and Internal Medicine, Policlinico Universitario Agostino Gemelli, Sacro Cuore Catholic University, Rome, Italy
| | - D Russo
- San Marco Hospice and Palliative Care, Latina, Italy
| | | | | | - R di Marzo
- San Marco Hospice and Palliative Care, Latina, Italy
| | - R Vellucci
- alliative Care and Pain Therapy Unit - Anesthesiology and Resuscitation Department of Careggi University Hospital, Florence, Italy
| | - F Gori
- Section of Anesthesia, Intensive Care, and Pain Medicine, Santa Maria della Misericordia University Hospital, Perugia, Italy
| | - B Bifarini
- Section of Anesthesia, Intensive Care, and Pain Medicine, Santa Maria della Misericordia University Hospital, Perugia, Italy
| | - E Chiné
- Unit of Pain Therapy, Policlinic of Tor Vergata, Rome, Italy
| | - R Carpenedo
- Unit of Pain Therapy, Policlinic of Tor Vergata, Rome, Italy
| | - T Paolucci
- Department of Medical and Oral Sciences and Biotechnologies (DiSmob), Physical medicine and Rehabilitation unit, G. D'Annunzio University of Chieti-Pescara, Italy
| | - C Giorgio
- Rehabilitation Unit, F. Pirinei Hospital, Altamura, BA, Italy
| | - R Ritarossi
- Department of Anesthesiology, Critical Care and Pain Medicine, La Sapienza University of Rome, Rome, Italy
| | - A Calò
- Department of Anesthesiology, Critical Care and Pain Medicine, La Sapienza University of Rome, Rome, Italy
| | - L Luongo
- Department of experimental medicine, division of pharmacology, universita della Campania "L. Vanvitelli" Naples, Italy
| | - S Natoli
- Dept. of Clinical Science and Translational Medicine. University of Rome Tor Vergata, Italy
| |
Collapse
|
16
|
Minhas R, Shekhda K, Palan M, Anthony K, Vogazianou A, Rossi M. RHABDOMYOLYSIS SECONDARY TO RAPID CORRECTION OF HYPONATREMIA IN A PATIENT WITH PSYHCOGENIC POLYDIPSIA. Acta Endocrinol (Buchar) 2023; 19:345-348. [PMID: 38356977 PMCID: PMC10863958 DOI: 10.4183/aeb.2023.345] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/16/2024]
Abstract
Patients with chronic schizophrenia and psychosis are more prone to develop hyponatremia. Hyponatremia could be due to medications e.g. antidepressants/antipsychotics or secondary to psychogenic polydipsia. They often present with altered consciousness, seizures and falls. Rapid correction of hyponatremia in patients with psychogenic polydipsia has been associated to cause rhabdomyolysis, an under-recognized yet serious condition which if left untreated can result in various complications e.g. acute kidney injury, electrolyte abnormalities. We report a case of young patient who had background illness of schizophrenia and presented to department with severe hyponatremia secondary to psychogenic polydipsia and was eventually diagnosed as case of rhabdomyolysis due to rapid correction of hyponatremia. Objective of case report is to highlight the correct diagnosis of underlying cause of hyponatremia and challenges associated with managing rhabdomyolysis with IV fluids that can result in worsening of hyponatremia, hence emphasizing the importance of close monitoring of sodium levels and measurement of creatine kinase in any patient who presents with severe hyponatremia, particularly in the presence of other risk factors for rhabdomyolysis and consideration of careful fluid administration strategies in relation to the relative onset and risk of over-correcting hyponatremia.
Collapse
Affiliation(s)
- R. Minhas
- Whittington Hospital - Diabetes Endocrinology, London
| | - K.M. Shekhda
- Whittington Hospital, London, United Kingdom of Great Britain and Northern Ireland
| | - M. Palan
- Whittington Hospital, London, United Kingdom of Great Britain and Northern Ireland
| | - K. Anthony
- Whittington Hospital, London, United Kingdom of Great Britain and Northern Ireland
| | - A. Vogazianou
- Whittington Hospital, London, United Kingdom of Great Britain and Northern Ireland
| | - M. Rossi
- Whittington Hospital, London, United Kingdom of Great Britain and Northern Ireland
| |
Collapse
|
17
|
Cimini A, Imperi E, Picano A, Rossi M. Electrospun nanofibers for medical face mask with protection capabilities against viruses: State of the art and perspective for industrial scale-up. Appl Mater Today 2023; 32:101833. [PMID: 37152683 PMCID: PMC10151159 DOI: 10.1016/j.apmt.2023.101833] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 12/16/2022] [Revised: 04/13/2023] [Accepted: 04/25/2023] [Indexed: 05/09/2023]
Abstract
Face masks have proven to be a useful protection from airborne viruses and bacteria, especially in the recent years pandemic outbreak when they effectively lowered the risk of infection from Coronavirus disease (COVID-19) or Omicron variants, being recognized as one of the main protective measures adopted by the World Health Organization (WHO). The need for improving the filtering efficiency performance to prevent penetration of fine particulate matter (PM), which can be potential bacteria or virus carriers, has led the research into developing new methods and techniques for face mask fabrication. In this perspective, Electrospinning has shown to be the most efficient technique to get either synthetic or natural polymers-based fibers with size down to the nanoscale providing remarkable performance in terms of both particle filtration and breathability. The aim of this Review is to give further insight into the implementation of electrospun nanofibers for the realization of the next generation of face masks, with functionalized membranes via addiction of active material to the polymer solutions that can give optimal features about antibacterial, antiviral, self-sterilization, and electrical energy storage capabilities. Furthermore, the recent advances regarding the use of renewable materials and green solvent strategies to improve the sustainability of electrospun membranes and to fabricate eco-friendly filters are here discussed, especially in view of the large-scale nanofiber production where traditional membrane manufacturing may result in a high environmental and health risk.
Collapse
Affiliation(s)
- A Cimini
- Department of Basic and Applied Sciences for Engineering, University of Rome Sapienza, Rome 00161, Italy
- LABOR s.r.l., Industrial Research Laboratory, Via Giacomo Peroni, 386, Rome, Italy
| | - E Imperi
- LABOR s.r.l., Industrial Research Laboratory, Via Giacomo Peroni, 386, Rome, Italy
| | - A Picano
- LABOR s.r.l., Industrial Research Laboratory, Via Giacomo Peroni, 386, Rome, Italy
| | - M Rossi
- Department of Basic and Applied Sciences for Engineering, University of Rome Sapienza, Rome 00161, Italy
- Research Center for Nanotechnology for Engineering of Sapienza (CNIS), University of Rome Sapienza, Rome 00185, Italy
| |
Collapse
|
18
|
Rossi M, Pessolano G, Gambaro G. What has vaccination against COVID-19 in CKD patients taught us? J Nephrol 2023:10.1007/s40620-023-01640-w. [PMID: 37140817 PMCID: PMC10157569 DOI: 10.1007/s40620-023-01640-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/03/2023] [Indexed: 05/05/2023]
Abstract
Effective vaccination strategies are of crucial importance to protecting patients who are vulnerable to infections, such as patients with chronic kidney disease. This is because the decreased efficiency of the immune system in chronic kidney disease impairs vaccine-induced immunisation. COVID-19 has prompted investigation of the immune response to SARS-CoV-2 vaccines in chronic kidney disease and in kidney transplant recipients in an effort to improve efficacy. The seroconversion rate after two vaccine doses is reduced, especially in kidney transplant recipients. Furthermore, although the seroconversion rate in chronic kidney disease patients is as high as in healthy subjects, anti-spike antibody titres are lower than in healthy vaccinated individuals, and these titres decrease rapidly. Although the vaccine-induced anti-spike antibody titre correlates with neutralising antibody levels and with protection against COVID-19, the protective prognostic significance of their titre is decreased due to the emergence of SARS-CoV-2 variants other than the Wuhan index virus against which the original vaccines were produced. Cellular immunity is also relevant, and because of cross-reactivity to the spike protein, epitopes of different viral variants confer protection against newly emerging variants of SARS-CoV-2. A multi-dose vaccination strategy is the most effective way to obtain a sufficient serological response. In kidney transplant recipients, a 5-week discontinuation period from antimetabolite drugs in concomitance with vaccine administration may also increase the vaccine's efficacy. The newly acquired knowledge obtained from COVID-19 vaccination is of general interest for the success of other vaccinations in chronic kidney disease patients.
Collapse
Affiliation(s)
- Mattia Rossi
- Division of Nephrology, Department of Medicine, University of Verona, Piazzale A. Stefani 1, 37126, Verona, Italy.
| | - Giuseppina Pessolano
- Division of Nephrology, Department of Medicine, University of Verona, Piazzale A. Stefani 1, 37126, Verona, Italy
| | - Giovanni Gambaro
- Division of Nephrology, Department of Medicine, University of Verona, Piazzale A. Stefani 1, 37126, Verona, Italy
| |
Collapse
|
19
|
Rossi M, Tritapepe L, Conigliaro R, Fanti L, Monzani R, De Robertis E, Martino R, Pietrini L, Sbaraglia F, Pasquale L, Petrini F. Rethink analgo-sedation in digestive endoscopy: the role of scientific societies in tracing training path. Eur Rev Med Pharmacol Sci 2023; 27:4670-4677. [PMID: 37259750 DOI: 10.26355/eurrev_202305_32478] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
OBJECTIVE The Italian Society of Anesthesia, Analgesia, Reanimation and Intensive Care Medicine (SIAARTI) and the Italian Society of Digestive Endoscopy (SIED) worked together to produce a joint Good Clinical Practice (GCP) on analgo-sedation in digestive endoscopy and launched a survey to support the document. The aim was to identify and describe the actual clinical practice of sedation in Italian digestive endoscopy units and offer material for a wider and more widespread discussion among anesthetists and endoscopists. SUBJECTS AND METHODS A national survey was planned, in order to support the statements of the GCP. Twelve thousand and five hundred questionnaires were sent to the members of SIAARTI and SIED in June 2020. RESULTS A total of 662 forms (5.3%) returned completed. Highly complex procedures are performed according to 70% of respondents; daily anesthesiologist's assistance is guaranteed in 26%, for scheduled sessions in 14.5% and as needed in 8%. 69% of respondents declared not to have a dedicated team of anesthesiologists, while just 5% reported an anesthesiologist in charge. A complete monitoring system was assured by 70% of respondents. Dedicated pathways for COVID-19-positive patients were confirmed in <40% of the answers. With regard to moderate/deep sedation, 90% of respondents stated that an anesthetist decides timing and doses. Propofol was exclusively administered by anesthetists according to 94% of answers, and for 6% of respondents the endoscopist is allowed to administer propofol in presence of a dedicated nurse, but with a readily available anesthetist. Only 32.8% of respondents reported institutional training courses on procedural analgo-sedation. CONCLUSIONS The need to provide patients scheduled for endoscopy procedures with an adequate analgo-sedation is becoming an increasing concern, well-known in almost all countries, but many factors compromise the quality of patient care. Results of a national survey would give strength to the need for a shared GCP in gastrointestinal endoscopy. Training and certification of non-anesthetist professionals should be one of the main ways to center the objective.
Collapse
Affiliation(s)
- M Rossi
- Department of Anesthesia and Intensive Care, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Rossi M, Mele C, Rossetto Giaccherino R, Meomartino L, Brero D, Marsan G, Aimaretti G, Ghigo E, Pagano L. Post-Surgical Indications to Radioiodine Treatment and Potential Risk Factors for Post-Treatment Recurrence in Patients with Intermediate-Risk Differentiated Thyroid Carcinoma. J Pers Med 2023; 13:jpm13050775. [PMID: 37240945 DOI: 10.3390/jpm13050775] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2023] [Revised: 04/20/2023] [Accepted: 04/28/2023] [Indexed: 05/28/2023] Open
Abstract
In this multicentric retrospective observational study, we investigated the potential risk factors for radioiodine (RAI) indication and the post-treatment recurrence of intermediate-risk differentiated thyroid cancer (DTC) 1 and 3 years from diagnosis. We included 121 patients who underwent thyroidectomy for intermediate-risk DTC. The 92 patients (76.0%) who underwent RAI treatment had a higher prevalence of extra-thyroid micro-extension (mETE) (p = 0.03), pT3 staging (p = 0.03) and recourse to therapeutic central (p = 0.04) and lateral (p = 0.01) neck dissection, as well as higher numbers (p = 0.02) and greater dimensions (p = 0.01) of lymph node metastases, compared with untreated patients. Relapse was observed in 18.1% and 20.7% of cases 1 and 3 years from diagnosis, respectively, with no significant differences between groups. A lower age at diagnosis (p = 0.03) and higher levels of stimulated thyroglobulin (Tg) (p = 0.04) emerged as the only independent risk factors for tumour relapse at 1 year. Tumour relapse at 3 years was only independently predicted by the presence of tumour relapse at 1 year (p = 0.04). In conclusion, mETE, pT3 and the presence of large, multiple or clinically evident lymph node metastases represent the main indicators for referring patients to RAI treatment. Early recurrence may be considered the most relevant factor when planning further surveillance.
Collapse
Affiliation(s)
- Mattia Rossi
- Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University of Turin, 10126 Turin, Italy
| | - Chiara Mele
- Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale, 28100 Novara, Italy
| | - Ruth Rossetto Giaccherino
- Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University of Turin, 10126 Turin, Italy
| | - Letizia Meomartino
- Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University of Turin, 10126 Turin, Italy
| | - Denise Brero
- Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University of Turin, 10126 Turin, Italy
| | - Giulia Marsan
- Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale, 28100 Novara, Italy
| | - Gianluca Aimaretti
- Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale, 28100 Novara, Italy
| | - Ezio Ghigo
- Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University of Turin, 10126 Turin, Italy
| | - Loredana Pagano
- Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University of Turin, 10126 Turin, Italy
| |
Collapse
|
21
|
Behera S, Belyeu JR, Chen X, Paulin LF, Nguyen NQH, Newman E, Mahmoud M, Menon VK, Qi Q, Joshi P, Marcovina S, Rossi M, Roller E, Han J, Onuchic V, Avery CL, Ballantyne CM, Rodriguez CJ, Kaplan RC, Muzny DM, Metcalf GA, Gibbs R, Yu B, Boerwinkle E, Eberle MA, Sedlazeck FJ. Identification of allele-specific KIV-2 repeats and impact on Lp(a) measurements for cardiovascular disease risk. bioRxiv 2023:2023.04.24.538128. [PMID: 37163057 PMCID: PMC10168217 DOI: 10.1101/2023.04.24.538128] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/11/2023]
Abstract
The abundance of Lp(a) protein holds significant implications for the risk of cardiovascular disease (CVD), which is directly impacted by the copy number (CN) of KIV-2, a 5.5 kbp sub-region. KIV-2 is highly polymorphic in the population and accurate analysis is challenging. In this study, we present the DRAGEN KIV-2 CN caller, which utilizes short reads. Data across 166 WGS show that the caller has high accuracy, compared to optical mapping and can further phase ~50% of the samples. We compared KIV-2 CN numbers to 24 previously postulated KIV-2 relevant SNVs, revealing that many are ineffective predictors of KIV-2 copy number. Population studies, including USA-based cohorts, showed distinct KIV-2 CN, distributions for European-, African-, and Hispanic-American populations and further underscored the limitations of SNV predictors. We demonstrate that the CN estimates correlate significantly with the available Lp(a) protein levels and that phasing is highly important.
Collapse
Affiliation(s)
- S Behera
- Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA
| | | | - X Chen
- Illumina Inc., San Diego, CA, USA
| | - L F Paulin
- Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA
| | - N Q H Nguyen
- School of Public Health, University of Texas Health Science Center at Houston, TX, USA
| | - E Newman
- Illumina Inc., San Diego, CA, USA
| | - M Mahmoud
- Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA
| | - V K Menon
- Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA
| | - Q Qi
- Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA
| | - P Joshi
- Medpace Reference Laboratories, Cincinnati, OH, USA
| | - S Marcovina
- University of Texas Southwestern Medical Center, Dallas, TX, USA
| | - M Rossi
- Illumina Inc., San Diego, CA, USA
| | - E Roller
- Illumina Inc., San Diego, CA, USA
| | - J Han
- Illumina Inc., San Diego, CA, USA
| | | | - C L Avery
- Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
| | - C M Ballantyne
- Department of Medicine, Baylor College of Medicine, Houston, TX, USA
| | - C J Rodriguez
- Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA
| | - R C Kaplan
- Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA
- Fred Hutchinson Cancer Center, Public Health Sciences Division, Seattle WA 98109
| | - D M Muzny
- Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA
| | - G A Metcalf
- Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA
| | - R Gibbs
- Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA
| | - B Yu
- School of Public Health, University of Texas Health Science Center at Houston, TX, USA
| | - E Boerwinkle
- Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA
- School of Public Health, University of Texas Health Science Center at Houston, TX, USA
| | | | - F J Sedlazeck
- Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA
- Department of Computer Science, Rice University, 6100 Main Street, Houston, TX, USA
| |
Collapse
|
22
|
Wu H, L'Imperio V, Rossi M, Kapp ME, Paueksakon P. Differences between κ and λ light chain amyloidosis analyzed by a pathologic scoring system. Am J Clin Pathol 2023:7080499. [PMID: 36933186 DOI: 10.1093/ajcp/aqad017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2022] [Accepted: 01/29/2023] [Indexed: 03/19/2023] Open
Abstract
OBJECTIVES Amyloid light chain (AL)-κ and AL-λ share common histopathologic changes; however, the potential difference in clinical manifestations, histologic findings, and clinical significance between the 2 subtypes remain unclear. METHODS In a retrospective study, 94 kidney biopsies for AL amyloidosis were evaluated using the composite scarring injury score (CSIS) and amyloid score (AS). Results were then compared between AL-κ and AL-λ. RESULTS Comparing AS and CSIS between AL-κ and AL-λ, the AS was significantly higher in AL-κ than in AL-λ, with 2 components of AS (capillary wall and vascular amyloid) scoring higher in AL-κ than in AL-λ, while mesangial and interstitial ASs were similar in the 2 cohorts. In addition, the proportion of periodic acid-Schiff strong-staining amyloid in AL-κ was markedly higher than in AL-λ. There was no significant difference in CSIS and its components between the 2 subtypes of AL amyloidosis. CONCLUSIONS Overall, AL-κ presents with higher serum creatinine and a higher AS score than AL-λ at biopsy, which may indicate a worse prognosis and be an important reference for clinical management.
Collapse
Affiliation(s)
- Huijuan Wu
- Department of Pathology, School of Basic Medical Sciences, Fudan University, Shanghai, China
| | - Vincenzo L'Imperio
- Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy
| | - Mattia Rossi
- Department of Medicine, Renal Unit, University and Hospital of Verona Piazzale Stefani, Verona, Italy
| | - Meghan E Kapp
- Department of Pathology, Case Western Reserve University School of Medicine and University Hospitals, Cleveland, OH, US
| | - Paisit Paueksakon
- Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, US
| |
Collapse
|
23
|
Paez-Maggio M, Rossi M, Martinez V, Wainberg F, Merello M. Life events and the onset of motor symptoms in Parkinson's disease. Parkinsonism Relat Disord 2023; 107:105283. [PMID: 36638549 DOI: 10.1016/j.parkreldis.2023.105283] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/08/2022] [Revised: 12/29/2022] [Accepted: 01/08/2023] [Indexed: 01/11/2023]
Abstract
BACKGROUND Whether there may be any relationship between stressful or traumatic life events (LE) and the subsequent motor symptoms onset in Parkinson's disease (PD) is still controversial. OBJECTIVES To explore whether a subjectively perceived as stressful or traumatic LE were more frequently present in a group of recent motor onset parkinsonian patients (Recent Onset Parkinsonism - ROP) compared with healthy controls (HC) and a group of patients already diagnosed as PD. METHODS A consecutive series of 139 ROP patients, 138 matched PD patients and 138 HC were pooled through a validated LE exposure questionnaire evaluating the number of patients affected by LE and the amount of LE per group occurred in the last year, segregating by subjective severity in total and severe LE. RESULTS There was no significant difference in the percentage of patients affected by total (p = 0.134) nor by severe (p = 0.133) LE within the 3 groups. No significant difference was observed in the number of total LE between ROP and HC (p = 0.063), ROP and PD (p = 0.688), nor in severe LE (ROP vs. HC, p = 0.637. ROP vs. PD, p = 0.500). CONCLUSIONS During the year of parkinsonian motor symptoms onset, the number of ROP patients exposed to total or severe LE or the amount of total or severe LE suffered by ROP were not significantly different to the group of PD patients or HC. A casual relationship between LE and the onset of motor symptoms in parkinsonian patients may be suggested.
Collapse
Affiliation(s)
- M Paez-Maggio
- Movement Disorders Service, Neuroscience Department, Institute for Neurological Research Raúl Carrea (FLENI), Buenos Aires, Argentina
| | - M Rossi
- Movement Disorders Service, Neuroscience Department, Institute for Neurological Research Raúl Carrea (FLENI), Buenos Aires, Argentina; National Research Council (CONICET), Buenos Aires, Argentina
| | - V Martinez
- Movement Disorders Service, Neuroscience Department, Institute for Neurological Research Raúl Carrea (FLENI), Buenos Aires, Argentina
| | - F Wainberg
- Movement Disorders Service, Neuroscience Department, Institute for Neurological Research Raúl Carrea (FLENI), Buenos Aires, Argentina
| | - M Merello
- Movement Disorders Service, Neuroscience Department, Institute for Neurological Research Raúl Carrea (FLENI), Buenos Aires, Argentina; National Research Council (CONICET), Buenos Aires, Argentina.
| |
Collapse
|
24
|
Egalini F, Marinelli L, Rossi M, Motta G, Prencipe N, Rossetto Giaccherino R, Pagano L, Grottoli S, Giordano R. Endocrine disrupting chemicals: effects on pituitary, thyroid and adrenal glands. Endocrine 2022; 78:395-405. [PMID: 35604630 PMCID: PMC9637063 DOI: 10.1007/s12020-022-03076-x] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/16/2022] [Accepted: 05/08/2022] [Indexed: 11/28/2022]
Abstract
BACKGROUND In recent years, scientific research has increasingly focused on Endocrine Disrupting Chemicals (EDCs) and demonstrated their relevant role in the functional impairment of endocrine glands. This induced regulatory authorities to ban some of these compounds and to carefully investigate others in order to prevent EDCs-related conditions. As a result, we witnessed a growing awareness and interest on this topic. AIMS This paper aims to summarize current evidence regarding the detrimental effects of EDCs on pivotal endocrine glands like pituitary, thyroid and adrenal ones. Particularly, we directed our attention on the known and the hypothesized mechanisms of endocrine dysfunction brought by EDCs. We also gave a glimpse on recent findings from pioneering studies that could in the future shed a light on the pathophysiology of well-known, but poorly understood, endocrine diseases like hormone-producing adenomas. CONCLUSIONS Although intriguing, studies on endocrine dysfunctions brought by EDCs are challenging, in particular when investigating long-term effects of EDCs on humans. However, undoubtedly, it represents a new intriguing field of science research.
Collapse
Affiliation(s)
- Filippo Egalini
- Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126, Turin, Italy.
| | - Lorenzo Marinelli
- Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126, Turin, Italy
| | - Mattia Rossi
- Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126, Turin, Italy
| | - Giovanna Motta
- Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126, Turin, Italy
| | - Nunzia Prencipe
- Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126, Turin, Italy
| | - Ruth Rossetto Giaccherino
- Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126, Turin, Italy
| | - Loredana Pagano
- Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126, Turin, Italy
| | - Silvia Grottoli
- Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126, Turin, Italy
| | - Roberta Giordano
- Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126, Turin, Italy
- Department of Biological and Clinical Science, University of Turin, Regione Gonzole 10, 10043, Orbassano (TO), Italy
| |
Collapse
|
25
|
Rossi M, Giannini C, Gangemi C, Gambaro G. ["New antigens" in membranous glomerulonephritis: let's take a closer look]. G Ital Nefrol 2022; 39:39-05-2022-02. [PMID: 36563071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
Membranous Nephropathy (MN) is characterized by the presence of subepithelial deposits. MN has been traditionally classified as primary if it is not associated with other pathologies, or secondary if it is associated with autoimmune diseases, infections or malignancies. The identification of target podocyte antigen was a critical point in the understanding of the disease: firstly in 2009 with M-type phospholipase A2 receptor (PLA2R) and then in 2014 with Thrombospondin Type 1 Domain Containing 7A (THSD7A). In the last years using an innovative approach based on laser microdissection and tandem mass spectrometry (MS/MS) has allowed the identification of new target antigen/protein as EXT1/2, NELL-1, NCAM1, SEMA3B, PCHD7, HTRA1, TGFBR3. Some of these proteins have been found in both primary and secondary MN, blurring the line between the two forms. Further studies are necessary to define and understand the clinical features of different antigen associated diseases. The aim of this review is to take a closer look at the new antigens and to evaluate how their discovery can change MN classification.
Collapse
Affiliation(s)
- Mattia Rossi
- Divisione di Nefrologia, Dipartimento di Medicina, Università di Verona, Verona
| | - Carolina Giannini
- Divisione di Nefrologia, Dipartimento di Medicina, Università di Verona, Verona
| | - Concetta Gangemi
- Divisione di Nefrologia, Dipartimento di Medicina, Università di Verona, Verona
| | - Giovanni Gambaro
- Divisione di Nefrologia, Dipartimento di Medicina, Università di Verona, Verona
| |
Collapse
|
26
|
Agodi A, Rapisarda V, Bonfanti P, Rossi M, De Gaetano Donati K, Murri R, Barchitta M. European studies to evaluate COVID-19 vaccine effectiveness in HCWs: results from Italian hospitals. Eur J Public Health 2022. [PMCID: PMC9619887 DOI: 10.1093/eurpub/ckac130.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
Abstract
Background Evaluating COVID-19 vaccine coverage and risk factors is useful to develop public health strategies against COVID-19 pandemic. In the framework of two studies commissioned by the European Centre for Disease Prevention and Control (ECDC) and coordinated by Epiconcept, France, we reported findings about incidence and seroprevalence among healthcare workers (HCWs) enrolled from three Italian hospitals. Methods From July 2021 to date, the AOUP “G. Rodolico-San Marco” (Catania), the San Gerardo Hospital (Monza) and the Policlinico Gemelli (Rome) participated in the ECDC study to measure COVID-19 vaccine effectiveness. Catania and Rome also participated to the ECDC study of nosocomial transmission. HCWs were asked to complete a weekly questionnaire to report changes in health status and professional/personal exposures. At recruitment, a nasopharyngeal swab for RT-PCR and a blood sample for serology test were collected. Moreover, HCWs were followed-up with a weekly or bimonthly nasopharyngeal or saliva swabs. Blood samples were collected every one or two months. Results A total of 226 HCWs was enrolled from Catania, 330 from Rome and 132 from Monza in the COVID-19 vaccine effectiveness study. As of February 2022, PCR tests performed were 2270 in Catania, 5475 in Rome and 891 in Monza sites. Moreover, the serological tests performed were 845 in Catania, 760 in Rome and 395 in Monza sites. A total of 6 SARS-CoV-2 infections were identified in Catania, 34 in Rome and 4 in Monza sites. Interestingly, the study of nosocomial transmission reported the highest incidence rate in Catania (4 per 10,000 person-day), while 0.7 per 10,000 person-day in Rome. During the study period seroprevalence declined by 17% among HWCs enrolled in Catania. Conclusions Our findings revealed low number of COVID-19 infections, with high COVID-19 vaccine coverage among HCWs. However, further analyses are needed to provide more robust estimates of vaccine effectiveness. Key messages
Collapse
Affiliation(s)
- A Agodi
- AOU Policlinico G. Rodolico - San Marco, University of Catania , Catania, Italy
- University of Catania , Catania, Italy
| | - V Rapisarda
- Department MEDCLIN, University of Catania , Catania, Italy
| | - P Bonfanti
- San Gerardo Hospital, Hospital , Monza, Italy
- University of Milano-Bicocca, University , Milan, Italy
| | - M Rossi
- San Gerardo Hospital, Hospital , Monza, Italy
| | | | - R Murri
- Fondazione PU Agostino Gemelli, IRCCS , Rome, Italy
| | | |
Collapse
|
27
|
Sbarigia C, Tacconi S, Mura F, Rossi M, Dinarelli S, Dini L. High-resolution atomic force microscopy as a tool for topographical mapping of surface budding. Front Cell Dev Biol 2022; 10:975919. [PMID: 36313576 PMCID: PMC9597496 DOI: 10.3389/fcell.2022.975919] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2022] [Accepted: 09/26/2022] [Indexed: 11/21/2022] Open
Abstract
Extracellular vesicles (EVs) are membranous nanoparticles secreted by almost all cell types. Reflecting the physiopathological state of the parental cell, EVs circulate in all body fluids, reaching distant cell targets and delivering different bioactive cargoes. As biological carriers, EVs influence their microenvironment altering cellular responses, being considered promising biomarkers for both physiological and pathological conditions. EVs are heterogeneous in terms of size and composition, depending on cell type and exposure to stimuli, and different methods have been developed to characterize their morphological, biophysical, and biochemical features. Among them, electron microscopy (EM) is the main technique used, however, the lack of standardized protocols makes it difficult to characterize EVs with a good reproducibility, thus using multiple approaches may represent a way to obtain more precise information. Furthermore, the relationship between architecture and function, not only in a molecular, but also in a cellular level, is gaining growing emphasis, characterizing morphometric parameters may represent a distinct, but effective approach to study the physiopathological state of the cell. Atomic force microscopy (AFM), may represent a promising method to study in detail EVs dynamics throughout the cell surface and its variations related to the physiological state, overcoming the limits of EM, and providing more reliable information. In this study, human neuroblastoma SH-SY5Y cell line, a cellular model to investigate neurodegeneration and oxidative stress, has been used to perform a comparative morphological and quantitative analysis of membrane budding and isolated large vesicles-enriched (microvesicles-like vesicles; MVs) fraction from control or oxidative stressed cells. Our main goal was to build up a methodology to characterize EVs morphology and spatial distribution over the cell surface in different physiological conditions, and to evaluate the efficacy of AFM against conventional EM. Interestingly, both microscopy techniques were effective for this analysis, but AFM allowed to reveal a differential profiling of plasma membrane budding between the physiological and the stress condition, indicating a potential relationship between mechanical characteristics and functional role. The results obtained may provide interesting perspectives for the use of AFM to study EVs, validating a morphometric approach to understand the pathophysiological state of the cell related to EVs trafficking.
Collapse
Affiliation(s)
- C. Sbarigia
- Department of Biology and Biotechnology “C. Darwin”, University of Rome Sapienza, Rome, Italy
| | - S. Tacconi
- Department of Biology and Biotechnology “C. Darwin”, University of Rome Sapienza, Rome, Italy
| | - F. Mura
- Research Center for Nanotechnology for Engineering of Sapienza (CNIS), University of Rome Sapienza, Rome, Italy
| | - M. Rossi
- Research Center for Nanotechnology for Engineering of Sapienza (CNIS), University of Rome Sapienza, Rome, Italy
- Department of Basic and Applied Sciences for Engineering, University of Rome Sapienza, Rome, Italy
| | - S. Dinarelli
- Institute for the Structure of Matter (ISM), National Research Council (CNR) Rome, Rome, Italy
| | - L. Dini
- Department of Biology and Biotechnology “C. Darwin”, University of Rome Sapienza, Rome, Italy
- Research Center for Nanotechnology for Engineering of Sapienza (CNIS), University of Rome Sapienza, Rome, Italy
- CNR Nanotec, Lecce, Italy
- *Correspondence: L. Dini,
| |
Collapse
|
28
|
Porcari A, Rossi M, Cappelli F, Canepa M, Musumeci B, Cipriani A, Tini G, Varra' GG, Argiro' A, Sessarego E, Sinigiani G, Di Bella G, Rapezzi C, Sinagra G, Merlo M. Incidence and risk factors for pacemaker implantation in light chain and transthyretin cardiac amyloidosis. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1771] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
The incidence and risk factors of pacemaker (PM) implantation in patients with cardiac amyloidosis (CA) are largely unexplored.
Purpose
We sought to characterise the trends in the incidence of permanent PM and to identify baseline predictors of future PM implantation in light chain (AL) and transthyretin (ATTR) CA.
Methods
Multicentre, retrospective, observational study. Consecutive patients with AL and ATTR-CA diagnosed or referred at participating Centres between 2017 and 2020 were included. Clinical data recorded within ± 1 month from baseline evaluation were collected from electronic medical records. The primary outcome of the study was the need for clinically-indicated PM implantation. Reversible causes of conduction system disease were systematically ruled out before PM implantation. Patients with PM (n=41) and/or permanent defibrillator in situ (n=13) at the time of CA diagnosis were excluded.
Results
The study population consisted of 405 patients: 29.4% AL, 14.6% variant ATTR and 56% wild-type ATTR; 82.5% were males, with median age 76 years. During a median follow-up of 33 months (interquartile range 21–46), 36 (8.9%) patients experienced the primary outcome: 10 patients with AL-CA, 2 with variant ATTR-CA and 24 with wild-type ATTR-CA (p=0.08). At multivariable analysis, history of atrial fibrillation (hazard ratio [HR] 3.80, p=0.002), PR interval (HR 1.013, p=0.002) and QRS >120 ms (HR 4.7, p=0.001) on baseline ECG were independently associated with PM implantation (Figure 1). In the individual patient, the contemporary presence of these 3 factors yielded the highest risk of PM implantation (HR 6.26, p=0.003).
Conclusion
In a large cohort of AL and ATTR-CA, the incidence of PM implantation was high accounting for ≈9% of patients in the 3 years following the diagnosis. History of atrial fibrillation, longer PR interval and QRS >120 ms identified CA patients at high-risk of future PM implantation (Figure 2).
CA patients with these features might need close monitoring during follow-up for the development of conduction system disease requiring PM implantation.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- A Porcari
- Giuliano Isontina University Health Authority, Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department , Trieste , Italy
| | - M Rossi
- Giuliano Isontina University Health Authority, Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department , Trieste , Italy
| | - F Cappelli
- Careggi University Hospital, Cardiomyopathy Unit , Florence , Italy
| | - M Canepa
- Ospedale Policlinico San Martino IRCCS, Cardiovascular Unit, Department of Internal Medicine , Genoa , Italy
| | - B Musumeci
- Sapienza University of Rome, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology , Rome , Italy
| | - A Cipriani
- University of Padova, Department of Cardiac, Thoracic and Vascular Sciences and Public Health , Padua , Italy
| | - G Tini
- Sapienza University of Rome, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology , Rome , Italy
| | - G G Varra'
- Giuliano Isontina University Health Authority, Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department , Trieste , Italy
| | - A Argiro'
- Careggi University Hospital, Cardiomyopathy Unit , Florence , Italy
| | - E Sessarego
- Ospedale Policlinico San Martino IRCCS, Cardiovascular Unit, Department of Internal Medicine , Genoa , Italy
| | - G Sinigiani
- University of Padova, Department of Cardiac, Thoracic and Vascular Sciences and Public Health , Padua , Italy
| | - G Di Bella
- University of Messina, Department of Cardiology , Messina , Italy
| | - C Rapezzi
- University of Ferrara, Cardiothoracic Department , Ferrara , Italy
| | - G Sinagra
- Giuliano Isontina University Health Authority, Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department , Trieste , Italy
| | - M Merlo
- Giuliano Isontina University Health Authority, Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department , Trieste , Italy
| |
Collapse
|
29
|
Lore N, Di Marco F, Saliu F, Spitaleri A, Nicola F, Rossi M, Cariani L, Cirillo D. 513 Unravelling the pathogenicity of Mycobacterium abscessus clinical isolates in cystic fibrosis pulmonary epithelial cell and mouse models of respiratory infection. J Cyst Fibros 2022. [DOI: 10.1016/s1569-1993(22)01203-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
30
|
Scalera I, De Carlis R, Patrono D, Gringeri E, Olivieri T, Pagano D, Lai Q, Rossi M, Gruttadauria S, Di Benedetto F, Cillo U, Romagnoli R, Lupo LG, De Carlis L. How useful is the machine perfusion in liver transplantation? An answer from a national survey. Front Surg 2022; 9:975150. [PMID: 36211259 PMCID: PMC9535084 DOI: 10.3389/fsurg.2022.975150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2022] [Accepted: 08/29/2022] [Indexed: 11/13/2022] Open
Abstract
Machine perfusion (MP) has been shown worldwide to offer many advantages in liver transplantation, but it still has some gray areas. The purpose of the study is to evaluate the donor risk factors of grafts, perfused with any MP, that might predict an ineffective MP setting and those would trigger post-transplant early allograft dysfunction (EAD). Data from donors of all MP-perfused grafts at six liver transplant centers have been analyzed, whether implanted or discarded after perfusion. The first endpoint was the negative events after perfusion (NegE), which is the number of grafts discarded plus those that were implanted but lost after the transplant. A risk factor analysis for NegE was performed and marginal grafts for MP were identified. Finally, the risk of EAD was analyzed, considering only implanted grafts. From 2015 to September 2019, 158 grafts were perfused with MP: 151 grafts were implanted and 7 were discarded after the MP phase because they did not reach viability criteria. Of 151, 15 grafts were lost after transplant, so the NegE group consisted of 22 donors. In univariate analysis, the donor risk index >1.7, the presence of hypertension in the medical history, static cold ischemia time, and the moderate or severe macrovesicular steatosis were the significant factors for NegE. Multivariate analysis confirmed that macrosteatosis >30% was an independent risk factor for NegE (odd ratio 5.643, p = 0.023, 95% confidence interval, 1.27–24.98). Of 151 transplanted patients, 34% experienced EAD and had worse 1- and 3-year-survival, compared with those who did not face EAD (NoEAD), 96% and 96% for EAD vs. 89% and 71% for NoEAD, respectively (p = 0.03). None of the donor/graft characteristics was associated with EAD even if the graft was moderately steatotic or fibrotic or from an aged donor. For the first time, this study shows that macrovesicular steatosis >30% might be a warning factor involved in the risk of graft loss or a cause of graft discard after the MP treatment. On the other hand, the MP seems to be useful in reducing the donor and graft weight in the development of EAD.
Collapse
Affiliation(s)
- Irene Scalera
- Hepatobiliary and Liver Transplant Unit, Department of Emergency and Organ Transplantation, University Hospital Policlinic of Bari, Bari, Italy
- Correspondence: Irene Scalera
| | - R. De Carlis
- Department of General Surgery and Transplantation, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
| | - D. Patrono
- General Surgery 2U-Liver Transplant Centre, A.O.U. “Città della Salute e della Scienza”, Turin, Italy
| | - E. Gringeri
- Hepatobiliary Surgery and Liver Transplantation Unit, University Hospital of Padua, Padua, Italy
| | - T. Olivieri
- Hepato-Pancreato-Biliary Surgery and Liver Transplant Center, University of Modena and Reggio Emilia, Modena, Italy
| | - D. Pagano
- Department for the Treatment and the Study of Abdominal Diseases and Abdominal Transplantation, IRCCS-ISMETT, UPMC, Palermo, Italy
- Department of Surgery and Medical and Surgical Specialties, University of Catania, Catania, Italy
| | - Q. Lai
- Liver Transplant Unit, Sapienza University of Rome, Rome, Italy
| | - M. Rossi
- Liver Transplant Unit, Sapienza University of Rome, Rome, Italy
| | - S. Gruttadauria
- Department for the Treatment and the Study of Abdominal Diseases and Abdominal Transplantation, IRCCS-ISMETT, UPMC, Palermo, Italy
- Department of Surgery and Medical and Surgical Specialties, University of Catania, Catania, Italy
| | - F. Di Benedetto
- Hepato-Pancreato-Biliary Surgery and Liver Transplant Center, University of Modena and Reggio Emilia, Modena, Italy
| | - U. Cillo
- Hepatobiliary Surgery and Liver Transplantation Unit, University Hospital of Padua, Padua, Italy
| | - R. Romagnoli
- General Surgery 2U-Liver Transplant Centre, A.O.U. “Città della Salute e della Scienza”, Turin, Italy
| | - L. G. Lupo
- Hepatobiliary and Liver Transplant Unit, Department of Emergency and Organ Transplantation, University Hospital Policlinic of Bari, Bari, Italy
| | - L. De Carlis
- Department of General Surgery and Transplantation, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
- Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
| |
Collapse
|
31
|
Conti Nibali M, Rossi M, Sciortino T, Gay L, Lopci E, Fernandes B, Rudà R, Bello L. P03.08.B Proton Therapy and recurrent Lower Grade Glioma: clinical and radiological aspects, intraoperative findings and histo-pathological features. Neuro Oncol 2022. [DOI: 10.1093/neuonc/noac174.112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Radiation therapy (RT) plays a central role in management of central nervous system disease, in particular in the multimodality management of low(er) and high-grade CNS gliomas. New strategy that involved Proton Therapy (PT) have been experienced in the last years. No data are available about re-surgery of lesion irradiated with protons.
Material and Methods
We reviewed our single Unit experience of re-surgery of Lower-Grade Glioma patients that received, in their neuro-oncological history, a treatment with PT. We collect clinical data, intra-operative findings, histopathological features and oncological and clinical outcome after surgery.
Results
We collected three cases of young with an IDH1-mutated tumor that underwent to Proton Therapy (PT). In two cases PT was performed due to progression of disease, in one case as adjuvant therapy after first surgical treatment. In all cases we performed surgery within three years after PT. All patients complained drug resistant epilepsy after PT with symptom relief after surgery and one patient complained a spine fracture due to corticosteroids intake to control radionecrosis’s symptoms after PT. In the pre-operative work-up all patient performed a 11-C-Methionin PET scan that revealed an increase of tracer uptake in the suspected area of tumor progression. In one case advanced MRI protocol with PWI was performed to further distinguish and sample area of pseudoprogression and tumor progression. In two patients area of gliosis and necrosis was find at the histological examination.
Conclusion
Our experience, although limited to three case, provided a clinical and radiological example of the small cohort of patients that performed surgery after a Prothon Radiotherapy. Clinical presentation was heterogenous except a poor seizure control. Despite time elapsed since PT, areas of radionecrosis were found in the histopathological samples of 2/3 of patients. Moreover, we need to collect more data to draw a complete picture in this complex field.
Collapse
Affiliation(s)
| | - M Rossi
- Università degli Studi di Milano , Milano , Italy
| | | | - L Gay
- Università degli Studi di Milano , Milano , Italy
| | - E Lopci
- Humanitas Research Hospital , Milano , Italy
| | - B Fernandes
- Humanitas Research Hospital , Milano , Italy
| | - R Rudà
- Ospedale CastelFranco Veneto , Treviso , Italy
| | - L Bello
- Università degli Studi di Milano , Milano , Italy
| |
Collapse
|
32
|
Gay L, Rossi M, Sciortino T, Conti Nibali M, Simonelli M, Navarria P, Rudà R, Soffietti R, Bello L. P07.08.B Surgical management of recurrent lower-grade gliomas: analysis of oncological and functional outcomes and associated factors. Neuro Oncol 2022. [DOI: 10.1093/neuonc/noac174.140] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Presently, there are no clear evidence-based recommendations for the surgical management of progressive or recurrent lower-grade gliomas (LGGs). In our work, we evaluated the oncological (PFS, OS) and functional (neurological, neuropsychological, quality of life evaluation) outcomes of a series of LGGs treated in a 5-year period. The aim was to identify clinical, imaging, and molecular factors, associated with better outcomes, to be implemented in the treatment decision making process.
Material and Methods
In our retrospective analysis, 738 recurrent LGGs were included (follow-up 7.9 years; IQR:6-9); 550 were surgically treated, 495 with open resection (with brain mapping techniques), and 55 with tumor biopsy (with frameless stereotactic technique).
Results
Overall, 521 patients (70.6%) recurred. Of those treated with open resection 63.5% relapsed. Tumor progression was histologically confirmed in 72.5% of cases, no valuable tumor (effect of treatment) in 27.5% of cases (particularly in cases previously treated with RT and CHT), histo-molecular conversion (astrocytoma instead of oligodendroglioma diagnosis) in 7.5% of cases, malignant transformation in 38.7% of cases. Among the clinical (patient functional status, previous PFS, previous EOR, previous CHT and duration of CHT, previous RT), imaging (type of recurrence, i.e. typical versus atypical, speed of growth, contrast enhancement), and molecular (IDH, codeletion, ATRX, MGMT, tumor grade, CDNK status) factors analyzed, longest PFS of recurrent tumors was associated with patient functional status, previous PFS, previous EOR, speed of growth (>6 mm/year), atypical type of recurrence, tumor grade, presence of codeletion, and CDNK status. Best functional outcome associated with surgical resection, EOR, and tumor grade; worst functional outcome with RT and malignant transformation. Longest OS associated with previous EOR, surgical resection, tumor grade, presence of co-deletion. Malignant transformation was associated to previous EOR. Among patients submitted solely to tumor biopsy, changes in MGMT methylation status and in IDH status were observed in 65.3% and 5% of cases, respectively. Modification in IDH status was associated with atypical (distant) type of recurrence. New histo-molecular profile helped in the treatment decision making process.
Conclusion
Surgical resection of recurrent LGGs is associated with longer PFS and OS. Tumor biopsy should be considered, when surgery considered unfeasible, to tailor adjuvant treatment.
Collapse
Affiliation(s)
- L Gay
- Neurosurgical Oncological Unit, Dept of Oncology and Hemato-oncology, Università degli Studi di Milano , Milano , Italy
| | - M Rossi
- Neurosurgical Oncological Unit, Dept of Oncology and Hemato-oncology, Università degli Studi di Milano , Milano , Italy
| | - T Sciortino
- Neurosurgical Oncological Unit, Dept of Oncology and Hemato-oncology, Università degli Studi di Milano , Milano , Italy
| | - M Conti Nibali
- Neurosurgical Oncological Unit, Dept of Oncology and Hemato-oncology, Università degli Studi di Milano , Milano , Italy
| | - M Simonelli
- Humanitas Cancer Center, Humanitas Research Hospital, IRCCS , Milano , Italy
| | - P Navarria
- Humanitas Cancer Center, Humanitas Research Hospital, IRCCS , Milano , Italy
| | - R Rudà
- Department of Neurology, Castelfranco Veneto Hospital , Castelfranco Veneto , Italy
| | - R Soffietti
- Neuro-Oncologia, Città della Salute e della Scienza, Università di Torino , Torino , Italy
| | - L Bello
- Neurosurgical Oncological Unit, Dept of Oncology and Hemato-oncology, Università degli Studi di Milano , Milano , Italy
| |
Collapse
|
33
|
Puglisi G, Viganò L, Sciortino T, Leonetti A, Rossi M, Conti Nibali M, Gay L, Fornia L, Cerri G, Bello L. P01.14.B Visuospatial selective attention deficit after resection of right hemisphere gliomas: a multivariate lesion symptom mapping and diffusion tractography study. Neuro Oncol 2022. [DOI: 10.1093/neuonc/noac174.086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
The ability to select relevant information to current behavioural goals despite concomitant distractors (i.e. selective attention) is crucial for daily life. Despite the implication of fronto-parietal network in sustaining visuospatial selective attention has been considered crucial, the role of subcortical structures is still unclear. Aim of this study was to evaluate the impact of neurosurgical removal of right gliomas on visuospatial selective attention performances.
Material and Methods
The visuospatial selective attention domain was assessed pre- and postoperatively (1 month follow-up) in 73 patients operated for right hemisphere gliomas. Support-vector-regression lesion-symptom mapping and disconnectome analysis (Lesion Quantification Toolkit, HCP 1065 data) were used to evaluate the relationship between the resection cavities and the postoperative performance on a standardized selective attention test. To test and refine the atlas-based results, in a subset of 17 patients with preoperative diffusion tractography, the postoperative outcome was correlated with the percentage of disconnection for different white matter tracts.
Results
Results showed that resection of a cluster enclosing the SMA-complex and the surrounding white matter was significantly associated with a decline in visuospatial selective attention performances (p<.05). Disconnectome analysis at population level revealed that the deficit was significantly correlated with the resection of superior cortico-striatal fibres, superior thalamic radiations, corticopontine projections, callosal connections and fibres of the frontal aslant tract. Within all the cortico-subcortical terminations of these tracts, disconnection of streamlines of the SMA-complex was the most associated with selective attention deficits. Tractography in single patients confirmed the population level results and suggested that ventro-lateral resections in case of inferior frontal or insular tumours significantly disconnecting the frontal aslant tract but sparing superior projection fibres were not associated with any postoperative disturbances.
Conclusion
Results show converging evidence to support a critical role for the SMA/preSMA and its projections in maintaining efficiency of attentive control. The present results reveal the importance of a fronto-medial descending connectivity in mediating the voluntary control of visuospatial selective attention. From a surgical standpoint, to avoid postoperative deficits, it seems crucial to preserve SMA projection pathways, while the disconnection of the frontal aslant tract is feasible without any postoperative decline.
Collapse
Affiliation(s)
| | - L Viganò
- University of Milan , Milan , Italy
| | | | | | - M Rossi
- University of Milan , Milan , Italy
| | | | - L Gay
- University of Milan , Milan , Italy
| | - L Fornia
- University of Milan , Milan , Italy
| | - G Cerri
- University of Milan , Milan , Italy
| | - L Bello
- University of Milan , Milan , Italy
| |
Collapse
|
34
|
Kommers IO, Eijgelaar RS, Barkhof F, Bouget D, Pedersen A, Ardon H, Bello L, Berger MS, Bouwknegt W, Conti Nibali M, Furtner J, Han SJ, Han SJ, Hervey-Jumper S, Hervey-Jumper S, Idema AJS, Kiesel B, Kloet A, Nandoe Tewarie R, Mandonnet E, Reinertsen I, Robe PA, Rossi M, Sciortino T, Solheim O, van den Brink WA, Vandertop PW, Wagemakers M, Widhalm G, Witte MG, Zwinderman AH, De Witt Hamer PC. P11.37.B When to resect or biopsy for patients with supratentorial glioblastoma: a multivariable prediction model. Neuro Oncol 2022. [DOI: 10.1093/neuonc/noac174.226] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
The prospects of a patient with suspected glioblastoma may rely heavily on the indication for surgical resection versus biopsy only. Biopsy percentages vary considerably across hospitals and guidelines for treatment of glioblastoma lack criteria for surgical decision-making. To identify patient and tumor characteristics associated with the decision to resect or biopsy a glioblastoma and to develop and validate a prediction model for decision support.
Material and Methods
Clinical data and pre-operative MRI scans were collected for adults who underwent first-time surgery for supratentorial glioblastoma from a registry-based cohort study of 12 hospitals from the Netherlands, Germany, France, Italy, and the United States between 1st of January 2007 and 31st of December 2011. The main outcome was the type of surgical procedure: surgical resection or biopsy only. Predictors were patient- and tumor-related characteristics. Radiological factors were extracted from MRI using an automated tumor segmentation method. A prediction model was constructed using multivariable logistic regression analysis. The model was cross-validated and externally validated with a leave-one-hospital-out approach.
Results
Out of 1053 patients treated for glioblastoma, 28% underwent biopsy only. Biopsy rates varied from 15-40% across hospitals. The prediction model showed excellent discrimination with an average area under the curve of 0.86. Of the patient-related characteristics, younger age was associated more with resection and Karnofsky Performance Score of 60 or less with biopsy. Of the tumor-related characteristics, a location in the right hemisphere, unifocality, no tumor midline crossing, and no involvement of the cortical spinal tract, were associated with resection, as well as a high expected resectability index, a location in the right occipital lobe, and a higher percentage of tumor in Schaefer’s dorsal or ventral attention, limbic, and default networks. External validation proved acceptable to outstanding discrimination with areas under the curve ranging between 0.79 and 0.92 for hospitals.
Conclusion
A prediction model is presented and validated to support the decision to resect or to biopsy a patient with a suspected supratentorial glioblastoma. In this prediction model, tumor-related characteristics were more informative than patient-related factors. This may support surgical decision-making for individual patients, or facilitate comparisons of patient cohorts between surgeons or institutions.
Collapse
Affiliation(s)
- I O Kommers
- Department of Neurosurgery, Amsterdam University Medical Centers, Vrije Universiteit , Amsterdam , Netherlands
- Cancer Center Amsterdam, Brain Tumor Center, Amsterdam University Medical Centers , Amsterdam , Netherlands
| | - R S Eijgelaar
- Department of Neurosurgery, Amsterdam University Medical Centers, Vrije Universiteit , Amsterdam , Netherlands
- Cancer Center Amsterdam, Brain Tumor Center, Amsterdam University Medical Centers , Amsterdam , Netherlands
| | - F Barkhof
- Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Vrije Universiteit , Amsterdam , Netherlands
- Institutes of Neurology and Healthcare Engineering, University College London , London , United Kingdom
| | - D Bouget
- Department of Health Research, SINTEF Digital , Trondheim , Norway
| | - A Pedersen
- Department of Health Research, SINTEF Digital , Trondheim , Norway
| | - H Ardon
- Department of Neurosurgery, Twee Steden Hospital , Tilburg , Netherlands
| | - L Bello
- Neurosurgical Oncology Unit, Department of Oncology and Hemato-Oncology, Humanitas Research Hospital, Università Degli Studi di Milano , Milano , Italy
| | - M S Berger
- Department of Neurological Surgery, University of California San Francisco , San Fransisco, CA , United States
| | - W Bouwknegt
- Medische Kliniek Velsen , Velsen , Netherlands
| | - M Conti Nibali
- Neurosurgical Oncology Unit, Department of Oncology and Hemato-Oncology, Humanitas Research Hospital, Università Degli Studi di Milano , Milano , Italy
| | - J Furtner
- Department of Biomedical Imaging and Image-Guided Therapy, Medical University Vienna , Wien , Austria
| | - S J Han
- Department of Neurological Surgery, Oregon Health & Science University , Portland, OR , United States
| | - S J Han
- Department of Neurological Surgery, Oregon Health & Science University , Portland, OR , United States
| | - S Hervey-Jumper
- Department of Neurological Surgery, University of California San Francisco , San Fransisco, CA , United States
| | - S Hervey-Jumper
- Department of Neurological Surgery, University of California San Francisco , San Fransisco, CA , United States
| | - A J S Idema
- Department of Neurosurgery, Northwest Clinics , Alkmaar , Netherlands
| | - B Kiesel
- Department of Neurosurgery, Medical University Vienna, , Wien , Austria
| | - A Kloet
- Department of Neurosurgery, Haaglanden Medical Center , The Hague , Netherlands
| | - R Nandoe Tewarie
- Department of Neurosurgery, Haaglanden Medical Center , The Hague , Netherlands
| | - E Mandonnet
- Department of Neurological Surgery, Hôpital Lariboisière , Paris , France
| | - I Reinertsen
- Department of Health Research, SINTEF Digital , Trondheim , Norway
| | - P A Robe
- Department of Neurology and Neurosurgery, University Medical Center Utrecht , Utrecht , Netherlands
| | - M Rossi
- Neurosurgical Oncology Unit, Department of Oncology and Hemato-Oncology, Humanitas Research Hospital, Università Degli Studi di Milano , Milano , Italy
| | - T Sciortino
- Neurosurgical Oncology Unit, Department of Oncology and Hemato-Oncology, Humanitas Research Hospital, Università Degli Studi di Milano , Milano , Italy
| | - O Solheim
- Department of Neurosurgery, St. Olavs University Hospital , Trondheim , Norway
- Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology , Trondheim , Norway
| | | | - P W Vandertop
- Department of Neurosurgery, Amsterdam University Medical Centers, Vrije Universiteit , Amsterdam , Netherlands
- Cancer Center Amsterdam, Brain Tumor Center, Amsterdam University Medical Centers , Amsterdam , Netherlands
| | - M Wagemakers
- Department of Neurosurgery, University Medical Center Groningen, University of Groningen , Groningen , Netherlands
| | - G Widhalm
- Department of Neurosurgery, Medical University Vienna , Wien , Austria
| | - M G Witte
- Department of Radiation Oncology, The Netherlands Cancer Institute , Amsterdam , Netherlands
| | - A H Zwinderman
- Department of Clinical Epidemiology and Biostatistics, Amsterdam University Medical Centers, University of Amsterdam , Amsterdam , Netherlands
| | - P C De Witt Hamer
- Department of Neurosurgery, Amsterdam University Medical Centers, Vrije Universiteit , Amsterdam , Netherlands
- Cancer Center Amsterdam, Brain Tumor Center, Amsterdam University Medical Centers , Amsterdam , Netherlands
| |
Collapse
|
35
|
Conti Nibali M, Puglisi G, Leonetti A, Rossi M, Gay L, Sciortino T, Mattioli L, Gambaretti M, Viganò L, Bello L. P01.19.A The temporo-parieto-occipital junction in the non-dominant hemisphere as a challenging hub for glioma surgery: functional and oncological outcomes. Neuro Oncol 2022. [DOI: 10.1093/neuonc/noac174.091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
The temporo-parieto-occipital junction (TPOJ) in the non-dominant hemisphere is a complex region intersected by multiple white matter bundles (Optic radiations, Inferior-fronto-occipital tract, inferior-longitudinalis-tract, superior-longitudinalis-tract, vertical-occipital-tract, medial-dorsal-longitudinal-tract, parietal-aslant-tract), subserving several high-level neurological functions such as spatial recognition, visual agnosia, visual field, attention and working memory. Few data are available on the optimum brain mapping strategy to be adopted for resecting tumors involving this area. Ideally it should allow surgeon to effectively identify several tracts and safely preserve all functions.
Material and Methods
We developed a proper protocol to approach this complex area integrating, in awake condition, intraoperative visual test (iVT) to mapping visual field, semantic association test (SRAT) to prevent visual agnosia and preserve working memory, hand manipulation task (hMT) to preserve spatial abilities. We reviewed its efficacy in a series of 38 patients with tumors involving non-dominant TPOJ, looking to functional (neurologic-neuropsychological) and oncological (EOR) outcomes. we perform a lesion symptom map and a disconnectome analysis to evaluate what region predict a decline in neuropsychological function and which tract of white brain matter are correlated in the decline of performance.
Results
Feasibility was high and all patients were able to perform and complete the protocol, which lasted, on the average11 min cortically and 25 min subcortically. Specificity was >95%. Immediate post-operative deficits were documented in 87.4% of patients, permanent in 3.9% (visual field, visual spatial abilities). Attentive and emotional domains were those mostly affected in the neuropsychological evaluation. Lesion symptom mapping and disconnectomic analysis showed that the postoperative decrease in neuropsychological performance was associated with resection of a cluster of voxels corresponding to the anterior portion of the temporo-parietal junction. The white matter tracts mainly involved were the anterior and posterior segment of the middle longitudinal fasciculus (aMdLF and pMdLF) and the parietal aslant tract (PAT).
Conclusion
Effective and safe resection of tumors involving non-dominant TPOJ is feasible. The adoption of a specific brain mapping protocol in awake setting is recommended to achieve a full functional preservation and extend tumor resection. Further analysis should be performed to assess the role of this subcortical tracts.
Collapse
Affiliation(s)
| | - G Puglisi
- Università degli Studi di Milano , Milano , Italy
| | - A Leonetti
- Univeristà degli Studi di Milano , Milano , Italy
| | - M Rossi
- Università degli Studi di Milano , Milano , Italy
| | - L Gay
- Università degli Studi di Milano , Milano , Italy
| | | | - L Mattioli
- Università degli Studi di Milano , Milano , Italy
| | - M Gambaretti
- Università degli Studi di Milano , Milano , Italy
| | - L Viganò
- Università degli Studi di Milano , Milano , Italy
| | - L Bello
- Università degli Studi di Milano , Milano , Italy
| |
Collapse
|
36
|
Gay L, Rossi M, Conti Nibali M, Sciortino T, Bello L. OS07.7.A Rate and type of recurrence of lower-grade gliomas submitted to functional neurosurgical approach: the impact of the extent of resection. Neuro Oncol 2022. [DOI: 10.1093/neuonc/noac174.052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
In the last decade, different published studies enlightened the extent-of-resection (EOR) as an independent factor for progression-free-survival (PFS) in patients with lower-grade gliomas (LGG). Aim of this study was to evaluate the impact of resections extending beyond FLAIR MRI abnormalities (supratotal), and eventual predictive factors and characteristics of recurrences.
Material and Methods
We retrospectively analysed 460 patients submitted to surgery between 2007 and 2016 with a presumptive diagnosis of LGG, i.e., harbouring a mass lesion with no enhancement on contrast-administered T1-weighted MRI-sequences. All resections were performed according to functional boundaries determined by brain mapping/monitoring technique, without any patient or tumor a priori selection. The EOR was defined by analyzing pre- and post-operative volumetric FLAIR images.
Results
The median pre-operative tumor volume was 43,7 cm3. A supratotal resection (SPR) was achieved in 31.4%, a gross-total (GTR) in 41.1%, a subtotal (STR) in 27.5%. WHO grade II/III gliomas were diagnosed in 347 cases (319 IDH-mutant, 28 IDH-wildtype). Median follow-up was 60 months. SPR versus other EOR was associated to increased PFS (log rank test, p=.000) and malignant PFS (p=.000). Data were confirmed also after IDH status stratification. Rate of immediate and permanent post-op deficits among different EOR were comparable. Pre-op tumor volume, parietal and insular sites, eloquent location and dominant hemisphere tumors, and astrocytoma histology were associated to recurrence (p<.05). In 95.1% of cases recurrences were peri-cavitary. Lesions invading the corpus callosum presented minor rate of relapse; recurrences were most frequently diffuse and at distant sites. After SPR most common radiological appearance of recurrence was solid, while after GTR and STR percentages of solid and diffuse patterns were similar. Occurrence of distant recurrences, away from the resection cavity, were most associated to SPR.
Conclusion
Our preliminary data suggests the dramatic impact in LGG of resections extending beyond FLAIR abnormalities on PFS and malignant PFS and on the characteristics of tumor recurrence.
Collapse
Affiliation(s)
- L Gay
- Neurosurgical Oncological Unit, Dept of Oncology and Hemato-oncology, Università degli Studi di Milano, Milano, Italy. , Milano , Italy
| | - M Rossi
- Neurosurgical Oncological Unit, Dept of Oncology and Hemato-oncology, Università degli Studi di Milano, Milano, Italy. , Milano , Italy
| | - M Conti Nibali
- Neurosurgical Oncological Unit, Dept of Oncology and Hemato-oncology, Università degli Studi di Milano, Milano, Italy. , Milano , Italy
| | - T Sciortino
- Neurosurgical Oncological Unit, Dept of Oncology and Hemato-oncology, Università degli Studi di Milano, Milano, Italy. , Milano , Italy
| | - L Bello
- Neurosurgical Oncological Unit, Dept of Oncology and Hemato-oncology, Università degli Studi di Milano, Milano, Italy. , Milano , Italy
| |
Collapse
|
37
|
Wollenberg A, Kinberger M, Arents B, Aszodi N, Avila Valle G, Barbarot S, Bieber T, Brough HA, Calzavara Pinton P, Christen-Zäch S, Deleuran M, Dittmann M, Dressler C, Fink-Wagner AH, Fosse N, Gáspár K, Gerbens L, Gieler U, Girolomoni G, Gregoriou S, Mortz CG, Nast A, Nygaard U, Redding M, Rehbinder EM, Ring J, Rossi M, Serra-Baldrich E, Simon D, Szalai ZZ, Szepietowski JC, Torrelo A, Werfel T, Flohr C. European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populations. J Eur Acad Dermatol Venereol 2022; 36:1904-1926. [PMID: 36056736 DOI: 10.1111/jdv.18429] [Citation(s) in RCA: 54] [Impact Index Per Article: 27.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2022] [Accepted: 06/03/2022] [Indexed: 12/01/2022]
Abstract
The evidence- and consensus-based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development Manual. Four consensus conferences were held between December 2020 and July 2021. Twenty-nine experts (including clinicians and patient representatives) from 12 European countries participated. This second part of the guideline includes recommendations and detailed information on basic therapy with emollients and moisturizers, topical anti-inflammatory treatment, antimicrobial and antipruritic treatment and UV phototherapy. Furthermore, this part of the guideline covers techniques for avoiding provocation factors, as well as dietary interventions, immunotherapy, complementary medicine and educational interventions for patients with atopic eczema and deals with occupational and psychodermatological aspects of the disease. It also contains guidance on treatment for paediatric and adolescent patients and pregnant or breastfeeding women, as well as considerations for patients who want to have a child. A chapter on the patient perspective is also provided. The first part of the guideline, published separately, contains recommendations and guidance on systemic treatment with conventional immunosuppressive drugs, biologics and janus kinase (JAK) inhibitors, as well as information on the scope and purpose of the guideline, and a section on guideline methodology.
Collapse
Affiliation(s)
- A Wollenberg
- Department of Dermatology and Allergy, LMU Munich, Munich, Germany.,Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Department of Dermatology, Brussels, Belgium
| | - M Kinberger
- Department of Dermatology, Venereology and Allergology, Division of Evidence-Based Medicine (dEBM), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - B Arents
- European Federation of Allergy and Airways Diseases Patients' Associations (EFA), Brussels, Belgium
| | - N Aszodi
- Department of Dermatology and Allergy, LMU Munich, Munich, Germany
| | - G Avila Valle
- Department of Dermatology, Venereology and Allergology, Division of Evidence-Based Medicine (dEBM), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - S Barbarot
- Department of Dermatology, CHU Nantes, UMR 1280 PhAN, INRAE, Nantes Université, Nantes, France
| | - T Bieber
- Department of Dermatology and Allergy, University Hospital of Bonn, Bonn, Germany
| | - H A Brough
- Children's Allergy Service, Evelina London Children's Hospital, Guy's and St. Thomas' NHS Foundation Trust, London, and Paediatric Allergy Group, Department of Women and Children's Health, School of Life Course Sciences, King's College London, London, UK
| | | | | | - M Deleuran
- Aarhus University Hospital, Aarhus, Denmark
| | - M Dittmann
- Department of Dermatology, Venereology and Allergology, Division of Evidence-Based Medicine (dEBM), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - C Dressler
- Department of Dermatology, Venereology and Allergology, Division of Evidence-Based Medicine (dEBM), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - A H Fink-Wagner
- Global Allergy and Airways diseases Patient Platform GAAPP, Vienna, Austria
| | - N Fosse
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
| | - K Gáspár
- Department of Dermatology of the University of Debrecen, Debrecen, Hungary
| | - L Gerbens
- Department of Dermatology, Amsterdam UMC (University Medical Centers), Amsterdam, The Netherlands
| | - U Gieler
- Department Dermatology, University of Giessen, Giessen, Germany
| | - G Girolomoni
- Dermatology and Venereology Section, Department of Medicine, University of Verona, Verona, Italy
| | - S Gregoriou
- Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece
| | - C G Mortz
- Department of Dermatology and Allergy Centre, Odense University Hospital, University of Southern Denmark, Odense, Denmark
| | - A Nast
- Department of Dermatology, Venereology and Allergology, Division of Evidence-Based Medicine (dEBM), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - U Nygaard
- Department of Dermato-Venerology, Aarhus University Hospital, Aarhus, Denmark
| | - M Redding
- Eczema Outreach Support (UK), Linlithgow, UK
| | - E M Rehbinder
- Dermatology Department, Oslo University Hospital, Oslo, Norway
| | - J Ring
- Department Dermatology Allergology Biederstein, Technical University Munich, Munich, Germany
| | - M Rossi
- Dermatology Unit, Spedali Civili Hospital Brescia, Brescia, Italy
| | | | - D Simon
- Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
| | - Z Z Szalai
- Pediatric Dermatology Unit, Heim Pál National Children's Institute Budapest, Budapest, Hungary
| | - J C Szepietowski
- Department of Dermatology, Venereology and Allergology, Wrocław Medical University, Wrocław, Poland
| | - A Torrelo
- Hospital Infantil Niño Jesús, Madrid, Spain
| | - T Werfel
- Hannover Medical School, Hanover, Germany
| | - C Flohr
- St John's Institute of Dermatology, King's College London, London, UK.,Guy's & St Thomas' NHS Foundation Trust, London, UK
| |
Collapse
|
38
|
La Rosa G, Iaconelli M, Veneri C, Mancini P, Bonanno Ferraro G, Brandtner D, Lucentini L, Bonadonna L, Rossi M, Grigioni M, Suffredini E. The rapid spread of SARS-COV-2 Omicron variant in Italy reflected early through wastewater surveillance. Sci Total Environ 2022; 837:155767. [PMID: 35533857 DOI: 10.5281/zenodo.5985319] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Received: 02/18/2022] [Revised: 05/02/2022] [Accepted: 05/03/2022] [Indexed: 05/25/2023]
Abstract
The SARS-CoV-2 Omicron variant emerged in South Africa in November 2021, and has later been identified worldwide, raising serious concerns. A real-time RT-PCR assay was designed for the rapid screening of the Omicron variant, targeting characteristic mutations of the spike gene. The assay was used to test 737 sewage samples collected throughout Italy (19/21 Regions) between 11 November and 25 December 2021, with the aim of assessing the spread of the Omicron variant in the country. Positive samples were also tested with a real-time RT-PCR developed by the European Commission, Joint Research Centre (JRC), and through nested RT-PCR followed by Sanger sequencing. Overall, 115 samples tested positive for Omicron SARS-CoV-2 variant. The first occurrence was detected on 7 December, in Veneto, North Italy. Later on, the variant spread extremely fast in three weeks, with prevalence of positive wastewater samples rising from 1.0% (1/104 samples) in the week 5-11 December, to 17.5% (25/143 samples) in the week 12-18, to 65.9% (89/135 samples) in the week 19-25, in line with the increase in cases of infection with the Omicron variant observed during December in Italy. Similarly, the number of Regions/Autonomous Provinces in which the variant was detected increased from one in the first week, to 11 in the second, and to 17 in the last one. The presence of the Omicron variant was confirmed by the JRC real-time RT-PCR in 79.1% (91/115) of the positive samples, and by Sanger sequencing in 66% (64/97) of PCR amplicons. In conclusion, we designed an RT-qPCR assay capable to detect the Omicron variant, which can be successfully used for the purpose of wastewater-based epidemiology. We also described the history of the introduction and diffusion of the Omicron variant in the Italian population and territory, confirming the effectiveness of sewage monitoring as a powerful surveillance tool.
Collapse
Affiliation(s)
- G La Rosa
- Department of Environment and Health, Istituto Superiore di Sanità, Rome, Italy.
| | - M Iaconelli
- Department of Environment and Health, Istituto Superiore di Sanità, Rome, Italy
| | - C Veneri
- Department of Environment and Health, Istituto Superiore di Sanità, Rome, Italy
| | - P Mancini
- Department of Environment and Health, Istituto Superiore di Sanità, Rome, Italy
| | - G Bonanno Ferraro
- Department of Environment and Health, Istituto Superiore di Sanità, Rome, Italy
| | | | - L Lucentini
- Department of Environment and Health, Istituto Superiore di Sanità, Rome, Italy
| | - L Bonadonna
- Department of Environment and Health, Istituto Superiore di Sanità, Rome, Italy
| | - M Rossi
- Independent Researcher, Rome, Italy
| | - M Grigioni
- National Center for Innovative Technologies in Public Health, Istituto Superiore di Sanità, Rome, Italy
| | - E Suffredini
- Department of Food Safety, Nutrition and Veterinary Public Health, Istituto Superiore di Sanità, Rome, Italy
| |
Collapse
|
39
|
La Rosa G, Iaconelli M, Veneri C, Mancini P, Bonanno Ferraro G, Brandtner D, Lucentini L, Bonadonna L, Rossi M, Grigioni M, Suffredini E. The rapid spread of SARS-COV-2 Omicron variant in Italy reflected early through wastewater surveillance. Sci Total Environ 2022; 837:155767. [PMID: 35533857 PMCID: PMC9074219 DOI: 10.1016/j.scitotenv.2022.155767] [Citation(s) in RCA: 28] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/18/2022] [Revised: 05/02/2022] [Accepted: 05/03/2022] [Indexed: 05/21/2023]
Abstract
The SARS-CoV-2 Omicron variant emerged in South Africa in November 2021, and has later been identified worldwide, raising serious concerns. A real-time RT-PCR assay was designed for the rapid screening of the Omicron variant, targeting characteristic mutations of the spike gene. The assay was used to test 737 sewage samples collected throughout Italy (19/21 Regions) between 11 November and 25 December 2021, with the aim of assessing the spread of the Omicron variant in the country. Positive samples were also tested with a real-time RT-PCR developed by the European Commission, Joint Research Centre (JRC), and through nested RT-PCR followed by Sanger sequencing. Overall, 115 samples tested positive for Omicron SARS-CoV-2 variant. The first occurrence was detected on 7 December, in Veneto, North Italy. Later on, the variant spread extremely fast in three weeks, with prevalence of positive wastewater samples rising from 1.0% (1/104 samples) in the week 5-11 December, to 17.5% (25/143 samples) in the week 12-18, to 65.9% (89/135 samples) in the week 19-25, in line with the increase in cases of infection with the Omicron variant observed during December in Italy. Similarly, the number of Regions/Autonomous Provinces in which the variant was detected increased from one in the first week, to 11 in the second, and to 17 in the last one. The presence of the Omicron variant was confirmed by the JRC real-time RT-PCR in 79.1% (91/115) of the positive samples, and by Sanger sequencing in 66% (64/97) of PCR amplicons. In conclusion, we designed an RT-qPCR assay capable to detect the Omicron variant, which can be successfully used for the purpose of wastewater-based epidemiology. We also described the history of the introduction and diffusion of the Omicron variant in the Italian population and territory, confirming the effectiveness of sewage monitoring as a powerful surveillance tool.
Collapse
Affiliation(s)
- G La Rosa
- Department of Environment and Health, Istituto Superiore di Sanità, Rome, Italy.
| | - M Iaconelli
- Department of Environment and Health, Istituto Superiore di Sanità, Rome, Italy
| | - C Veneri
- Department of Environment and Health, Istituto Superiore di Sanità, Rome, Italy
| | - P Mancini
- Department of Environment and Health, Istituto Superiore di Sanità, Rome, Italy
| | - G Bonanno Ferraro
- Department of Environment and Health, Istituto Superiore di Sanità, Rome, Italy
| | | | - L Lucentini
- Department of Environment and Health, Istituto Superiore di Sanità, Rome, Italy
| | - L Bonadonna
- Department of Environment and Health, Istituto Superiore di Sanità, Rome, Italy
| | - M Rossi
- Independent Researcher, Rome, Italy
| | - M Grigioni
- National Center for Innovative Technologies in Public Health, Istituto Superiore di Sanità, Rome, Italy
| | - E Suffredini
- Department of Food Safety, Nutrition and Veterinary Public Health, Istituto Superiore di Sanità, Rome, Italy
| |
Collapse
|
40
|
Wollenberg A, Kinberger M, Arents B, Aszodi N, Avila Valle G, Barbarot S, Bieber T, Brough HA, Calzavara Pinton P, Christen-Zäch S, Deleuran M, Dittmann M, Dressler C, Fink-Wagner AH, Fosse N, Gáspár K, Gerbens L, Gieler U, Girolomoni G, Gregoriou S, Mortz CG, Nast A, Nygaard U, Redding M, Rehbinder EM, Ring J, Rossi M, Serra-Baldrich E, Simon D, Szalai ZZ, Szepietowski JC, Torrelo A, Werfel T, Flohr C. European guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapy. J Eur Acad Dermatol Venereol 2022; 36:1409-1431. [PMID: 35980214 DOI: 10.1111/jdv.18345] [Citation(s) in RCA: 95] [Impact Index Per Article: 47.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2022] [Accepted: 04/29/2022] [Indexed: 01/03/2023]
Abstract
The evidence- and consensus-based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development Manual. Four consensus conferences were held between December 2020 and July 2021. Twenty-nine experts (including clinicians and patient representatives) from 12 European countries participated. This first part of the guideline includes general information on its scope and purpose, the health questions covered, target users and a methods section. It also provides guidance on which patients should be treated with systemic therapies, as well as recommendations and detailed information on each systemic drug. The systemic treatment options discussed in the guideline comprise conventional immunosuppressive drugs (azathioprine, ciclosporin, glucocorticosteroids, methotrexate and mycophenolate mofetil), biologics (dupilumab, lebrikizumab, nemolizumab, omalizumab and tralokinumab) and janus kinase inhibitors (abrocitinib, baricitinib and upadacitinib). Part two of the guideline will address avoidance of provocation factors, dietary interventions, immunotherapy, complementary medicine, educational interventions, occupational and psychodermatological aspects, patient perspective and considerations for paediatric, adolescent, pregnant and breastfeeding patients.
Collapse
Affiliation(s)
- A Wollenberg
- Department of Dermatology and Allergy, LMU Munich, Munich, Germany.,Department of Dermatology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium
| | - M Kinberger
- Division of Evidence-Based Medicine (dEBM), Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - B Arents
- European Federation of Allergy and Airways Diseases Patients' Associations (EFA), Brussels, Belgium
| | - N Aszodi
- Department of Dermatology and Allergy, LMU Munich, Munich, Germany
| | - G Avila Valle
- Division of Evidence-Based Medicine (dEBM), Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - S Barbarot
- Department of Dermatology, CHU Nantes, UMR 1280 PhAN, INRAE, Nantes Université, Nantes, France
| | - T Bieber
- Department of Dermatology and Allergy, University Hospital of Bonn, Bonn, Germany
| | - H A Brough
- Children's Allergy Service, Evelina London Children's Hospital, Guy's and St. Thomas' NHS Foundation Trust, London, UK.,Paediatric Allergy Group, Department of Women and Children's Health, School of Life Course Sciences, King's College London, London, UK
| | | | | | - M Deleuran
- Aarhus University Hospital, Aarhus, Denmark
| | - M Dittmann
- Division of Evidence-Based Medicine (dEBM), Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - C Dressler
- Division of Evidence-Based Medicine (dEBM), Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - A H Fink-Wagner
- Global Allergy and Airways Diseases Patient Platform GAAPP, Vienna, Austria
| | - N Fosse
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
| | - K Gáspár
- Department of Dermatology of the University of Debrecen, Debrecen, Hungary
| | - L Gerbens
- Department of Dermatology, Amsterdam UMC (University Medical Centers), Amsterdam, The Netherlands
| | - U Gieler
- Department of Dermatology, University of Giessen, Giessen, Germany
| | - G Girolomoni
- Dermatology and Venereology Section, Department of Medicine, University of Verona, Verona, Italy
| | - S Gregoriou
- Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece
| | - C G Mortz
- Department of Dermatology and Allergy Centre, Odense University Hospital, University of Southern Denmark, Odense, Denmark
| | - A Nast
- Division of Evidence-Based Medicine (dEBM), Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - U Nygaard
- Department of Dermato-Venerology, Aarhus University Hospital, Aarhus, Denmark
| | - M Redding
- Eczema Outreach Support (UK), Linlithgow, UK
| | - E M Rehbinder
- Dermatology Department, Oslo University Hospital, Oslo, Norway
| | - J Ring
- Department of Dermatology Allergology Biederstein, Technical University Munich, Munich, Germany
| | - M Rossi
- Dermatology Unit, Spedali Civili Hospital Brescia, Brescia, Italy
| | | | - D Simon
- Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
| | - Z Z Szalai
- Pediatric Dermatology Unit, Heim Pál National Children's Institute Budapest, Budapest, Hungary
| | - J C Szepietowski
- Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland
| | - A Torrelo
- Hospital Infantil Niño Jesús, Madrid, Spain
| | - T Werfel
- Hannover Medical School, Hannover, Germany
| | - C Flohr
- St John's Institute of Dermatology, King's College London, London, UK.,Guy's & St Thomas' NHS Foundation Trust, London, UK
| |
Collapse
|
41
|
Ferrucci SM, Rossi M, Fomina DS. 34332 Treatment patterns and prior medication usage before dupilumab treatment initiation in patients with AD: Real-world data from GLOBOSTAD. J Am Acad Dermatol 2022. [DOI: 10.1016/j.jaad.2022.06.522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
42
|
Giammarco S, Bellesi S, Metafuni E, Rossi M, Minnella G, Bacigalupo A, Sica S, Chiusolo P. Cord blood resilience in a patient with relapsing Ph + B lymphoblastic acute leukemia after hematopoietic stem cell transplantation. Ann Hematol 2022; 101:2565-2566. [PMID: 35994061 DOI: 10.1007/s00277-022-04962-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2022] [Accepted: 08/17/2022] [Indexed: 11/01/2022]
Affiliation(s)
- S Giammarco
- Dipartimento Di Diagnostica Per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli, 8, 00168, Rome, Italy
| | - S Bellesi
- Dipartimento Di Diagnostica Per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli, 8, 00168, Rome, Italy
| | - E Metafuni
- Dipartimento Di Diagnostica Per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli, 8, 00168, Rome, Italy
| | - M Rossi
- Dipartimento Di Diagnostica Per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli, 8, 00168, Rome, Italy
| | - G Minnella
- Dipartimento Di Diagnostica Per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli, 8, 00168, Rome, Italy
| | - A Bacigalupo
- Sezione Di Ematologia, Dipartimento Di Scienze Radiologiche Ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy
| | - S Sica
- Dipartimento Di Diagnostica Per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli, 8, 00168, Rome, Italy. .,Sezione Di Ematologia, Dipartimento Di Scienze Radiologiche Ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy.
| | - P Chiusolo
- Dipartimento Di Diagnostica Per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli, 8, 00168, Rome, Italy.,Sezione Di Ematologia, Dipartimento Di Scienze Radiologiche Ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy
| |
Collapse
|
43
|
Abud AA, Abi B, Acciarri R, Acero MA, Adames MR, Adamov G, Adamowski M, Adams D, Adinolfi M, Aduszkiewicz A, Aguilar J, Ahmad Z, Ahmed J, Aimard B, Ali-Mohammadzadeh B, Alion T, Allison K, Monsalve SA, AlRashed M, Alt C, Alton A, Alvarez R, Amedo P, Anderson J, Andreopoulos C, Andreotti M, Andrews M, Andrianala F, Andringa S, Anfimov N, Ankowski A, Antoniassi M, Antonova M, Antoshkin A, Antusch S, Aranda-Fernandez A, Arellano L, Arnold LO, Arroyave MA, Asaadi J, Asquith L, Aurisano A, Aushev V, Autiero D, Lara VA, Ayala-Torres M, Azfar F, Back A, Back H, Back JJ, Backhouse C, Bagaturia I, Bagby L, Balashov N, Balasubramanian S, Baldi P, Baller B, Bambah B, Barao F, Barenboim G, Alzas PB, Barker G, Barkhouse W, Barnes C, Barr G, Monarca JB, Barros A, Barros N, Barrow JL, Basharina-Freshville A, Bashyal A, Basque V, Batchelor C, Chagas EBD, Battat JBR, Battisti F, Bay F, Bazetto MCQ, Alba JLLB, Beacom JF, Bechetoille E, Behera B, Beigbeder C, Bellantoni L, Bellettini G, Bellini V, Beltramello O, Benekos N, Montiel CB, Neves FB, Berger J, Berkman S, Bernardini P, Berner RM, Bersani A, Bertolucci S, Betancourt M, Rodríguez AB, Bevan A, Bezawada Y, Bezerra TJC, Bhardwaj A, Bhatnagar V, Bhattacharjee M, Bhattarai D, Bhuller S, Bhuyan B, Biagi S, Bian J, Biassoni M, Biery K, Bilki B, Bishai M, Bitadze A, Blake A, Blaszczyk F, Blazey GC, Blucher E, Boissevain J, Bolognesi S, Bolton T, Bomben L, Bonesini M, Bongrand M, Bonilla-Diaz C, Bonini F, Booth A, Boran F, Bordoni S, Borkum A, Bostan N, Bour P, Bourgeois C, Boyden D, Bracinik J, Braga D, Brailsford D, Branca A, Brandt A, Bremer J, Breton D, Brew C, Brice SJ, Brizzolari C, Bromberg C, Brooke J, Bross A, Brunetti G, Brunetti M, Buchanan N, Budd H, Butorov I, Cagnoli I, Cai T, Caiulo D, Calabrese R, Calafiura P, Calcutt J, Calin M, Calvez S, Calvo E, Caminata A, Campanelli M, Caratelli D, Carber D, Carceller JC, Carini G, Carlus B, Carneiro MF, Carniti P, Terrazas IC, Carranza H, Carroll T, Forero JFC, Castillo A, Castromonte C, Catano-Mur E, Cattadori C, Cavalier F, Cavallaro G, Cavanna F, Centro S, Cerati G, Cervelli A, Villanueva AC, Chalifour M, Chappell A, Chardonnet E, Charitonidis N, Chatterjee A, Chattopadhyay S, Neyra MSSC, Chen H, Chen M, Chen Y, Chen Z, Chen-Wishart Z, Cheon Y, Cherdack D, Chi C, Childress S, Chirco R, Chiriacescu A, Chisnall G, Cho K, Choate S, Chokheli D, Chong PS, Christensen A, Christian D, Christodoulou G, Chukanov A, Chung M, Church E, Cicero V, Clarke P, Cline G, Coan TE, Cocco AG, Coelho JAB, Colton N, Conley E, Conley R, Conrad J, Convery M, Copello S, Cova P, Cremaldi L, Cremonesi L, Crespo-Anadón JI, Crisler M, Cristaldo E, Crnkovic J, Cross R, Cudd A, Cuesta C, Cui Y, Cussans D, Dalager O, da Motta H, Da Silva Peres L, David C, David Q, Davies GS, Davini S, Dawson J, De K, De S, Debbins P, De Bonis I, Decowski MP, De Gouvêa A, De Holanda PC, De Icaza Astiz IL, Deisting A, De Jong P, Delbart A, Delepine D, Delgado M, Dell’Acqua A, Delmonte N, De Lurgio P, de Mello Neto JRT, DeMuth DM, Dennis S, Densham C, Deptuch GW, De Roeck A, De Romeri V, De Souza G, Devi R, Dharmapalan R, Dias M, Diaz F, Díaz JS, Domizio SD, Giulio LD, Ding P, Noto LD, Dirkx G, Distefano C, Diurba R, Diwan M, Djurcic Z, Doering D, Dolan S, Dolek F, Dolinski M, Domine L, Donon Y, Douglas D, Douillet D, Dragone A, Drake G, Drielsma F, Duarte L, Duchesneau D, Duffy K, Dunne P, Dutta B, Duyang H, Dvornikov O, Dwyer D, Dyshkant A, Eads M, Earle A, Edmunds D, Eisch J, Emberger L, Emery S, Englezos P, Ereditato A, Erjavec T, Escobar C, Eurin G, Evans JJ, Ewart E, Ezeribe AC, Fahey K, Falcone A, Fani’ M, Farnese C, Farzan Y, Fedoseev D, Felix J, Feng Y, Fernandez-Martinez E, Menendez PF, Morales MF, Ferraro F, Fields L, Filip P, Filthaut F, Fiorini M, Fischer V, Fitzpatrick RS, Flanagan W, Fleming B, Flight R, Fogarty S, Foreman W, Fowler J, Fox W, Franc J, Francis K, Franco D, Freeman J, Freestone J, Fried J, Friedland A, Robayo FF, Fuess S, Furic IK, Furman K, Furmanski AP, Gabrielli A, Gago A, Gallagher H, Gallas A, Gallego-Ros A, Gallice N, Galymov V, Gamberini E, Gamble T, Ganacim F, Gandhi R, Gandrajula R, Gao F, Gao S, Garcia-Gamez D, García-Peris MÁ, Gardiner S, Gastler D, Gauvreau J, Ge G, Geffroy N, Gelli B, Gendotti A, Gent S, Ghorbani-Moghaddam Z, Giammaria P, Giammaria T, Giangiacomi N, Gibin D, Gil-Botella I, Gilligan S, Girerd C, Giri AK, Gnani D, Gogota O, Gold M, Gollapinni S, Gollwitzer K, Gomes RA, Bermeo LVG, Fajardo LSG, Gonnella F, Gonzalez-Diaz D, Gonzalez-Lopez M, Goodman MC, Goodwin O, Goswami S, Gotti C, Goudzovski E, Grace C, Gran R, Granados E, Granger P, Grant A, Grant C, Gratieri D, Green P, Greenler L, Greer J, Grenard J, Griffith WC, Groh M, Grudzinski J, Grzelak K, Gu W, Guardincerri E, Guarino V, Guarise M, Guenette R, Guerard E, Guerzoni M, Guffanti D, Guglielmi A, Guo B, Gupta A, Gupta V, Guthikonda KK, Gutierrez R, Guzowski P, Guzzo MM, Gwon S, Ha C, Haaf K, Habig A, Hadavand H, Haenni R, Hahn A, Haiston J, Hamacher-Baumann P, Hamernik T, Hamilton P, Han J, Harris DA, Hartnell J, Hartnett T, Harton J, Hasegawa T, Hasnip C, Hatcher R, Hatfield KW, Hatzikoutelis A, Hayes C, Hayrapetyan K, Hays J, Hazen E, He M, Heavey A, Heeger KM, Heise J, Henry S, Morquecho MAH, Herner K, Hewes J, Hilgenberg C, Hill T, Hillier SJ, Himmel A, Hinkle E, Hirsch LR, Ho J, Hoff J, Holin A, Hoppe E, Horton-Smith GA, Hostert M, Hourlier A, Howard B, Howell R, Hoyos J, Hristova I, Hronek MS, Huang J, Hulcher Z, Iles G, Ilic N, Iliescu AM, Illingworth R, Ingratta G, Ioannisian A, Irwin B, Isenhower L, Itay R, Jackson CM, Jain V, James E, Jang W, Jargowsky B, Jediny F, Jena D, Jeong YS, Jesús-Valls C, Ji X, Jiang L, Jiménez S, Jipa A, Johnson R, Johnson W, Johnston N, Jones B, Jones S, Judah M, Jung CK, Junk T, Jwa Y, Kabirnezhad M, Kaboth A, Kadenko I, Kakorin I, Kalitkina A, Kalra D, Kamiya F, Kaneshige N, Kaplan DM, Karagiorgi G, Karaman G, Karcher A, Karolak M, Karyotakis Y, Kasai S, Kasetti SP, Kashur L, Kazaryan N, Kearns E, Keener P, Kelly KJ, Kemp E, Kemularia O, Ketchum W, Kettell SH, Khabibullin M, Khotjantsev A, Khvedelidze A, Kim D, King B, Kirby B, Kirby M, Klein J, Klustova A, Kobilarcik T, Koehler K, Koerner LW, Koh DH, Kohn S, Koller PP, Kolupaeva L, Korablev D, Kordosky M, Kosc T, Kose U, Kostelecký VA, Kothekar K, Kralik R, Kreczko L, Krennrich F, Kreslo I, Kropp W, Kroupova T, Kubota S, Kudenko Y, Kudryavtsev VA, Kulagin S, Kumar J, Kumar P, Kunze P, Kurita N, Kuruppu C, Kus V, Kutter T, Kvasnicka J, Kwak D, Lambert A, Land B, Lane CE, Lang K, Langford T, Langstaff M, Larkin J, Lasorak P, Last D, Laundrie A, Laurenti G, Lawrence A, Lazanu I, LaZur R, Lazzaroni M, Le T, Leardini S, Learned J, LeBrun P, LeCompte T, Lee C, Lee SY, Miotto GL, Lehnert R, de Oliveira MAL, Leitner M, Lepin LM, Li SW, Li Y, Liao H, Lin CS, Lin Q, Lin S, Lineros RA, Ling J, Lister A, Littlejohn BR, Liu J, Liu Y, Lockwitz S, Loew T, Lokajicek M, Lomidze I, Long K, Lord T, LoSecco JM, Louis WC, Lu XG, Luk KB, Lunday B, Luo X, Luppi E, Lux T, Luzio VP, Maalmi J, MacFarlane D, Machado AA, Machado P, Macias CT, Macier JR, Maddalena A, Madera A, Madigan P, Magill S, Mahn K, Maio A, Major A, Maloney JA, Mandrioli G, Mandujano RC, Maneira J, Manenti L, Manly S, Mann A, Manolopoulos K, Plata MM, Manyam VN, Manzanillas L, Marchan M, Marchionni A, Marciano W, Marfatia D, Mariani C, Maricic J, Marie R, Marinho F, Marino AD, Marsden D, Marshak M, Marshall C, Marshall J, Marteau J, Martín-Albo J, Martinez N, Caicedo DAM, Miravé PM, Martynenko S, Mascagna V, Mason K, Mastbaum A, Matichard F, Matsuno S, Matthews J, Mauger C, Mauri N, Mavrokoridis K, Mawby I, Mazza R, Mazzacane A, Mazzucato E, McAskill T, McCluskey E, McConkey N, McFarland KS, McGrew C, McNab A, Mefodiev A, Mehta P, Melas P, Mena O, Mendez H, Mendez P, Méndez DP, Menegolli A, Meng G, Messier MD, Metcalf W, Mettler T, Mewes M, Meyer H, Miao T, Michna G, Miedema T, Mikola V, Milincic R, Miller G, Miller W, Mills J, Mineev O, Minotti A, Miranda OG, Miryala S, Mishra CS, Mishra SR, Mislivec A, Mitchell M, Mladenov D, Mocioiu I, Moffat K, Moggi N, Mohanta R, Mohayai TA, Mokhov N, Molina J, Bueno LM, Montagna E, Montanari A, Montanari C, Montanari D, Zetina LMM, Moon SH, Mooney M, Moor AF, Moreno D, Moretti D, Morris C, Mossey C, Mote M, Motuk E, Moura CA, Mousseau J, Mouster G, Mu W, Mualem L, Mueller J, Muether M, Mufson S, Muheim F, Muir A, Mulhearn M, Munford D, Muramatsu H, Murphy S, Musser J, Nachtman J, Nagu S, Nalbandyan M, Nandakumar R, Naples D, Narita S, Nath A, Navrer-Agasson A, Nayak N, Nebot-Guinot M, Negishi K, Nelson JK, Nesbit J, Nessi M, Newbold D, Newcomer M, Newton H, Nichol R, Nicolas-Arnaldos F, Nikolica A, Niner E, Nishimura K, Norman A, Norrick A, Northrop R, Novella P, Nowak JA, Oberling M, Ochoa-Ricoux J, Olivier A, Olshevskiy A, Onel Y, Onishchuk Y, Ott J, Pagani L, Palacio G, Palamara O, Palestini S, Paley JM, Pallavicini M, Palomares C, Vazquez WP, Pantic E, Paolone V, Papadimitriou V, Papaleo R, Papanestis A, Paramesvaran S, Parke S, Parozzi E, Parsa Z, Parvu M, Pascoli S, Pasqualini L, Pasternak J, Pater J, Patrick C, Patrizii L, Patterson RB, Patton SJ, Patzak T, Paudel A, Paulos B, Paulucci L, Pavlovic Z, Pawloski G, Payne D, Pec V, Peeters SJM, Perez AP, Pennacchio E, Penzo A, Peres OLG, Perry J, Pershey D, Pessina G, Petrillo G, Petta C, Petti R, Pia V, Piastra F, Pickering L, Pietropaolo F, Pimentel VL, Pinaroli G, Plows K, Plunkett R, Poling R, Pompa F, Pons X, Poonthottathil N, Poppi F, Pordes S, Porter J, Potekhin M, Potenza R, Potukuchi BVKS, Pozimski J, Pozzato M, Prakash S, Prakash T, Prest M, Prince S, Psihas F, Pugnere D, Qian X, Raaf JL, Radeka V, Rademacker J, Radics B, Rafique A, Raguzin E, Rai M, Rajaoalisoa M, Rakhno I, Rakotonandrasana A, Rakotondravohitra L, Rameika R, Delgado MAR, Ramson B, Rappoldi A, Raselli G, Ratoff P, Raut S, Razakamiandra RF, Rea EM, Real JS, Rebel B, Rechenmacher R, Reggiani-Guzzo M, Reichenbacher J, Reitzner SD, Sfar HR, Renshaw A, Rescia S, Resnati F, Ribas M, Riboldi S, Riccio C, Riccobene G, Rice LCJ, Ricol JS, Rigamonti A, Rigaut Y, Rincón EV, Ritchie-Yates H, Rivera D, Robert A, Rochester L, Roda M, Rodrigues P, Alonso MJR, Bonilla ER, Rondon JR, Rosauro-Alcaraz S, Rosenberg M, Rosier P, Roskovec B, Rossella M, Rossi M, Rout J, Roy P, Rubbia A, Rubbia C, Russell B, Ruterbories D, Rybnikov A, Saa-Hernandez A, Saakyan R, Sacerdoti S, Safford T, Sahu N, Sakashita K, Sala P, Samios N, Samoylov O, Sanchez MC, Sandberg V, Sanders DA, Sankey D, Santana S, Santos-Maldonado M, Saoulidou N, Sapienza P, Sarasty C, Sarcevic I, Savage G, Savinov V, Scaramelli A, Scarff A, Scarpelli A, Schefke T, Schellman H, Schifano S, Schlabach P, Schmitz D, Schneider AW, Scholberg K, Schukraft A, Segreto E, Selyunin A, Senise CR, Sensenig J, Sergi A, Sgalaberna D, Shaevitz MH, Shafaq S, Shaker F, Shamma M, Sharankova R, Sharma HR, Sharma R, Sharma RK, Shaw T, Shchablo K, Shepherd-Themistocleous C, Sheshukov A, Shin S, Shoemaker I, Shooltz D, Shrock R, Siegel H, Simard L, Sinclair J, Sinev G, Singh J, Singh J, Singh L, Singh P, Singh V, Sipos R, Sippach FW, Sirri G, Sitraka A, Siyeon K, Skarpaas K, Smith A, Smith E, Smith P, Smolik J, Smy M, Snider E, Snopok P, Snowden-Ifft D, Nunes MS, Sobel H, Soderberg M, Sokolov S, Salinas CJS, Söldner-Rembold S, Soleti SR, Solomey N, Solovov V, Sondheim WE, Sorel M, Sotnikov A, Soto-Oton J, Ugaldi FAS, Sousa A, Soustruznik K, Spagliardi F, Spanu M, Spitz J, Spooner NJC, Spurgeon K, Stancari M, Stanco L, Stanford C, Stein R, Steiner HM, Lisbôa AFS, Stewart J, Stillwell B, Stock J, Stocker F, Stokes T, Strait M, Strauss T, Strigari L, Stuart A, Suarez JG, Sunción JMS, Sullivan H, Summers D, Surdo A, Susic V, Suter L, Sutera CM, Svoboda R, Szczerbinska B, Szelc AM, Tanaka H, Tang S, Tapia A, Oregui BT, Tapper A, Tariq S, Tarpara E, Tata N, Tatar E, Tayloe R, Teklu AM, Tennessen P, Tenti M, Terao K, Ternes CA, Terranova F, Testera G, Thakore T, Thea A, Thompson JL, Thorn C, Timm SC, Tishchenko V, Tomassetti L, Tonazzo A, Torbunov D, Torti M, Tortola M, Tortorici F, Tosi N, Totani D, Toups M, Touramanis C, Travaglini R, Trevor J, Trilov S, Trzaska WH, Tsai Y, Tsai YT, Tsamalaidze Z, Tsang KV, Tsverava N, Tufanli S, Tull C, Tyley E, Tzanov M, Uboldi L, Uchida MA, Urheim J, Usher T, Uzunyan S, Vagins MR, Vahle P, Valder S, Valdiviesso GDA, Valencia E, Valentim R, Vallari Z, Vallazza E, Valle JWF, Vallecorsa S, Berg RV, de Water RGV, Forero DV, Vannerom D, Varanini F, Oliva DV, Varner G, Vasel J, Vasina S, Vasseur G, Vaughan N, Vaziri K, Ventura S, Verdugo A, Vergani S, Vermeulen MA, Verzocchi M, Vicenzi M, de Souza HV, Vignoli C, Vilela C, Viren B, Vrba T, Wachala T, Waldron AV, Wallbank M, Wallis C, Wang H, Wang J, Wang L, Wang MHLS, Wang X, Wang Y, Wang Y, Warburton K, Warner D, Wascko MO, Waters D, Watson A, Wawrowska K, Weatherly P, Weber A, Weber M, Wei H, Weinstein A, Wenman D, Wetstein M, White A, Whitehead LH, Whittington D, Wilking MJ, Wilkinson A, Wilkinson C, Williams Z, Wilson F, Wilson RJ, Wisniewski W, Wolcott J, Wongjirad T, Wood A, Wood K, Worcester E, Worcester M, Wresilo K, Wret C, Wu W, Wu W, Xiao Y, Xie F, Yaeggy B, Yandel E, Yang G, Yang K, Yang T, Yankelevich A, Yershov N, Yonehara K, Yoon YS, Young T, Yu B, Yu H, Yu H, Yu J, Yu Y, Yuan W, Zaki R, Zalesak J, Zambelli L, Zamorano B, Zani A, Zazueta L, Zeller GP, Zennamo J, Zeug K, Zhang C, Zhang S, Zhang Y, Zhao M, Zhivun E, Zhu G, Zimmerman ED, Zucchelli S, Zuklin J, Zutshi V, Zwaska R. Scintillation light detection in the 6-m drift-length ProtoDUNE Dual Phase liquid argon TPC. Eur Phys J C Part Fields 2022; 82:618. [PMID: 35859696 PMCID: PMC9288420 DOI: 10.1140/epjc/s10052-022-10549-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 03/31/2022] [Accepted: 06/24/2022] [Indexed: 06/15/2023]
Abstract
DUNE is a dual-site experiment for long-baseline neutrino oscillation studies, neutrino astrophysics and nucleon decay searches. ProtoDUNE Dual Phase (DP) is a 6 × 6 × 6 m 3 liquid argon time-projection-chamber (LArTPC) that recorded cosmic-muon data at the CERN Neutrino Platform in 2019-2020 as a prototype of the DUNE Far Detector. Charged particles propagating through the LArTPC produce ionization and scintillation light. The scintillation light signal in these detectors can provide the trigger for non-beam events. In addition, it adds precise timing capabilities and improves the calorimetry measurements. In ProtoDUNE-DP, scintillation and electroluminescence light produced by cosmic muons in the LArTPC is collected by photomultiplier tubes placed up to 7 m away from the ionizing track. In this paper, the ProtoDUNE-DP photon detection system performance is evaluated with a particular focus on the different wavelength shifters, such as PEN and TPB, and the use of Xe-doped LAr, considering its future use in giant LArTPCs. The scintillation light production and propagation processes are analyzed and a comparison of simulation to data is performed, improving understanding of the liquid argon properties.
Collapse
Affiliation(s)
- A. Abed Abud
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
- University of Liverpool, Liverpool, L69 7ZE UK
| | - B. Abi
- University of Oxford, Oxford, OX1 3RH UK
| | - R. Acciarri
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - M. A. Acero
- Universidad del Atlántico, Barranquilla, Atlántico Colombia
| | - M. R. Adames
- Universidade Tecnológica Federal do Paraná, Curitiba, Brazil
| | - G. Adamov
- Georgian Technical University, Tbilisi, Georgia
| | - M. Adamowski
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - D. Adams
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | | | | | - J. Aguilar
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - Z. Ahmad
- Variable Energy Cyclotron Centre, Kolkata, West Bengal 700 064 India
| | - J. Ahmed
- University of Warwick, Coventry, CV4 7AL UK
| | - B. Aimard
- Laboratoire d’Annecy de Physique des Particules, Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - B. Ali-Mohammadzadeh
- Università di Catania, 2, 95131 Catania, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Catania, 95123 Catania, Italy
| | - T. Alion
- University of Sussex, Brighton, BN1 9RH UK
| | - K. Allison
- University of Colorado Boulder, Boulder, CO 80309 USA
| | - S. Alonso Monsalve
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
- ETH Zurich, Zurich, Switzerland
| | - M. AlRashed
- Kansas State University, Manhattan, KS 66506 USA
| | - C. Alt
- ETH Zurich, Zurich, Switzerland
| | - A. Alton
- Augustana University, Sioux Falls, SD 57197 USA
| | - R. Alvarez
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | - P. Amedo
- Instituto Galego de Fisica de Altas Enerxias, A Coruña, Spain
| | - J. Anderson
- Argonne National Laboratory, Argonne, IL 60439 USA
| | - C. Andreopoulos
- University of Liverpool, Liverpool, L69 7ZE UK
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - M. Andreotti
- University of Ferrara, Ferrara, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Ferrara, 44122 Ferrara, Italy
| | - M. Andrews
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - F. Andrianala
- University of Antananarivo, 101 Antananarivo, Madagascar
| | - S. Andringa
- Laboratório de Instrumentação e Física Experimental de Partículas, 1649-003 Lisboa, 3004-516 Coimbra, Portugal
| | - N. Anfimov
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - A. Ankowski
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - M. Antoniassi
- Universidade Tecnológica Federal do Paraná, Curitiba, Brazil
| | - M. Antonova
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - A. Antoshkin
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - S. Antusch
- University of Basel, 4056 Basel, Switzerland
| | | | - L. Arellano
- University of Manchester, Manchester, M13 9PL UK
| | | | | | - J. Asaadi
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - L. Asquith
- University of Sussex, Brighton, BN1 9RH UK
| | - A. Aurisano
- University of Cincinnati, Cincinnati, OH 45221 USA
| | - V. Aushev
- Taras Shevchenko National University of Kyiv, Kyiv, 01601 Ukraine
| | - D. Autiero
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | | | - M. Ayala-Torres
- Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav), Mexico City, Mexico
| | - F. Azfar
- University of Oxford, Oxford, OX1 3RH UK
| | - A. Back
- Indiana University, Bloomington, IN 47405 USA
| | - H. Back
- Pacific Northwest National Laboratory, Richland, WA 99352 USA
| | - J. J. Back
- University of Warwick, Coventry, CV4 7AL UK
| | | | | | - L. Bagby
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - N. Balashov
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | | | - P. Baldi
- University of California Irvine, Irvine, CA 92697 USA
| | - B. Baller
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - B. Bambah
- University of Hyderabad, Gachibowli, Hyderabad, 500 046 India
| | - F. Barao
- Instituto Superior Técnico-IST, Universidade de Lisboa, 1049-001 Lisbon, Portugal
- Laboratório de Instrumentação e Física Experimental de Partículas, 1649-003 Lisboa, 3004-516 Coimbra, Portugal
| | - G. Barenboim
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - P. Barham Alzas
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - G. Barker
- University of Warwick, Coventry, CV4 7AL UK
| | - W. Barkhouse
- University of North Dakota, Grand Forks, ND 58202-8357 USA
| | - C. Barnes
- University of Michigan, Ann Arbor, MI 48109 USA
| | - G. Barr
- University of Oxford, Oxford, OX1 3RH UK
| | | | - A. Barros
- Universidade Tecnológica Federal do Paraná, Curitiba, Brazil
| | - N. Barros
- Faculdade de Ciências da Universidade de Lisboa-FCUL, 1749-016 Lisbon, Portugal
- Laboratório de Instrumentação e Física Experimental de Partículas, 1649-003 Lisboa, 3004-516 Coimbra, Portugal
| | - J. L. Barrow
- Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | | | - A. Bashyal
- Argonne National Laboratory, Argonne, IL 60439 USA
| | - V. Basque
- University of Manchester, Manchester, M13 9PL UK
| | | | | | | | | | - F. Bay
- Antalya Bilim University, 07190 Döşemealti/Antalya, Turkey
| | - M. C. Q. Bazetto
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | | | | | - E. Bechetoille
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - B. Behera
- Colorado State University, Fort Collins, CO 80523 USA
| | - C. Beigbeder
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - L. Bellantoni
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - V. Bellini
- Università di Catania, 2, 95131 Catania, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Catania, 95123 Catania, Italy
| | - O. Beltramello
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - N. Benekos
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | | | - F. Bento Neves
- Laboratório de Instrumentação e Física Experimental de Partículas, 1649-003 Lisboa, 3004-516 Coimbra, Portugal
| | - J. Berger
- Colorado State University, Fort Collins, CO 80523 USA
| | - S. Berkman
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - P. Bernardini
- Istituto Nazionale di Fisica Nucleare Sezione di Lecce, 73100 Lecce, Italy
- Università del Salento, 73100 Lecce, Italy
| | | | - A. Bersani
- Istituto Nazionale di Fisica Nucleare Sezione di Genova, 16146 Genoa, GE Italy
| | - S. Bertolucci
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - M. Betancourt
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - A. Bevan
- Queen Mary University of London, London, E1 4NS UK
| | - Y. Bezawada
- University of California Davis, Davis, CA 95616 USA
| | | | - A. Bhardwaj
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - V. Bhatnagar
- Panjab University, Chandigarh, U.T. 160014 India
| | - M. Bhattacharjee
- Indian Institute of Technology Guwahati, Guwahati, 781 039 India
| | - D. Bhattarai
- University of Mississippi, University, MS 38677 USA
| | - S. Bhuller
- University of Bristol, Bristol, BS8 1TL UK
| | - B. Bhuyan
- Indian Institute of Technology Guwahati, Guwahati, 781 039 India
| | - S. Biagi
- Istituto Nazionale di Fisica Nucleare Laboratori Nazionali del Sud, 95123 Catania, Italy
| | - J. Bian
- University of California Irvine, Irvine, CA 92697 USA
| | - M. Biassoni
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | - K. Biery
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - B. Bilki
- Beykent University, Istanbul, Turkey
- University of Iowa, Iowa City, IA 52242 USA
| | - M. Bishai
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - A. Bitadze
- University of Manchester, Manchester, M13 9PL UK
| | - A. Blake
- Lancaster University, Lancaster, LA1 4YB UK
| | - F. Blaszczyk
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - G. C. Blazey
- Northern Illinois University, DeKalb, IL 60115 USA
| | - E. Blucher
- University of Chicago, Chicago, IL 60637 USA
| | - J. Boissevain
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | - S. Bolognesi
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | - T. Bolton
- Kansas State University, Manhattan, KS 66506 USA
| | - L. Bomben
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- University of Insubria, Via Ravasi, 2, 21100 Varese, VA Italy
| | - M. Bonesini
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- Università del Milano-Bicocca, 20126 Milan, Italy
| | - M. Bongrand
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | | | - F. Bonini
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - A. Booth
- Queen Mary University of London, London, E1 4NS UK
| | - F. Boran
- Beykent University, Istanbul, Turkey
| | - S. Bordoni
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - A. Borkum
- University of Sussex, Brighton, BN1 9RH UK
| | - N. Bostan
- University of Notre Dame, Notre Dame, IN 46556 USA
| | - P. Bour
- Czech Technical University, 115 19 Prague 1, Czech Republic
| | - C. Bourgeois
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - D. Boyden
- Northern Illinois University, DeKalb, IL 60115 USA
| | - J. Bracinik
- University of Birmingham, Birmingham, B15 2TT UK
| | - D. Braga
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - A. Branca
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | - A. Brandt
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - J. Bremer
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - D. Breton
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - C. Brew
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - S. J. Brice
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - C. Brizzolari
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- Università del Milano-Bicocca, 20126 Milan, Italy
| | - C. Bromberg
- Michigan State University, East Lansing, MI 48824 USA
| | - J. Brooke
- University of Bristol, Bristol, BS8 1TL UK
| | - A. Bross
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - G. Brunetti
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- Università del Milano-Bicocca, 20126 Milan, Italy
| | | | - N. Buchanan
- Colorado State University, Fort Collins, CO 80523 USA
| | - H. Budd
- University of Rochester, Rochester, NY 14627 USA
| | - I. Butorov
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - I. Cagnoli
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - T. Cai
- York University, Toronto, M3J 1P3 Canada
| | - D. Caiulo
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - R. Calabrese
- University of Ferrara, Ferrara, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Ferrara, 44122 Ferrara, Italy
| | - P. Calafiura
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - J. Calcutt
- Oregon State University, Corvallis, OR 97331 USA
| | - M. Calin
- University of Bucharest, Bucharest, Romania
| | - S. Calvez
- Colorado State University, Fort Collins, CO 80523 USA
| | - E. Calvo
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | - A. Caminata
- Istituto Nazionale di Fisica Nucleare Sezione di Genova, 16146 Genoa, GE Italy
| | | | - D. Caratelli
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - D. Carber
- Colorado State University, Fort Collins, CO 80523 USA
| | | | - G. Carini
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - B. Carlus
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | | | - P. Carniti
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | | | - H. Carranza
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - T. Carroll
- University of Wisconsin Madison, Madison, WI 53706 USA
| | | | - A. Castillo
- Universidad Sergio Arboleda, 11022 Bogotá, Colombia
| | | | - E. Catano-Mur
- College of William and Mary, Williamsburg, VA 23187 USA
| | - C. Cattadori
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | - F. Cavalier
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - G. Cavallaro
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | - F. Cavanna
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - S. Centro
- Istituto Nazionale di Fisica Nucleare Sezione di Padova, 35131 Padua, Italy
- Universtà degli Studi di Padova, 35131 Padua, Italy
| | - G. Cerati
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - A. Cervelli
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - A. Cervera Villanueva
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - M. Chalifour
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | | | - E. Chardonnet
- Université de Paris, CNRS, Astroparticule et Cosmologie, 75006 Paris, France
| | - N. Charitonidis
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | | | - S. Chattopadhyay
- Variable Energy Cyclotron Centre, Kolkata, West Bengal 700 064 India
| | | | - H. Chen
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - M. Chen
- University of California Irvine, Irvine, CA 92697 USA
| | - Y. Chen
- University of Bern, 3012 Bern, Switzerland
| | - Z. Chen
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | | | - Y. Cheon
- Ulsan National Institute of Science and Technology, Ulsan, 689-798 South Korea
| | - D. Cherdack
- University of Houston, Houston, TX 77204 USA
| | - C. Chi
- Columbia University, New York, NY 10027 USA
| | - S. Childress
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - R. Chirco
- Illinois Institute of Technology, Chicago, IL 60616 USA
| | | | | | - K. Cho
- Korea Institute of Science and Technology Information, Daejeon, 34141 South Korea
| | - S. Choate
- Northern Illinois University, DeKalb, IL 60115 USA
| | - D. Chokheli
- Georgian Technical University, Tbilisi, Georgia
| | - P. S. Chong
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | | | - D. Christian
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - G. Christodoulou
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - A. Chukanov
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - M. Chung
- Ulsan National Institute of Science and Technology, Ulsan, 689-798 South Korea
| | - E. Church
- Pacific Northwest National Laboratory, Richland, WA 99352 USA
| | - V. Cicero
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - P. Clarke
- University of Edinburgh, Edinburgh, EH8 9YL UK
| | - G. Cline
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - T. E. Coan
- Southern Methodist University, Dallas, TX 75275 USA
| | - A. G. Cocco
- Istituto Nazionale di Fisica Nucleare Sezione di Napoli, 80126 Naples, Italy
| | - J. A. B. Coelho
- Université de Paris, CNRS, Astroparticule et Cosmologie, 75006 Paris, France
| | - N. Colton
- Colorado State University, Fort Collins, CO 80523 USA
| | - E. Conley
- Duke University, Durham, NC 27708 USA
| | - R. Conley
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - J. Conrad
- Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - M. Convery
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - S. Copello
- Istituto Nazionale di Fisica Nucleare Sezione di Genova, 16146 Genoa, GE Italy
| | - P. Cova
- Istituto Nazionale di Fisica Nucleare Sezione di Milano, 20133 Milan, Italy
- University of Parma, 43121 Parma, PR Italy
| | - L. Cremaldi
- University of Mississippi, University, MS 38677 USA
| | - L. Cremonesi
- Queen Mary University of London, London, E1 4NS UK
| | - J. I. Crespo-Anadón
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | - M. Crisler
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - E. Cristaldo
- Universidad Nacional de Asunción, San Lorenzo, Paraguay
| | - J. Crnkovic
- University of Mississippi, University, MS 38677 USA
| | - R. Cross
- Lancaster University, Lancaster, LA1 4YB UK
| | - A. Cudd
- University of Colorado Boulder, Boulder, CO 80309 USA
| | - C. Cuesta
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | - Y. Cui
- University of California Riverside, Riverside, CA 92521 USA
| | - D. Cussans
- University of Bristol, Bristol, BS8 1TL UK
| | - O. Dalager
- University of California Irvine, Irvine, CA 92697 USA
| | - H. da Motta
- Centro Brasileiro de Pesquisas Físicas, Rio de Janeiro, RJ 22290-180 Brazil
| | - L. Da Silva Peres
- Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-901 Brazil
| | - C. David
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
- York University, Toronto, M3J 1P3 Canada
| | - Q. David
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - G. S. Davies
- University of Mississippi, University, MS 38677 USA
| | - S. Davini
- Istituto Nazionale di Fisica Nucleare Sezione di Genova, 16146 Genoa, GE Italy
| | - J. Dawson
- Université de Paris, CNRS, Astroparticule et Cosmologie, 75006 Paris, France
| | - K. De
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - S. De
- University of Albany, SUNY, Albany, NY 12222 USA
| | - P. Debbins
- University of Iowa, Iowa City, IA 52242 USA
| | - I. De Bonis
- Laboratoire d’Annecy de Physique des Particules, Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - M. P. Decowski
- University of Amsterdam, 1098 XG Amsterdam, The Netherlands
- Nikhef National Institute of Subatomic Physics, 1098 XG Amsterdam, The Netherlands
| | | | - P. C. De Holanda
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | | | | | - P. De Jong
- University of Amsterdam, 1098 XG Amsterdam, The Netherlands
- Nikhef National Institute of Subatomic Physics, 1098 XG Amsterdam, The Netherlands
| | - A. Delbart
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | - D. Delepine
- Universidad de Guanajuato, C.P. 37000 Guanajuato, Mexico
| | - M. Delgado
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- Università del Milano-Bicocca, 20126 Milan, Italy
| | - A. Dell’Acqua
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - N. Delmonte
- Istituto Nazionale di Fisica Nucleare Sezione di Milano, 20133 Milan, Italy
- University of Parma, 43121 Parma, PR Italy
| | - P. De Lurgio
- Argonne National Laboratory, Argonne, IL 60439 USA
| | | | - D. M. DeMuth
- Valley City State University, Valley City, ND 58072 USA
| | - S. Dennis
- University of Cambridge, Cambridge, CB3 0HE UK
| | - C. Densham
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | | | - A. De Roeck
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - V. De Romeri
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - G. De Souza
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | - R. Devi
- University of Jammu, Jammu, 180006 India
| | | | - M. Dias
- Universidade Federal de São Paulo, São Paulo, 09913-030 Brazil
| | - F. Diaz
- Pontificia Universidad Católica del Perú, Lima, Peru
| | - J. S. Díaz
- Indiana University, Bloomington, IN 47405 USA
| | - S. Di Domizio
- Università degli Studi di Genova, Genoa, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Genova, 16146 Genoa, GE Italy
| | - L. Di Giulio
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - P. Ding
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - L. Di Noto
- Università degli Studi di Genova, Genoa, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Genova, 16146 Genoa, GE Italy
| | - G. Dirkx
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - C. Distefano
- Istituto Nazionale di Fisica Nucleare Laboratori Nazionali del Sud, 95123 Catania, Italy
| | - R. Diurba
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - M. Diwan
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - Z. Djurcic
- Argonne National Laboratory, Argonne, IL 60439 USA
| | - D. Doering
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - S. Dolan
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - F. Dolek
- Beykent University, Istanbul, Turkey
| | - M. Dolinski
- Drexel University, Philadelphia, PA 19104 USA
| | - L. Domine
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - Y. Donon
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - D. Douglas
- Michigan State University, East Lansing, MI 48824 USA
| | - D. Douillet
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - A. Dragone
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - G. Drake
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - F. Drielsma
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - L. Duarte
- Universidade Federal de São Paulo, São Paulo, 09913-030 Brazil
| | - D. Duchesneau
- Laboratoire d’Annecy de Physique des Particules, Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - K. Duffy
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - P. Dunne
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - B. Dutta
- Texas A &M University, College Station, 77840 USA
| | - H. Duyang
- University of South Carolina, Columbia, SC 29208 USA
| | | | - D. Dwyer
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - A. Dyshkant
- Northern Illinois University, DeKalb, IL 60115 USA
| | - M. Eads
- Northern Illinois University, DeKalb, IL 60115 USA
| | - A. Earle
- University of Sussex, Brighton, BN1 9RH UK
| | - D. Edmunds
- Michigan State University, East Lansing, MI 48824 USA
| | - J. Eisch
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - L. Emberger
- University of Manchester, Manchester, M13 9PL UK
- Max-Planck-Institut, 80805 Munich, Germany
| | - S. Emery
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | - P. Englezos
- Rutgers University, Piscataway, NJ 08854 USA
| | | | - T. Erjavec
- University of California Davis, Davis, CA 95616 USA
| | - C. Escobar
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - G. Eurin
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | - J. J. Evans
- University of Manchester, Manchester, M13 9PL UK
| | - E. Ewart
- Indiana University, Bloomington, IN 47405 USA
| | | | - K. Fahey
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - A. Falcone
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- Università del Milano-Bicocca, 20126 Milan, Italy
| | - M. Fani’
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | - C. Farnese
- Istituto Nazionale di Fisica Nucleare Sezione di Padova, 35131 Padua, Italy
| | - Y. Farzan
- Institute for Research in Fundamental Sciences, Tehran, Iran
| | - D. Fedoseev
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - J. Felix
- Universidad de Guanajuato, C.P. 37000 Guanajuato, Mexico
| | - Y. Feng
- Iowa State University, Ames, IA 50011 USA
| | | | - P. Fernandez Menendez
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | | | - F. Ferraro
- Università degli Studi di Genova, Genoa, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Genova, 16146 Genoa, GE Italy
| | - L. Fields
- University of Notre Dame, Notre Dame, IN 46556 USA
| | - P. Filip
- Institute of Physics, Czech Academy of Sciences, 182 00 Prague 8, Czech Republic
| | - F. Filthaut
- Nikhef National Institute of Subatomic Physics, 1098 XG Amsterdam, The Netherlands
- Radboud University, 6525 AJ Nijmegen, The Netherlands
| | - M. Fiorini
- University of Ferrara, Ferrara, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Ferrara, 44122 Ferrara, Italy
| | - V. Fischer
- Iowa State University, Ames, IA 50011 USA
| | | | - W. Flanagan
- University of Dallas, Irving, TX 75062-4736 USA
| | - B. Fleming
- Yale University, New Haven, CT 06520 USA
| | - R. Flight
- University of Rochester, Rochester, NY 14627 USA
| | - S. Fogarty
- Colorado State University, Fort Collins, CO 80523 USA
| | - W. Foreman
- Illinois Institute of Technology, Chicago, IL 60616 USA
| | - J. Fowler
- Duke University, Durham, NC 27708 USA
| | - W. Fox
- Indiana University, Bloomington, IN 47405 USA
| | - J. Franc
- Czech Technical University, 115 19 Prague 1, Czech Republic
| | - K. Francis
- Northern Illinois University, DeKalb, IL 60115 USA
| | - D. Franco
- Yale University, New Haven, CT 06520 USA
| | - J. Freeman
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - J. Freestone
- University of Manchester, Manchester, M13 9PL UK
| | - J. Fried
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - A. Friedland
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | | | - S. Fuess
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - I. K. Furic
- University of Florida, Gainesville, FL 32611-8440 USA
| | - K. Furman
- Queen Mary University of London, London, E1 4NS UK
| | - A. P. Furmanski
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - A. Gabrielli
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - A. Gago
- Pontificia Universidad Católica del Perú, Lima, Peru
| | | | - A. Gallas
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - A. Gallego-Ros
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | - N. Gallice
- Istituto Nazionale di Fisica Nucleare Sezione di Milano, 20133 Milan, Italy
- Università degli Studi di Milano, 20133 Milan, Italy
| | - V. Galymov
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - E. Gamberini
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - T. Gamble
- University of Sheffield, Sheffield, S3 7RH UK
| | - F. Ganacim
- Universidade Tecnológica Federal do Paraná, Curitiba, Brazil
| | - R. Gandhi
- Harish-Chandra Research Institute, Jhunsi, Allahabad, 211 019 India
| | - R. Gandrajula
- Michigan State University, East Lansing, MI 48824 USA
| | - F. Gao
- University of Pittsburgh, Pittsburgh, PA 15260 USA
| | - S. Gao
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | | | - M. Á. García-Peris
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - S. Gardiner
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - J. Gauvreau
- Occidental College, Los Angeles, CA 90041 USA
| | - G. Ge
- Columbia University, New York, NY 10027 USA
| | - N. Geffroy
- Laboratoire d’Annecy de Physique des Particules, Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - B. Gelli
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | | | - S. Gent
- South Dakota State University, Brookings, SD 57007 USA
| | | | - P. Giammaria
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | - T. Giammaria
- University of Ferrara, Ferrara, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Ferrara, 44122 Ferrara, Italy
| | | | - D. Gibin
- Istituto Nazionale di Fisica Nucleare Sezione di Padova, 35131 Padua, Italy
- Universtà degli Studi di Padova, 35131 Padua, Italy
| | - I. Gil-Botella
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | - S. Gilligan
- Oregon State University, Corvallis, OR 97331 USA
| | - C. Girerd
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - A. K. Giri
- Indian Institute of Technology Hyderabad, Hyderabad, 502285 India
| | - D. Gnani
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - O. Gogota
- Taras Shevchenko National University of Kyiv, Kyiv, 01601 Ukraine
| | - M. Gold
- University of New Mexico, Albuquerque, NM 87131 USA
| | - S. Gollapinni
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | - K. Gollwitzer
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - R. A. Gomes
- Universidade Federal de Goias, Goiania, GO 74690-900 Brazil
| | | | | | - F. Gonnella
- University of Birmingham, Birmingham, B15 2TT UK
| | | | | | | | - O. Goodwin
- University of Manchester, Manchester, M13 9PL UK
| | - S. Goswami
- Physical Research Laboratory, Ahmedabad, 380 009 India
| | - C. Gotti
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | | | - C. Grace
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - R. Gran
- University of Minnesota Duluth, Duluth, MN 55812 USA
| | - E. Granados
- Universidad de Guanajuato, C.P. 37000 Guanajuato, Mexico
| | - P. Granger
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | - A. Grant
- Daresbury Laboratory, Cheshire, WA4 4AD UK
| | - C. Grant
- Boston University, Boston, MA 02215 USA
| | - D. Gratieri
- Fluminense Federal University, 9 Icaraí, Niterói, RJ 24220-900 Brazil
| | - P. Green
- University of Manchester, Manchester, M13 9PL UK
| | - L. Greenler
- University of Wisconsin Madison, Madison, WI 53706 USA
| | - J. Greer
- University of Bristol, Bristol, BS8 1TL UK
| | - J. Grenard
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | | | - M. Groh
- Colorado State University, Fort Collins, CO 80523 USA
| | | | - K. Grzelak
- University of Warsaw, 02-093 Warsaw, Poland
| | - W. Gu
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | | | - V. Guarino
- Argonne National Laboratory, Argonne, IL 60439 USA
| | - M. Guarise
- University of Ferrara, Ferrara, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Ferrara, 44122 Ferrara, Italy
| | | | - E. Guerard
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M. Guerzoni
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - D. Guffanti
- Istituto Nazionale di Fisica Nucleare Sezione di Milano, 20133 Milan, Italy
| | - A. Guglielmi
- Istituto Nazionale di Fisica Nucleare Sezione di Padova, 35131 Padua, Italy
| | - B. Guo
- University of South Carolina, Columbia, SC 29208 USA
| | - A. Gupta
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - V. Gupta
- Nikhef National Institute of Subatomic Physics, 1098 XG Amsterdam, The Netherlands
| | | | | | - P. Guzowski
- University of Manchester, Manchester, M13 9PL UK
| | - M. M. Guzzo
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | - S. Gwon
- Chung-Ang University, Seoul, 06974 South Korea
| | - C. Ha
- Chung-Ang University, Seoul, 06974 South Korea
| | - K. Haaf
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - A. Habig
- University of Minnesota Duluth, Duluth, MN 55812 USA
| | - H. Hadavand
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - R. Haenni
- University of Bern, 3012 Bern, Switzerland
| | - A. Hahn
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - J. Haiston
- South Dakota School of Mines and Technology, Rapid City, SD 57701 USA
| | | | - T. Hamernik
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - P. Hamilton
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - J. Han
- University of Pittsburgh, Pittsburgh, PA 15260 USA
| | - D. A. Harris
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
- York University, Toronto, M3J 1P3 Canada
| | | | - T. Hartnett
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - J. Harton
- Colorado State University, Fort Collins, CO 80523 USA
| | - T. Hasegawa
- High Energy Accelerator Research Organization (KEK), Ibaraki, 305-0801 Japan
| | - C. Hasnip
- University of Oxford, Oxford, OX1 3RH UK
| | - R. Hatcher
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | | | - C. Hayes
- Indiana University, Bloomington, IN 47405 USA
| | | | - J. Hays
- Queen Mary University of London, London, E1 4NS UK
| | - E. Hazen
- Boston University, Boston, MA 02215 USA
| | - M. He
- University of Houston, Houston, TX 77204 USA
| | - A. Heavey
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - J. Heise
- Sanford Underground Research Facility, Lead, SD 57754 USA
| | - S. Henry
- University of Rochester, Rochester, NY 14627 USA
| | | | - K. Herner
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - J. Hewes
- University of Cincinnati, Cincinnati, OH 45221 USA
| | - C. Hilgenberg
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - T. Hill
- Idaho State University, Pocatello, ID 83209 USA
| | | | - A. Himmel
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - E. Hinkle
- University of Chicago, Chicago, IL 60637 USA
| | - L. R. Hirsch
- Universidade Tecnológica Federal do Paraná, Curitiba, Brazil
| | - J. Ho
- Harvard University, Cambridge, MA 02138 USA
| | - J. Hoff
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - A. Holin
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - E. Hoppe
- Pacific Northwest National Laboratory, Richland, WA 99352 USA
| | | | - M. Hostert
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - A. Hourlier
- Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - B. Howard
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - R. Howell
- University of Rochester, Rochester, NY 14627 USA
| | - J. Hoyos
- University of Medellín, Medellín, 050026 Colombia
| | - I. Hristova
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - M. S. Hronek
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - J. Huang
- University of California Davis, Davis, CA 95616 USA
| | - Z. Hulcher
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - G. Iles
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - N. Ilic
- University of Toronto, Toronto, ON M5S 1A1 Canada
| | - A. M. Iliescu
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - R. Illingworth
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - G. Ingratta
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - A. Ioannisian
- Yerevan Institute for Theoretical Physics and Modeling, Yerevan, 0036 Armenia
| | - B. Irwin
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - L. Isenhower
- Abilene Christian University, Abilene, TX 79601 USA
| | - R. Itay
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - C. M. Jackson
- Pacific Northwest National Laboratory, Richland, WA 99352 USA
| | - V. Jain
- University of Albany, SUNY, Albany, NY 12222 USA
| | - E. James
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - W. Jang
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - B. Jargowsky
- University of California Irvine, Irvine, CA 92697 USA
| | - F. Jediny
- Czech Technical University, 115 19 Prague 1, Czech Republic
| | - D. Jena
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - Y. S. Jeong
- Chung-Ang University, Seoul, 06974 South Korea
- University of Iowa, Iowa City, IA 52242 USA
| | - C. Jesús-Valls
- Institut de Física d’Altes Energies (IFAE)-Barcelona Institute of Science and Technology (BIST), Barcelona, Spain
| | - X. Ji
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - L. Jiang
- Virginia Tech, Blacksburg, VA 24060 USA
| | - S. Jiménez
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | - A. Jipa
- University of Bucharest, Bucharest, Romania
| | - R. Johnson
- University of Cincinnati, Cincinnati, OH 45221 USA
| | - W. Johnson
- South Dakota School of Mines and Technology, Rapid City, SD 57701 USA
| | - N. Johnston
- Indiana University, Bloomington, IN 47405 USA
| | - B. Jones
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - S. Jones
- University College London, London, WC1E 6BT UK
| | - M. Judah
- University of Pittsburgh, Pittsburgh, PA 15260 USA
| | - C. K. Jung
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | - T. Junk
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - Y. Jwa
- Columbia University, New York, NY 10027 USA
| | | | - A. Kaboth
- Royal Holloway College, London, TW20 0EX UK
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - I. Kadenko
- Taras Shevchenko National University of Kyiv, Kyiv, 01601 Ukraine
| | - I. Kakorin
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - A. Kalitkina
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - D. Kalra
- Columbia University, New York, NY 10027 USA
| | - F. Kamiya
- Universidade Federal do ABC, Santo André, SP 09210-580 Brazil
| | - N. Kaneshige
- University of California Santa Barbara, Santa Barbara, CA 93106 USA
| | - D. M. Kaplan
- Illinois Institute of Technology, Chicago, IL 60616 USA
| | | | - G. Karaman
- University of Iowa, Iowa City, IA 52242 USA
| | - A. Karcher
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - M. Karolak
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | - Y. Karyotakis
- Laboratoire d’Annecy de Physique des Particules, Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - S. Kasai
- National Institute of Technology, Kure College, Hiroshima, 737-8506 Japan
| | - S. P. Kasetti
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - L. Kashur
- Colorado State University, Fort Collins, CO 80523 USA
| | - N. Kazaryan
- Yerevan Institute for Theoretical Physics and Modeling, Yerevan, 0036 Armenia
| | - E. Kearns
- Boston University, Boston, MA 02215 USA
| | - P. Keener
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - K. J. Kelly
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - E. Kemp
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | | | - W. Ketchum
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - M. Khabibullin
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, 117312 Russia
| | - A. Khotjantsev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, 117312 Russia
| | | | - D. Kim
- Texas A &M University, College Station, 77840 USA
| | - B. King
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - B. Kirby
- Columbia University, New York, NY 10027 USA
| | - M. Kirby
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - J. Klein
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - A. Klustova
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - T. Kobilarcik
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - K. Koehler
- University of Wisconsin Madison, Madison, WI 53706 USA
| | | | - D. H. Koh
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - S. Kohn
- University of California Berkeley, Berkeley, CA 94720 USA
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | | | - L. Kolupaeva
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - D. Korablev
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - M. Kordosky
- College of William and Mary, Williamsburg, VA 23187 USA
| | - T. Kosc
- University Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, 38000 Grenoble, France
| | - U. Kose
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | | | | | - R. Kralik
- University of Sussex, Brighton, BN1 9RH UK
| | - L. Kreczko
- University of Bristol, Bristol, BS8 1TL UK
| | | | - I. Kreslo
- University of Bern, 3012 Bern, Switzerland
| | - W. Kropp
- University of California Irvine, Irvine, CA 92697 USA
| | - T. Kroupova
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - S. Kubota
- Harvard University, Cambridge, MA 02138 USA
| | - Y. Kudenko
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, 117312 Russia
| | | | - S. Kulagin
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, 117312 Russia
| | - J. Kumar
- University of Hawaii, Honolulu, HI 96822 USA
| | - P. Kumar
- University of Sheffield, Sheffield, S3 7RH UK
| | - P. Kunze
- Laboratoire d’Annecy de Physique des Particules, Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - N. Kurita
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - C. Kuruppu
- University of South Carolina, Columbia, SC 29208 USA
| | - V. Kus
- Czech Technical University, 115 19 Prague 1, Czech Republic
| | - T. Kutter
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - J. Kvasnicka
- Institute of Physics, Czech Academy of Sciences, 182 00 Prague 8, Czech Republic
| | - D. Kwak
- Ulsan National Institute of Science and Technology, Ulsan, 689-798 South Korea
| | - A. Lambert
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - B. Land
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - C. E. Lane
- Drexel University, Philadelphia, PA 19104 USA
| | - K. Lang
- University of Texas at Austin, Austin, TX 78712 USA
| | | | - M. Langstaff
- University of Manchester, Manchester, M13 9PL UK
| | - J. Larkin
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - P. Lasorak
- University of Sussex, Brighton, BN1 9RH UK
| | - D. Last
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - A. Laundrie
- University of Wisconsin Madison, Madison, WI 53706 USA
| | - G. Laurenti
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - A. Lawrence
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - I. Lazanu
- University of Bucharest, Bucharest, Romania
| | - R. LaZur
- Colorado State University, Fort Collins, CO 80523 USA
| | - M. Lazzaroni
- Istituto Nazionale di Fisica Nucleare Sezione di Milano, 20133 Milan, Italy
- Università degli Studi di Milano, 20133 Milan, Italy
| | - T. Le
- Tufts University, Medford, MA 02155 USA
| | - S. Leardini
- Instituto Galego de Fisica de Altas Enerxias, A Coruña, Spain
| | - J. Learned
- University of Hawaii, Honolulu, HI 96822 USA
| | - P. LeBrun
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - T. LeCompte
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - C. Lee
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - S. Y. Lee
- Jeonbuk National University, Jeonrabuk-do, 54896 South Korea
| | - G. Lehmann Miotto
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - R. Lehnert
- Indiana University, Bloomington, IN 47405 USA
| | | | - M. Leitner
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - L. M. Lepin
- University of Manchester, Manchester, M13 9PL UK
| | - S. W. Li
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - Y. Li
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - H. Liao
- Kansas State University, Manhattan, KS 66506 USA
| | - C. S. Lin
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - Q. Lin
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - S. Lin
- Louisiana State University, Baton Rouge, LA 70803 USA
| | | | - J. Ling
- Sun Yat-Sen University, Guangzhou, 510275 China
| | - A. Lister
- University of Wisconsin Madison, Madison, WI 53706 USA
| | | | - J. Liu
- University of California Irvine, Irvine, CA 92697 USA
| | - Y. Liu
- University of Chicago, Chicago, IL 60637 USA
| | - S. Lockwitz
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - T. Loew
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - M. Lokajicek
- Institute of Physics, Czech Academy of Sciences, 182 00 Prague 8, Czech Republic
| | - I. Lomidze
- Georgian Technical University, Tbilisi, Georgia
| | - K. Long
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - T. Lord
- University of Warwick, Coventry, CV4 7AL UK
| | | | - W. C. Louis
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | - X.-G. Lu
- University of Warwick, Coventry, CV4 7AL UK
| | - K. B. Luk
- University of California Berkeley, Berkeley, CA 94720 USA
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - B. Lunday
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - X. Luo
- University of California Santa Barbara, Santa Barbara, CA 93106 USA
| | - E. Luppi
- University of Ferrara, Ferrara, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Ferrara, 44122 Ferrara, Italy
| | - T. Lux
- Institut de Física d’Altes Energies (IFAE)-Barcelona Institute of Science and Technology (BIST), Barcelona, Spain
| | - V. P. Luzio
- Universidade Federal do ABC, Santo André, SP 09210-580 Brazil
| | - J. Maalmi
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - D. MacFarlane
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - A. A. Machado
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | - P. Machado
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - J. R. Macier
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - A. Maddalena
- Laboratori Nazionali del Gran Sasso, L’Aquila, AQ Italy
| | - A. Madera
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - P. Madigan
- University of California Berkeley, Berkeley, CA 94720 USA
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - S. Magill
- Argonne National Laboratory, Argonne, IL 60439 USA
| | - K. Mahn
- Michigan State University, East Lansing, MI 48824 USA
| | - A. Maio
- Faculdade de Ciências da Universidade de Lisboa-FCUL, 1749-016 Lisbon, Portugal
- Laboratório de Instrumentação e Física Experimental de Partículas, 1649-003 Lisboa, 3004-516 Coimbra, Portugal
| | - A. Major
- Duke University, Durham, NC 27708 USA
| | | | - G. Mandrioli
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | | | - J. Maneira
- Faculdade de Ciências da Universidade de Lisboa-FCUL, 1749-016 Lisbon, Portugal
- Laboratório de Instrumentação e Física Experimental de Partículas, 1649-003 Lisboa, 3004-516 Coimbra, Portugal
| | - L. Manenti
- University College London, London, WC1E 6BT UK
| | - S. Manly
- University of Rochester, Rochester, NY 14627 USA
| | - A. Mann
- Tufts University, Medford, MA 02155 USA
| | | | | | - V. N. Manyam
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - L. Manzanillas
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M. Marchan
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - A. Marchionni
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - W. Marciano
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - D. Marfatia
- University of Hawaii, Honolulu, HI 96822 USA
| | | | - J. Maricic
- University of Hawaii, Honolulu, HI 96822 USA
| | - R. Marie
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - F. Marinho
- Universidade Federal de São Carlos, Araras, SP 13604-900 Brazil
| | - A. D. Marino
- University of Colorado Boulder, Boulder, CO 80309 USA
| | - D. Marsden
- University of Manchester, Manchester, M13 9PL UK
| | - M. Marshak
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - C. Marshall
- University of Rochester, Rochester, NY 14627 USA
| | | | - J. Marteau
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - J. Martín-Albo
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - N. Martinez
- Kansas State University, Manhattan, KS 66506 USA
| | | | - P. Martínez Miravé
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - S. Martynenko
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | - V. Mascagna
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- University of Insubria, Via Ravasi, 2, 21100 Varese, VA Italy
| | - K. Mason
- Tufts University, Medford, MA 02155 USA
| | - A. Mastbaum
- Rutgers University, Piscataway, NJ 08854 USA
| | - F. Matichard
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - S. Matsuno
- University of Hawaii, Honolulu, HI 96822 USA
| | - J. Matthews
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - C. Mauger
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - N. Mauri
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | | | - I. Mawby
- University of Warwick, Coventry, CV4 7AL UK
| | - R. Mazza
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | - A. Mazzacane
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - E. Mazzucato
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | | | - E. McCluskey
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - N. McConkey
- University of Manchester, Manchester, M13 9PL UK
| | | | - C. McGrew
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | - A. McNab
- University of Manchester, Manchester, M13 9PL UK
| | - A. Mefodiev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, 117312 Russia
| | - P. Mehta
- Jawaharlal Nehru University, New Delhi, 110067 India
| | - P. Melas
- University of Athens, 157 84 Zografou, Greece
| | - O. Mena
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - H. Mendez
- University of Puerto Rico, Mayaguez, PR 00681 USA
| | - P. Mendez
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - D. P. Méndez
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - A. Menegolli
- Istituto Nazionale di Fisica Nucleare Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Pavia, 27100 Pavia, PV Italy
| | - G. Meng
- Istituto Nazionale di Fisica Nucleare Sezione di Padova, 35131 Padua, Italy
| | | | - W. Metcalf
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - T. Mettler
- University of Bern, 3012 Bern, Switzerland
| | - M. Mewes
- Indiana University, Bloomington, IN 47405 USA
| | - H. Meyer
- Wichita State University, Wichita, KS 67260 USA
| | - T. Miao
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - G. Michna
- South Dakota State University, Brookings, SD 57007 USA
| | - T. Miedema
- Nikhef National Institute of Subatomic Physics, 1098 XG Amsterdam, The Netherlands
- Radboud University, 6525 AJ Nijmegen, The Netherlands
| | - V. Mikola
- University College London, London, WC1E 6BT UK
| | - R. Milincic
- University of Hawaii, Honolulu, HI 96822 USA
| | - G. Miller
- University of Manchester, Manchester, M13 9PL UK
| | - W. Miller
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - J. Mills
- Tufts University, Medford, MA 02155 USA
| | - O. Mineev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, 117312 Russia
| | - A. Minotti
- Istituto Nazionale di Fisica Nucleare Sezione di Milano, 20133 Milan, Italy
- Università del Milano-Bicocca, 20126 Milan, Italy
| | - O. G. Miranda
- Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav), Mexico City, Mexico
| | - S. Miryala
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - C. S. Mishra
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - S. R. Mishra
- University of South Carolina, Columbia, SC 29208 USA
| | - A. Mislivec
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - M. Mitchell
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - D. Mladenov
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - I. Mocioiu
- Pennsylvania State University, University Park, PA 16802 USA
| | - K. Moffat
- Durham University, Durham, DH1 3LE UK
| | - N. Moggi
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - R. Mohanta
- University of Hyderabad, Gachibowli, Hyderabad, 500 046 India
| | - T. A. Mohayai
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - N. Mokhov
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - J. Molina
- Universidad Nacional de Asunción, San Lorenzo, Paraguay
| | - L. Molina Bueno
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - E. Montagna
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - A. Montanari
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - C. Montanari
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
- Istituto Nazionale di Fisica Nucleare Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Pavia, 27100 Pavia, PV Italy
| | - D. Montanari
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - L. M. Montañno Zetina
- Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav), Mexico City, Mexico
| | - S. H. Moon
- Ulsan National Institute of Science and Technology, Ulsan, 689-798 South Korea
| | - M. Mooney
- Colorado State University, Fort Collins, CO 80523 USA
| | - A. F. Moor
- University of Cambridge, Cambridge, CB3 0HE UK
| | - D. Moreno
- Universidad Antonio Nariño, Bogotá, Colombia
| | - D. Moretti
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | - C. Morris
- University of Houston, Houston, TX 77204 USA
| | - C. Mossey
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - M. Mote
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - E. Motuk
- University College London, London, WC1E 6BT UK
| | - C. A. Moura
- Universidade Federal do ABC, Santo André, SP 09210-580 Brazil
| | - J. Mousseau
- University of Michigan, Ann Arbor, MI 48109 USA
| | - G. Mouster
- Lancaster University, Lancaster, LA1 4YB UK
| | - W. Mu
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - L. Mualem
- California Institute of Technology, Pasadena, CA 91125 USA
| | - J. Mueller
- Colorado State University, Fort Collins, CO 80523 USA
| | - M. Muether
- Wichita State University, Wichita, KS 67260 USA
| | - S. Mufson
- Indiana University, Bloomington, IN 47405 USA
| | - F. Muheim
- University of Edinburgh, Edinburgh, EH8 9YL UK
| | - A. Muir
- Daresbury Laboratory, Cheshire, WA4 4AD UK
| | - M. Mulhearn
- University of California Davis, Davis, CA 95616 USA
| | - D. Munford
- University of Houston, Houston, TX 77204 USA
| | - H. Muramatsu
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | | | - J. Musser
- Indiana University, Bloomington, IN 47405 USA
| | | | - S. Nagu
- University of Lucknow, Lucknow, Uttar Pradesh 226007 India
| | - M. Nalbandyan
- Yerevan Institute for Theoretical Physics and Modeling, Yerevan, 0036 Armenia
| | - R. Nandakumar
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - D. Naples
- University of Pittsburgh, Pittsburgh, PA 15260 USA
| | - S. Narita
- Iwate University, Morioka, Iwate 020-8551 Japan
| | - A. Nath
- Indian Institute of Technology Guwahati, Guwahati, 781 039 India
| | | | - N. Nayak
- University of California Irvine, Irvine, CA 92697 USA
| | | | - K. Negishi
- Iwate University, Morioka, Iwate 020-8551 Japan
| | - J. K. Nelson
- College of William and Mary, Williamsburg, VA 23187 USA
| | - J. Nesbit
- University of Wisconsin Madison, Madison, WI 53706 USA
| | - M. Nessi
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - D. Newbold
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - M. Newcomer
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - H. Newton
- Daresbury Laboratory, Cheshire, WA4 4AD UK
| | - R. Nichol
- University College London, London, WC1E 6BT UK
| | | | - A. Nikolica
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - E. Niner
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - A. Norman
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - A. Norrick
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - R. Northrop
- University of Chicago, Chicago, IL 60637 USA
| | - P. Novella
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | | | - M. Oberling
- Argonne National Laboratory, Argonne, IL 60439 USA
| | | | - A. Olivier
- University of Rochester, Rochester, NY 14627 USA
| | - A. Olshevskiy
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - Y. Onel
- University of Iowa, Iowa City, IA 52242 USA
| | - Y. Onishchuk
- Taras Shevchenko National University of Kyiv, Kyiv, 01601 Ukraine
| | - J. Ott
- University of California Irvine, Irvine, CA 92697 USA
| | - L. Pagani
- University of California Davis, Davis, CA 95616 USA
| | - G. Palacio
- Universidad EIA, Envigado, Antioquia, Colombia
| | - O. Palamara
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - S. Palestini
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - J. M. Paley
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - M. Pallavicini
- Università degli Studi di Genova, Genoa, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Genova, 16146 Genoa, GE Italy
| | - C. Palomares
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | | | - E. Pantic
- University of California Davis, Davis, CA 95616 USA
| | - V. Paolone
- University of Pittsburgh, Pittsburgh, PA 15260 USA
| | | | - R. Papaleo
- Istituto Nazionale di Fisica Nucleare Laboratori Nazionali del Sud, 95123 Catania, Italy
| | - A. Papanestis
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | | | - S. Parke
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - E. Parozzi
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- Università del Milano-Bicocca, 20126 Milan, Italy
| | - Z. Parsa
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - M. Parvu
- University of Bucharest, Bucharest, Romania
| | - S. Pascoli
- Università del Bologna, 40127 Bologna, Italy
- Durham University, Durham, DH1 3LE UK
| | - L. Pasqualini
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - J. Pasternak
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - J. Pater
- University of Manchester, Manchester, M13 9PL UK
| | - C. Patrick
- University College London, London, WC1E 6BT UK
| | - L. Patrizii
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | | | - S. J. Patton
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - T. Patzak
- Université de Paris, CNRS, Astroparticule et Cosmologie, 75006 Paris, France
| | - A. Paudel
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - B. Paulos
- University of Wisconsin Madison, Madison, WI 53706 USA
| | - L. Paulucci
- Universidade Federal do ABC, Santo André, SP 09210-580 Brazil
| | - Z. Pavlovic
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - G. Pawloski
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - D. Payne
- University of Liverpool, Liverpool, L69 7ZE UK
| | - V. Pec
- Institute of Physics, Czech Academy of Sciences, 182 00 Prague 8, Czech Republic
| | | | - A. Pena Perez
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - E. Pennacchio
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - A. Penzo
- University of Iowa, Iowa City, IA 52242 USA
| | - O. L. G. Peres
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | - J. Perry
- University of Edinburgh, Edinburgh, EH8 9YL UK
| | | | - G. Pessina
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | - G. Petrillo
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - C. Petta
- Università di Catania, 2, 95131 Catania, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Catania, 95123 Catania, Italy
| | - R. Petti
- University of South Carolina, Columbia, SC 29208 USA
| | - V. Pia
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - F. Piastra
- University of Bern, 3012 Bern, Switzerland
| | - L. Pickering
- Michigan State University, East Lansing, MI 48824 USA
| | - F. Pietropaolo
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
- Istituto Nazionale di Fisica Nucleare Sezione di Padova, 35131 Padua, Italy
| | - V. L. Pimentel
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
- Centro de Tecnologia da Informacao Renato Archer, Amarais, Campinas, SP CEP 13069-901 Brazil
| | - G. Pinaroli
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - K. Plows
- University of Oxford, Oxford, OX1 3RH UK
| | - R. Plunkett
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - R. Poling
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - F. Pompa
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - X. Pons
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | | | - F. Poppi
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - S. Pordes
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - J. Porter
- University of Sussex, Brighton, BN1 9RH UK
| | - M. Potekhin
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - R. Potenza
- Università di Catania, 2, 95131 Catania, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Catania, 95123 Catania, Italy
| | | | - J. Pozimski
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - M. Pozzato
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - S. Prakash
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | - T. Prakash
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - M. Prest
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | - S. Prince
- Harvard University, Cambridge, MA 02138 USA
| | - F. Psihas
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - D. Pugnere
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - X. Qian
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - J. L. Raaf
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - V. Radeka
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | | | | | - A. Rafique
- Argonne National Laboratory, Argonne, IL 60439 USA
| | - E. Raguzin
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - M. Rai
- University of Warwick, Coventry, CV4 7AL UK
| | | | - I. Rakhno
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | | | - R. Rameika
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - B. Ramson
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - A. Rappoldi
- Istituto Nazionale di Fisica Nucleare Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Pavia, 27100 Pavia, PV Italy
| | - G. Raselli
- Istituto Nazionale di Fisica Nucleare Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Pavia, 27100 Pavia, PV Italy
| | - P. Ratoff
- Lancaster University, Lancaster, LA1 4YB UK
| | - S. Raut
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | | | - E. M. Rea
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - J. S. Real
- University Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, 38000 Grenoble, France
| | - B. Rebel
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
- University of Wisconsin Madison, Madison, WI 53706 USA
| | - R. Rechenmacher
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - J. Reichenbacher
- South Dakota School of Mines and Technology, Rapid City, SD 57701 USA
| | - S. D. Reitzner
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - H. Rejeb Sfar
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - A. Renshaw
- University of Houston, Houston, TX 77204 USA
| | - S. Rescia
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - F. Resnati
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - M. Ribas
- Universidade Tecnológica Federal do Paraná, Curitiba, Brazil
| | - S. Riboldi
- Istituto Nazionale di Fisica Nucleare Sezione di Milano, 20133 Milan, Italy
| | - C. Riccio
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | - G. Riccobene
- Istituto Nazionale di Fisica Nucleare Laboratori Nazionali del Sud, 95123 Catania, Italy
| | | | - J. S. Ricol
- University Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, 38000 Grenoble, France
| | - A. Rigamonti
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | | | | | | | - D. Rivera
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | - A. Robert
- University Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, 38000 Grenoble, France
| | - L. Rochester
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - M. Roda
- University of Liverpool, Liverpool, L69 7ZE UK
| | | | | | | | | | | | - M. Rosenberg
- University of Pittsburgh, Pittsburgh, PA 15260 USA
| | - P. Rosier
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - B. Roskovec
- University of California Irvine, Irvine, CA 92697 USA
| | - M. Rossella
- Istituto Nazionale di Fisica Nucleare Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Pavia, 27100 Pavia, PV Italy
| | - M. Rossi
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - J. Rout
- Jawaharlal Nehru University, New Delhi, 110067 India
| | - P. Roy
- Wichita State University, Wichita, KS 67260 USA
| | | | - C. Rubbia
- Gran Sasso Science Institute, L’Aquila, Italy
| | - B. Russell
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | | | - A. Rybnikov
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | | | - R. Saakyan
- University College London, London, WC1E 6BT UK
| | - S. Sacerdoti
- Université de Paris, CNRS, Astroparticule et Cosmologie, 75006 Paris, France
| | - T. Safford
- Michigan State University, East Lansing, MI 48824 USA
| | - N. Sahu
- Indian Institute of Technology Hyderabad, Hyderabad, 502285 India
| | - K. Sakashita
- High Energy Accelerator Research Organization (KEK), Ibaraki, 305-0801 Japan
| | - P. Sala
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
- Istituto Nazionale di Fisica Nucleare Sezione di Milano, 20133 Milan, Italy
| | - N. Samios
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - O. Samoylov
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | | | - V. Sandberg
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | | | - D. Sankey
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - S. Santana
- University of Puerto Rico, Mayaguez, PR 00681 USA
| | | | | | - P. Sapienza
- Istituto Nazionale di Fisica Nucleare Laboratori Nazionali del Sud, 95123 Catania, Italy
| | - C. Sarasty
- University of Cincinnati, Cincinnati, OH 45221 USA
| | | | - G. Savage
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - V. Savinov
- University of Pittsburgh, Pittsburgh, PA 15260 USA
| | - A. Scaramelli
- Istituto Nazionale di Fisica Nucleare Sezione di Pavia, 27100 Pavia, Italy
| | - A. Scarff
- University of Sheffield, Sheffield, S3 7RH UK
| | - A. Scarpelli
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - T. Schefke
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - H. Schellman
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
- Oregon State University, Corvallis, OR 97331 USA
| | - S. Schifano
- University of Ferrara, Ferrara, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Ferrara, 44122 Ferrara, Italy
| | - P. Schlabach
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - D. Schmitz
- University of Chicago, Chicago, IL 60637 USA
| | - A. W. Schneider
- Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | | | - A. Schukraft
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - E. Segreto
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | - A. Selyunin
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - C. R. Senise
- Universidade Federal de São Paulo, São Paulo, 09913-030 Brazil
| | - J. Sensenig
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - A. Sergi
- University of Birmingham, Birmingham, B15 2TT UK
| | | | | | - S. Shafaq
- Jawaharlal Nehru University, New Delhi, 110067 India
| | - F. Shaker
- York University, Toronto, M3J 1P3 Canada
| | - M. Shamma
- University of California Riverside, Riverside, CA 92521 USA
| | | | | | - R. Sharma
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - R. K. Sharma
- Punjab Agricultural University, Ludhiana, 141004 India
| | - T. Shaw
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - K. Shchablo
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | | | - A. Sheshukov
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - S. Shin
- Jeonbuk National University, Jeonrabuk-do, 54896 South Korea
| | | | - D. Shooltz
- Michigan State University, East Lansing, MI 48824 USA
| | - R. Shrock
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | - H. Siegel
- Columbia University, New York, NY 10027 USA
| | - L. Simard
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - J. Sinclair
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - G. Sinev
- South Dakota School of Mines and Technology, Rapid City, SD 57701 USA
| | - J. Singh
- University of Lucknow, Lucknow, Uttar Pradesh 226007 India
| | - J. Singh
- University of Lucknow, Lucknow, Uttar Pradesh 226007 India
| | - L. Singh
- Central University of South Bihar, Gaya, 824236 India
| | - P. Singh
- Queen Mary University of London, London, E1 4NS UK
| | - V. Singh
- Banaras Hindu University, Varanasi, 221 005 India
- Central University of South Bihar, Gaya, 824236 India
| | - R. Sipos
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | | | - G. Sirri
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - A. Sitraka
- South Dakota School of Mines and Technology, Rapid City, SD 57701 USA
| | - K. Siyeon
- Chung-Ang University, Seoul, 06974 South Korea
| | - K. Skarpaas
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - A. Smith
- University of Cambridge, Cambridge, CB3 0HE UK
| | - E. Smith
- Indiana University, Bloomington, IN 47405 USA
| | - P. Smith
- Indiana University, Bloomington, IN 47405 USA
| | - J. Smolik
- Czech Technical University, 115 19 Prague 1, Czech Republic
| | - M. Smy
- University of California Irvine, Irvine, CA 92697 USA
| | - E. Snider
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - P. Snopok
- Illinois Institute of Technology, Chicago, IL 60616 USA
| | | | | | - H. Sobel
- University of California Irvine, Irvine, CA 92697 USA
| | | | - S. Sokolov
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | | | | | - S. R. Soleti
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - N. Solomey
- Wichita State University, Wichita, KS 67260 USA
| | - V. Solovov
- Laboratório de Instrumentação e Física Experimental de Partículas, 1649-003 Lisboa, 3004-516 Coimbra, Portugal
| | - W. E. Sondheim
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | - M. Sorel
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - A. Sotnikov
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - J. Soto-Oton
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | | | - A. Sousa
- University of Cincinnati, Cincinnati, OH 45221 USA
| | - K. Soustruznik
- Institute of Particle and Nuclear Physics of the Faculty of Mathematics and Physics of the Charles University, 180 00 Prague 8, Czech Republic
| | | | - M. Spanu
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- Università del Milano-Bicocca, 20126 Milan, Italy
| | - J. Spitz
- University of Michigan, Ann Arbor, MI 48109 USA
| | | | | | - M. Stancari
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - L. Stanco
- Istituto Nazionale di Fisica Nucleare Sezione di Padova, 35131 Padua, Italy
- Universtà degli Studi di Padova, 35131 Padua, Italy
| | | | - R. Stein
- University of Bristol, Bristol, BS8 1TL UK
| | - H. M. Steiner
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | | | - J. Stewart
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | | | - J. Stock
- South Dakota School of Mines and Technology, Rapid City, SD 57701 USA
| | - F. Stocker
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - T. Stokes
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - M. Strait
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - T. Strauss
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - L. Strigari
- Texas A &M University, College Station, 77840 USA
| | - A. Stuart
- Universidad de Colima, Colima, Mexico
| | | | | | - H. Sullivan
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - D. Summers
- University of Mississippi, University, MS 38677 USA
| | - A. Surdo
- Istituto Nazionale di Fisica Nucleare Sezione di Lecce, 73100 Lecce, Italy
| | - V. Susic
- University of Basel, 4056 Basel, Switzerland
| | - L. Suter
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - C. M. Sutera
- Università di Catania, 2, 95131 Catania, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Catania, 95123 Catania, Italy
| | - R. Svoboda
- University of California Davis, Davis, CA 95616 USA
| | - B. Szczerbinska
- Texas A &M University-Corpus Christi, Corpus Christi, TX 78412 USA
| | - A. M. Szelc
- University of Edinburgh, Edinburgh, EH8 9YL UK
| | - H. Tanaka
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - S. Tang
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - A. Tapia
- University of Medellín, Medellín, 050026 Colombia
| | | | - A. Tapper
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - S. Tariq
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - E. Tarpara
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - N. Tata
- Harvard University, Cambridge, MA 02138 USA
| | - E. Tatar
- Idaho State University, Pocatello, ID 83209 USA
| | - R. Tayloe
- Indiana University, Bloomington, IN 47405 USA
| | - A. M. Teklu
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | - P. Tennessen
- Antalya Bilim University, 07190 Döşemealti/Antalya, Turkey
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - M. Tenti
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - K. Terao
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - C. A. Ternes
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - F. Terranova
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- Università del Milano-Bicocca, 20126 Milan, Italy
| | - G. Testera
- Istituto Nazionale di Fisica Nucleare Sezione di Genova, 16146 Genoa, GE Italy
| | - T. Thakore
- University of Cincinnati, Cincinnati, OH 45221 USA
| | - A. Thea
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | | | - C. Thorn
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - S. C. Timm
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - L. Tomassetti
- University of Ferrara, Ferrara, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Ferrara, 44122 Ferrara, Italy
| | - A. Tonazzo
- Université de Paris, CNRS, Astroparticule et Cosmologie, 75006 Paris, France
| | - D. Torbunov
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - M. Torti
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- Università del Milano-Bicocca, 20126 Milan, Italy
| | - M. Tortola
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - F. Tortorici
- Università di Catania, 2, 95131 Catania, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Catania, 95123 Catania, Italy
| | - N. Tosi
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - D. Totani
- University of California Santa Barbara, Santa Barbara, CA 93106 USA
| | - M. Toups
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - R. Travaglini
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - J. Trevor
- California Institute of Technology, Pasadena, CA 91125 USA
| | - S. Trilov
- University of Bristol, Bristol, BS8 1TL UK
| | | | - Y. Tsai
- University of California Irvine, Irvine, CA 92697 USA
| | - Y.-T. Tsai
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | | | - K. V. Tsang
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - N. Tsverava
- Georgian Technical University, Tbilisi, Georgia
| | - S. Tufanli
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - C. Tull
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - E. Tyley
- University of Sheffield, Sheffield, S3 7RH UK
| | - M. Tzanov
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - L. Uboldi
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | | | - J. Urheim
- Indiana University, Bloomington, IN 47405 USA
| | - T. Usher
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - S. Uzunyan
- Northern Illinois University, DeKalb, IL 60115 USA
| | - M. R. Vagins
- Kavli Institute for the Physics and Mathematics of the Universe, Kashiwa, Chiba 277-8583 Japan
| | - P. Vahle
- College of William and Mary, Williamsburg, VA 23187 USA
| | - S. Valder
- University of Sussex, Brighton, BN1 9RH UK
| | | | - E. Valencia
- Universidad de Guanajuato, C.P. 37000 Guanajuato, Mexico
| | - R. Valentim
- Universidade Federal de São Paulo, São Paulo, 09913-030 Brazil
| | - Z. Vallari
- California Institute of Technology, Pasadena, CA 91125 USA
| | - E. Vallazza
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | - J. W. F. Valle
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - S. Vallecorsa
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - R. Van Berg
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | | | | | - D. Vannerom
- Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - F. Varanini
- Istituto Nazionale di Fisica Nucleare Sezione di Padova, 35131 Padua, Italy
| | - D. Vargas Oliva
- Institut de Física d’Altes Energies (IFAE)-Barcelona Institute of Science and Technology (BIST), Barcelona, Spain
| | - G. Varner
- University of Hawaii, Honolulu, HI 96822 USA
| | - J. Vasel
- Indiana University, Bloomington, IN 47405 USA
| | - S. Vasina
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - G. Vasseur
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | - N. Vaughan
- Oregon State University, Corvallis, OR 97331 USA
| | - K. Vaziri
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - S. Ventura
- Istituto Nazionale di Fisica Nucleare Sezione di Padova, 35131 Padua, Italy
| | - A. Verdugo
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | - S. Vergani
- University of Cambridge, Cambridge, CB3 0HE UK
| | - M. A. Vermeulen
- Nikhef National Institute of Subatomic Physics, 1098 XG Amsterdam, The Netherlands
| | - M. Verzocchi
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - M. Vicenzi
- Università degli Studi di Genova, Genoa, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Genova, 16146 Genoa, GE Italy
| | - H. Vieira de Souza
- Université de Paris, CNRS, Astroparticule et Cosmologie, 75006 Paris, France
| | - C. Vignoli
- Laboratori Nazionali del Gran Sasso, L’Aquila, AQ Italy
| | - C. Vilela
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - B. Viren
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - T. Vrba
- Czech Technical University, 115 19 Prague 1, Czech Republic
| | - T. Wachala
- H. Niewodniczański Institute of Nuclear Physics, Polish Academy of Sciences, Kraków, Poland
| | - A. V. Waldron
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - M. Wallbank
- University of Cincinnati, Cincinnati, OH 45221 USA
| | - C. Wallis
- Colorado State University, Fort Collins, CO 80523 USA
| | - H. Wang
- University of California Los Angeles, Los Angeles, CA 90095 USA
| | - J. Wang
- South Dakota School of Mines and Technology, Rapid City, SD 57701 USA
| | - L. Wang
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | | | - X. Wang
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - Y. Wang
- University of California Los Angeles, Los Angeles, CA 90095 USA
| | - Y. Wang
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | | | - D. Warner
- Colorado State University, Fort Collins, CO 80523 USA
| | - M. O. Wascko
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - D. Waters
- University College London, London, WC1E 6BT UK
| | - A. Watson
- University of Birmingham, Birmingham, B15 2TT UK
| | - K. Wawrowska
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
- University of Sussex, Brighton, BN1 9RH UK
| | | | - A. Weber
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
- Johannes Gutenberg-Universität Mainz, 55122 Mainz, Germany
| | - M. Weber
- University of Bern, 3012 Bern, Switzerland
| | - H. Wei
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | | | - D. Wenman
- University of Wisconsin Madison, Madison, WI 53706 USA
| | | | - A. White
- University of Texas at Arlington, Arlington, TX 76019 USA
| | | | | | - M. J. Wilking
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | | | - C. Wilkinson
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - Z. Williams
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - F. Wilson
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - R. J. Wilson
- Colorado State University, Fort Collins, CO 80523 USA
| | - W. Wisniewski
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | | | | | - A. Wood
- University of Houston, Houston, TX 77204 USA
| | - K. Wood
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - E. Worcester
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - M. Worcester
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - K. Wresilo
- University of Cambridge, Cambridge, CB3 0HE UK
| | - C. Wret
- University of Rochester, Rochester, NY 14627 USA
| | - W. Wu
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - W. Wu
- University of California Irvine, Irvine, CA 92697 USA
| | - Y. Xiao
- University of California Irvine, Irvine, CA 92697 USA
| | - F. Xie
- University of Sussex, Brighton, BN1 9RH UK
| | - B. Yaeggy
- University of Cincinnati, Cincinnati, OH 45221 USA
| | - E. Yandel
- University of California Santa Barbara, Santa Barbara, CA 93106 USA
| | - G. Yang
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | - K. Yang
- University of Oxford, Oxford, OX1 3RH UK
| | - T. Yang
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - N. Yershov
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, 117312 Russia
| | - K. Yonehara
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - Y. S. Yoon
- Chung-Ang University, Seoul, 06974 South Korea
| | - T. Young
- University of North Dakota, Grand Forks, ND 58202-8357 USA
| | - B. Yu
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - H. Yu
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - H. Yu
- Sun Yat-Sen University, Guangzhou, 510275 China
| | - J. Yu
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - Y. Yu
- Illinois Institute of Technology, Chicago, IL 60616 USA
| | - W. Yuan
- University of Edinburgh, Edinburgh, EH8 9YL UK
| | - R. Zaki
- York University, Toronto, M3J 1P3 Canada
| | - J. Zalesak
- Institute of Physics, Czech Academy of Sciences, 182 00 Prague 8, Czech Republic
| | - L. Zambelli
- Laboratoire d’Annecy de Physique des Particules, Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - B. Zamorano
- University of Granada & CAFPE, 18002 Granada, Spain
| | - A. Zani
- Istituto Nazionale di Fisica Nucleare Sezione di Milano, 20133 Milan, Italy
| | - L. Zazueta
- College of William and Mary, Williamsburg, VA 23187 USA
| | - G. P. Zeller
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - J. Zennamo
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - K. Zeug
- University of Wisconsin Madison, Madison, WI 53706 USA
| | - C. Zhang
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - S. Zhang
- Indiana University, Bloomington, IN 47405 USA
| | - Y. Zhang
- University of Pittsburgh, Pittsburgh, PA 15260 USA
| | - M. Zhao
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - E. Zhivun
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - G. Zhu
- Ohio State University, Columbus, OH 43210 USA
| | | | - S. Zucchelli
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - J. Zuklin
- Institute of Physics, Czech Academy of Sciences, 182 00 Prague 8, Czech Republic
| | - V. Zutshi
- Northern Illinois University, DeKalb, IL 60115 USA
| | - R. Zwaska
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | |
Collapse
|
44
|
Kouli O, Murray V, Bhatia S, Cambridge WA, Kawka M, Shafi S, Knight SR, Kamarajah SK, McLean KA, Glasbey JC, Khaw RA, Ahmed W, Akhbari M, Baker D, Borakati A, Mills E, Thavayogan R, Yasin I, Raubenheimer K, Ridley W, Sarrami M, Zhang G, Egoroff N, Pockney P, Richards T, Bhangu A, Creagh-Brown B, Edwards M, Harrison EM, Lee M, Nepogodiev D, Pinkney T, Pearse R, Smart N, Vohra R, Sohrabi C, Jamieson A, Nguyen M, Rahman A, English C, Tincknell L, Kakodkar P, Kwek I, Punjabi N, Burns J, Varghese S, Erotocritou M, McGuckin S, Vayalapra S, Dominguez E, Moneim J, Salehi M, Tan HL, Yoong A, Zhu L, Seale B, Nowinka Z, Patel N, Chrisp B, Harris J, Maleyko I, Muneeb F, Gough M, James CE, Skan O, Chowdhury A, Rebuffa N, Khan H, Down B, Fatimah Hussain Q, Adams M, Bailey A, Cullen G, Fu YXJ, McClement B, Taylor A, Aitken S, Bachelet B, Brousse de Gersigny J, Chang C, Khehra B, Lahoud N, Lee Solano M, Louca M, Rozenbroek P, Rozitis E, Agbinya N, Anderson E, Arwi G, Barry I, Batchelor C, Chong T, Choo LY, Clark L, Daniels M, Goh J, Handa A, Hanna J, Huynh L, Jeon A, Kanbour A, Lee A, Lee J, Lee T, Leigh J, Ly D, McGregor F, Moss J, Nejatian M, O'Loughlin E, Ramos I, Sanchez B, Shrivathsa A, Sincari A, Sobhi S, Swart R, Trimboli J, Wignall P, Bourke E, Chong A, Clayton S, Dawson A, Hardy E, Iqbal R, Le L, Mao S, Marinelli I, Metcalfe H, Panicker D, R HH, Ridgway S, Tan HH, Thong S, Van M, Woon S, Woon-Shoo-Tong XS, Yu S, Ali K, Chee J, Chiu C, Chow YW, Duller A, Nagappan P, Ng S, Selvanathan M, Sheridan C, Temple M, Do JE, Dudi-Venkata NN, Humphries E, Li L, Mansour LT, Massy-Westropp C, Fang B, Farbood K, Hong H, Huang Y, Joan M, Koh C, Liu YHA, Mahajan T, Muller E, Park R, Tanudisastro M, Wu JJG, Chopra P, Giang S, Radcliffe S, Thach P, Wallace D, Wilkes A, Chinta SH, Li J, Phan J, Rahman F, Segaran A, Shannon J, Zhang M, Adams N, Bonte A, Choudhry A, Colterjohn N, Croyle JA, Donohue J, Feighery A, Keane A, McNamara D, Munir K, Roche D, Sabnani R, Seligman D, Sharma S, Stickney Z, Suchy H, Tan R, Yordi S, Ahmed I, Aranha M, El Sabawy D, Garwood P, Harnett M, Holohan R, Howard R, Kayyal Y, Krakoski N, Lupo M, McGilberry W, Nepon H, Scoleri Y, Urbina C, Ahmad Fuad MF, Ahmed O, Jaswantlal D, Kelly E, Khan MHT, Naidu D, Neo WX, O'Neill R, Sugrue M, Abbas JD, Abdul-Fattah S, Azlan A, Barry K, Idris NS, Kaka N, Mc Dermott D, Mohammad Nasir MN, Mozo M, Rehal A, Shaikh Yousef M, Wong RH, Curran E, Gardner M, Hogan A, Julka R, Lasser G, Ní Chorráin N, Ting J, Browne R, George S, Janjua Z, Leung Shing V, Megally M, Murphy S, Ravenscroft L, Vedadi A, Vyas V, Bryan A, Sheikh A, Ubhi J, Vannelli K, Vawda A, Adeusi L, Doherty C, Fitzgerald C, Gallagher H, Gill P, Hamza H, Hogan M, Kelly S, Larry J, Lynch P, Mazeni NA, O'Connell R, O'Loghlin R, Singh K, Abbas Syed R, Ali A, Alkandari B, Arnold A, Arora E, Azam R, Breathnach C, Cheema J, Compton M, Curran S, Elliott JA, Jayasamraj O, Mohammed N, Noone A, Pal A, Pandey S, Quinn P, Sheridan R, Siew L, Tan EP, Tio SW, Toh VTR, Walsh M, Yap C, Yassa J, Young T, Agarwal N, Almoosawy SA, Bowen K, Bruce D, Connachan R, Cook A, Daniell A, Elliott M, Fung HKF, Irving A, Laurie S, Lee YJ, Lim ZX, Maddineni S, McClenaghan RE, Muthuganesan V, Ravichandran P, Roberts N, Shaji S, Solt S, Toshney E, Arnold C, Baker O, Belais F, Bojanic C, Byrne M, Chau CYC, De Soysa S, Eldridge M, Fairey M, Fearnhead N, Guéroult A, Ho JSY, Joshi K, Kadiyala N, Khalid S, Khan F, Kumar K, Lewis E, Magee J, Manetta-Jones D, Mann S, McKeown L, Mitrofan C, Mohamed T, Monnickendam A, Ng AYKC, Ortu A, Patel M, Pope T, Pressling S, Purohit K, Saji S, Shah Foridi J, Shah R, Siddiqui SS, Surman K, Utukuri M, Varghese A, Williams CYK, Yang JJ, Billson E, Cheah E, Holmes P, Hussain S, Murdock D, Nicholls A, Patel P, Ramana G, Saleki M, Spence H, Thomas D, Yu C, Abousamra M, Brown C, Conti I, Donnelly A, Durand M, French N, Goan R, O'Kane E, Rubinchik P, Gardiner H, Kempf B, Lai YL, Matthews H, Minford E, Rafferty C, Reid C, Sheridan N, Al Bahri T, Bhoombla N, Rao BM, Titu L, Chatha S, Field C, Gandhi T, Gulati R, Jha R, Jones Sam MT, Karim S, Patel R, Saunders M, Sharma K, Abid S, Heath E, Kurup D, Patel A, Ali M, Cresswell B, Felstead D, Jennings K, Kaluarachchi T, Lazzereschi L, Mayson H, Miah JE, Reinders B, Rosser A, Thomas C, Williams H, Al-Hamid Z, Alsadoun L, Chlubek M, Fernando P, Gaunt E, Gercek Y, Maniar R, Ma R, Matson M, Moore S, Morris A, Nagappan PG, Ratnayake M, Rockall L, Shallcross O, Sinha A, Tan KE, Virdee S, Wenlock R, Donnelly HA, Ghazal R, Hughes I, Liu X, McFadden M, Misbert E, Mogey P, O'Hara A, Peace C, Rainey C, Raja P, Salem M, Salmon J, Tan CH, Alves D, Bahl S, Baker C, Coulthurst J, Koysombat K, Linn T, Rai P, Sharma A, Shergill A, Ahmed M, Ahmed S, Belk LH, Choudhry H, Cummings D, Dixon Y, Dobinson C, Edwards J, Flint J, Franco Da Silva C, Gallie R, Gardener M, Glover T, Greasley M, Hatab A, Howells R, Hussey T, Khan A, Mann A, Morrison H, Ng A, Osmond R, Padmakumar N, Pervaiz F, Prince R, Qureshi A, Sawhney R, Sigurdson B, Stephenson L, Vora K, Zacken A, Cope P, Di Traglia R, Ferarrio I, Hackett N, Healicon R, Horseman L, Lam LI, Meerdink M, Menham D, Murphy R, Nimmo I, Ramaesh A, Rees J, Soame R, Dilaver N, Adebambo D, Brown E, Burt J, Foster K, Kaliyappan L, Knight P, Politis A, Richardson E, Townsend J, Abdi M, Ball M, Easby S, Gill N, Ho E, Iqbal H, Matthews M, Nubi S, Nwokocha JO, Okafor I, Perry G, Sinartio B, Vanukuru N, Walkley D, Welch T, Yates J, Yeshitila N, Bryans K, Campbell B, Gray C, Keys R, Macartney M, Chamberlain G, Khatri A, Kucheria A, Lee STP, Reese G, Roy choudhury J, Tan WYR, Teh JJ, Ting A, Kazi S, Kontovounisios C, Vutipongsatorn K, Amarnath T, Balasubramanian N, Bassett E, Gurung P, Lim J, Panjikkaran A, Sanalla A, Alkoot M, Bacigalupo V, Eardley N, Horton M, Hurry A, Isti C, Maskell P, Nursiah K, Punn G, Salih H, Epanomeritakis E, Foulkes A, Henderson R, Johnston E, McCullough H, McLarnon M, Morrison E, Cheung A, Cho SH, Eriksson F, Hedges J, Low Z, May C, Musto L, Nagi S, Nur S, Salau E, Shabbir S, Thomas MC, Uthayanan L, Vig S, Zaheer M, Zeng G, Ashcroft-Quinn S, Brown R, Hayes J, McConville R, French R, Gilliam A, Sheetal S, Shehzad MU, Bani W, Christie I, Franklyn J, Khan M, Russell J, Smolarek S, Varadarassou R, Ahmed SK, Narayanaswamy S, Sealy J, Shah M, Dodhia V, Manukyan A, O'Hare R, Orbell J, Chung I, Forenc K, Gupta A, Agarwal A, Al Dabbagh A, Bennewith R, Bottomley J, Chu TSM, Chu YYA, Doherty W, Evans B, Hainsworth P, Hosfield T, Li CH, McCullagh I, Mehta A, Thaker A, Thompson B, Virdi A, Walker H, Wilkins E, Dixon C, Hassan MR, Lotca N, Tong KS, Batchelor-Parry H, Chaudhari S, Harris T, Hooper J, Johnson C, Mulvihill C, Nayler J, Olutobi O, Piramanayagam B, Stones K, Sussman M, Weaver C, Alam F, Al Rawi M, Andrew F, Arrayeh A, Azizan N, Hassan A, Iqbal Z, John I, Jones M, Kalake O, Keast M, Nicholas J, Patil A, Powell K, Roberts P, Sabri A, Segue AK, Shah A, Shaik Mohamed SA, Shehadeh A, Shenoy S, Tong A, Upcott M, Vijayasingam D, Anarfi S, Dauncey J, Devindaran A, Havalda P, Komninos G, Mwendwa E, Norman C, Richards J, Urquhart A, Allan J, Cahya E, Hunt H, McWhirter C, Norton R, Roxburgh C, Tan JY, Ali Butt S, Hansdot S, Haq I, Mootien A, Sanchez I, Vainas T, Deliyannis E, Tan M, Vipond M, Chittoor Satish NN, Dattani A, De Carvalho L, Gaston-Grubb M, Karunanithy L, Lowe B, Pace C, Raju K, Roope J, Taylor C, Youssef H, Munro T, Thorn C, Wong KHF, Yunus A, Chawla S, Datta A, Dinesh AA, Field D, Georgi T, Gwozdz A, Hamstead E, Howard N, Isleyen N, Jackson N, Kingdon J, Sagoo KS, Schizas A, Yin L, Aung E, Aung YY, Franklin S, Han SM, Kim WC, Martin Segura A, Rossi M, Ross T, Tirimanna R, Wang B, Zakieh O, Ben-Arzi H, Flach A, Jackson E, Magers S, Olu abara C, Rogers E, Sugden K, Tan H, Veliah S, Walton U, Asif A, Bharwada Y, Bowley D, Broekhuizen A, Cooper L, Evans N, Girdlestone H, Ling C, Mann H, Mehmood N, Mulvenna CL, Rainer N, Trout I, Gujjuri R, Jeyaraman D, Leong E, Singh D, Smith E, Anderton J, Barabas M, Goyal S, Howard D, Joshi A, Mitchell D, Weatherby T, Badminton R, Bird R, Burtle D, Choi NY, Devalia K, Farr E, Fischer F, Fish J, Gunn F, Jacobs D, Johnston P, Kalakoutas A, Lau E, Loo YNAF, Louden H, Makariou N, Mohammadi K, Nayab Y, Ruhomaun S, Ryliskyte R, Saeed M, Shinde P, Sudul M, Theodoropoulou K, Valadao-Spoorenberg J, Vlachou F, Arshad SR, Janmohamed AM, Noor M, Oyerinde O, Saha A, Syed Y, Watkinson W, Ahmadi H, Akintunde A, Alsaady A, Bradley J, Brothwood D, Burton M, Higgs M, Hoyle C, Katsura C, Lathan R, Louani A, Mandalia R, Prihartadi AS, Qaddoura B, Sandland-Taylor L, Thadani S, Thompson A, Walshaw J, Teo S, Ali S, Bawa JH, Fox S, Gargan K, Haider SA, Hanna N, Hatoum A, Khan Z, Krzak AM, Li T, Pitt J, Tan GJS, Ullah Z, Wilson E, Cleaver J, Colman J, Copeland L, Coulson A, Davis P, Faisal H, Hassan F, Hughes JT, Jabr Y, Mahmoud Ali F, Nahaboo Solim ZN, Sangheli A, Shaya S, Thompson R, Cornwall H, De Andres Crespo M, Fay E, Findlay J, Groves E, Jones O, Killen A, Millo J, Thomas S, Ward J, Wilkins M, Zaki F, Zilber E, Bhavra K, Bilolikar A, Charalambous M, Elawad A, Eleni A, Fawdon R, Gibbins A, Livingstone D, Mala D, Oke SE, Padmakumar D, Patsalides MA, Payne D, Ralphs C, Roney A, Sardar N, Stefanova K, Surti F, Timms R, Tosney G, Bannister J, Clement NS, Cullimore V, Kamal F, Lendor J, McKay J, Mcswiggan J, Minhas N, Seneviratne K, Simeen S, Valverde J, Watson N, Bloom I, Dinh TH, Hirniak J, Joseph R, Kansagra M, Lai CKN, Melamed N, Patel J, Randev J, Sedighi T, Shurovi B, Sodhi J, Vadgama N, Abdulla S, Adabavazeh B, Champion A, Chennupati R, Chu K, Devi S, Haji A, Schulz J, Testa F, Davies P, Gurung B, Howell S, Modi P, Pervaiz A, Zahid M, Abdolrazaghi S, Abi Aoun R, Anjum Z, Bawa G, Bhardwaj R, Brown S, Enver M, Gill D, Gopikrishna D, Gurung D, Kanwal A, Kaushal P, Khanna A, Lovell E, McEvoy C, Mirza M, Nabeel S, Naseem S, Pandya K, Perkins R, Pulakal R, Ray M, Reay C, Reilly S, Round A, Seehra J, Shakeel NM, Singh B, Vijay Sukhnani M, Brown L, Desai B, Elzanati H, Godhaniya J, Kavanagh E, Kent J, Kishor A, Liu A, Norwood M, Shaari N, Wood C, Wood M, Brown A, Chellapuri A, Ferriman A, Ghosh I, Kulkarni N, Noton T, Pinto A, Rajesh S, Varghese B, Wenban C, Aly R, Barciela C, Brookes T, Corrin E, Goldsworthy M, Mohamed Azhar MS, Moore J, Nakhuda S, Ng D, Pillay S, Port S, Abdullah M, Akinyemi J, Islam S, Kale A, Lewis A, Manjunath T, McCabe H, Misra S, Stubley T, Tam JP, Waraich N, Chaora T, Ford C, Osinkolu I, Pong G, Rai J, Risquet R, Ainsworth J, Ayandokun P, Barham E, Barrett G, Barry J, Bisson E, Bridges I, Burke D, Cann J, Cloney M, Coates S, Cripps P, Davies C, Francis N, Green S, Handley G, Hathaway D, Hurt L, Jenkins S, Johnston C, Khadka A, McGee U, Morris D, Murray R, Norbury C, Pierrepont Z, Richards C, Ross O, Ruddy A, Salmon C, Shield M, Soanes K, Spencer N, Taverner S, Williams C, Wills-Wood W, Woodward S, Chow J, Fan J, Guest O, Hunter I, Moon WY, Arthur-Quarm S, Edwards P, Hamlyn V, McEneaney L, N D G, Pranoy S, Ting M, Abada S, Alawattegama LH, Ashok A, Carey C, Gogna A, Haglund C, Hurley P, Leelo N, Liu B, Mannan F, Paramjothy K, Ramlogan K, Raymond-Hayling O, Shanmugarajah A, Solichan D, Wilkinson B, Ahmad NA, Allan D, Amin A, Bakina C, Burns F, Cameron F, Campbell A, Cavanagh S, Chan SMZ, Chapman S, Chong V, Edelsten E, Ekpete O, El Sheikh M, Ghose R, Hassane A, Henderson C, Hilton-Christie S, Husain M, Hussain H, Javid Z, Johnson-Ogbuneke J, Johnston A, Khalil M, Leung TCC, Makin I, Muralidharan V, Naeem M, Patil P, Ravichandran S, Saraeva D, Shankey-Smith W, Sharma N, Swan R, Waudby-West R, Wilkinson A, Wright K, Balasubramanian A, Bhatti S, Chalkley M, Chou WK, Dixon M, Evans L, Fisher K, Gandhi P, Ho S, Lau YB, Lowe S, Meechan C, Murali N, Musonda C, Njoku P, Ochieng L, Pervez MU, Seebah K, Shaikh I, Sikder MA, Vanker R, Alom J, Bajaj V, Coleman O, Finch G, Goss J, Jenkins C, Kontothanassis A, Liew MS, Ng K, Outram M, Shakeel MM, Tawn J, Zuhairy S, Chapple K, Cinnamond A, Coleman S, George HA, Goulder L, Hare N, Hawksley J, Kret A, Luesley A, Mecia L, Porter H, Puddy E, Richardson G, Sohail B, Srikaran V, Tadross D, Tobin J, Tokidis E, Young L, Ashdown T, Bratsos S, Koomson A, Kufuor A, Lim MQ, Shah S, Thorne EPC, Warusavitarne J, Xu S, Abigail S, Ahmed A, Ahmed J, Akmal A, Al-Khafaji M, Amini B, Arshad M, Bogie E, Brazkiewicz M, Carroll M, Chandegra A, Cirelli C, Deng A, Fairclough S, Fung YJ, Gornell C, Green RL, Green SV, Gulamhussein AHM, Isaac AG, Jan R, Jegatheeswaran L, Knee M, Kotecha J, Kotecha S, Maxwell-Armstrong C, McIntyre C, Mendis N, Naing TKP, Oberman J, Ong ZX, Ramalingam A, Saeed Adam A, Tan LL, Towell S, Yadav J, Anandampillai R, Chung S, Hounat A, Ibrahim B, Jeyakumar G, Khalil A, Khan UA, Nair G, Owusu-Ayim M, Wilson M, Kanani A, Kilkelly B, Ogunmwonyi I, Ong L, Samra B, Schomerus L, Shea J, Turner O, Yang Y, Amin M, Blott N, Clark A, Feather A, Forrest M, Hague S, Hamilton K, Higginbotham G, Hope E, Karimian S, Loveday K, Malik H, McKenna O, Noor A, Onsiong C, Patel B, Radcliffe N, Shah P, Tye L, Verma K, Walford R, Yusufi U, Zachariah M, Casey A, Doré C, Fludder V, Fortescue L, Kalapu SS, Karel E, Khera G, Smith C, Appleton B, Ashaye A, Boggon E, Evans A, Faris Mahmood H, Hinchcliffe Z, Marei O, Silva I, Spooner C, Thomas G, Timlin M, Wellington J, Yao SL, Abdelrazek M, Abdelrazik Y, Bee F, Joseph A, Mounce A, Parry G, Vignarajah N, Biddles D, Creissen A, Kolhe S, K T, Lea A, Ledda V, O'Loughlin P, Scanlon J, Shetty N, Weller C, Abdalla M, Adeoye A, Bhatti M, Chadda KR, Chu J, Elhakim H, Foster-Davies H, Rabie M, Tailor B, Webb S, Abdelrahim ASA, Choo SY, Jiwa A, Mangam S, Murray S, Shandramohan A, Aghanenu O, Budd W, Hayre J, Khanom S, Liew ZY, McKinney R, Moody N, Muhammad-Kamal H, Odogwu J, Patel D, Roy C, Sattar Z, Shahrokhi N, Sinha I, Thomson E, Wonga L, Bain J, Khan J, Ricardo D, Bevis R, Cherry C, Darkwa S, Drew W, Griffiths E, Konda N, Madani D, Mak JKC, Meda B, Odunukwe U, Preest G, Raheel F, Rajaseharan A, Ramgopal A, Risbrooke C, Selvaratnam K, Sethunath G, Tabassum R, Taylor J, Thakker A, Wijesingha N, Wybrew R, Yasin T, Ahmed Osman A, Alfadhel S, Carberry E, Chen JY, Drake I, Glen P, Jayasuriya N, Kawar L, Myatt R, Sinan LOH, Siu SSY, Tjen V, Adeboyejo O, Bacon H, Barnes R, Birnie C, D'Cunha Kamath A, Hughes E, Middleton S, Owen R, Schofield E, Short C, Smith R, Wang H, Willett M, Zimmerman M, Balfour J, Chadwick T, Coombe-Jones M, Do Le HP, Faulkner G, Hobson K, Shehata Z, Beattie M, Chmielewski G, Chong C, Donnelly B, Drusch B, Ellis J, Farrelly C, Feyi-Waboso J, Hibell I, Hoade L, Ho C, Jones H, Kodiatt B, Lidder P, Ni Cheallaigh L, Norman R, Patabendi I, Penfold H, Playfair M, Pomeroy S, Ralph C, Rottenburg H, Sebastian J, Sheehan M, Stanley V, Welchman J, Ajdarpasic D, Antypas A, Azouaghe O, Basi S, Bettoli G, Bhattarai S, Bommireddy L, Bourne K, Budding J, Cookey-Bresi R, Cummins T, Davies G, Fabelurin C, Gwilliam R, Hanley J, Hird A, Kruczynska A, Langhorne B, Lund J, Lutchman I, McGuinness R, Neary M, Pampapathi S, Pang E, Podbicanin S, Rai N, Redhouse White G, Sujith J, Thomas P, Walker I, Winterton R, Anderson P, Barrington M, Bhadra K, Clark G, Fowler G, Gibson C, Hudson S, Kaminskaite V, Lawday S, Longshaw A, MacKrill E, McLachlan F, Murdeshwar A, Nieuwoudt R, Parker P, Randall R, Rawlins E, Reeves SA, Rye D, Sirkis T, Sykes B, Ventress N, Wosinska N, Akram B, Burton L, Coombs A, Long R, Magowan D, Ong C, Sethi M, Williams G, Chan C, Chan LH, Fernando D, Gaba F, Khor Z, Les JW, Mak R, Moin S, Ng Kee Kwong KC, Paterson-Brown S, Tew YY, Bardon A, Burrell K, Coldwell C, Costa I, Dexter E, Hardy A, Khojani M, Mazurek J, Raymond T, Reddy V, Reynolds J, Soma A, Agiotakis S, Alsusa H, Desai N, Peristerakis I, Adcock A, Ayub H, Bennett T, Bibi F, Brenac S, Chapman T, Clarke G, Clark F, Galvin C, Gwyn-Jones A, Henry-Blake C, Kerner S, Kiandee M, Lovett A, Pilecka A, Ravindran R, Siddique H, Sikand T, Treadwell K, Akmal K, Apata A, Barton O, Broad G, Darling H, Dhuga Y, Emms L, Habib S, Jain R, Jeater J, Kan CYP, Kathiravelupillai A, Khatkar H, Kirmani S, Kulasabanathan K, Lacey H, Lal K, Manafa C, Mansoor M, McDonald S, Mittal A, Mustoe S, Nottrodt L, Oliver P, Papapetrou I, Pattinson F, Raja M, Reyhani H, Shahmiri A, Small O, Soni U, Aguirrezabala Armbruster B, Bunni J, Hakim MA, Hawkins-Hooker L, Howell KA, Hullait R, Jaskowska A, Ottewell L, Thomas-Jones I, Vasudev A, Clements B, Fenton J, Gill M, Haider S, Lim AJM, Maguire H, McMullan J, Nicoletti J, Samuel S, Unais MA, White N, Yao PC, Yow L, Boyle C, Brady R, Cheekoty P, Cheong J, Chew SJHL, Chow R, Ganewatta Kankanamge D, Mamer L, Mohammed B, Ng Chieng Hin J, Renji Chungath R, Royston A, Sharrad E, Sinclair R, Tingle S, Treherne K, Wyatt F, Maniarasu VS, Moug S, Appanna T, Bucknall T, Hussain F, Owen A, Parry M, Parry R, Sagua N, Spofforth K, Yuen ECT, Bosley N, Hardie W, Moore T, Regas C, Abdel-Khaleq S, Ali N, Bashiti H, Buxton-Hopley R, Constantinides M, D'Afflitto M, Deshpande A, Duque Golding J, Frisira E, Germani Batacchi M, Gomaa A, Hay D, Hutchison R, Iakovou A, Iakovou D, Ismail E, Jefferson S, Jones L, Khouli Y, Knowles C, Mason J, McCaughan R, Moffatt J, Morawala A, Nadir H, Neyroud F, Nikookam Y, Parmar A, Pinto L, Ramamoorthy R, Richards E, Thomson S, Trainer C, Valetopoulou A, Vassiliou A, Wantman A, Wilde S, Dickinson M, Rockall T, Senn D, Wcislo K, Zalmay P, Adelekan K, Allen K, Bajaj M, Gatumbu P, Hang S, Hashmi Y, Kaur T, Kawesha A, Kisiel A, Woodmass M, Adelowo T, Ahari D, Alhwaishel K, Atherton R, Clayton B, Cockroft A, Curtis Lopez C, Hilton M, Ismail N, Kouadria M, Lee L, MacConnachie A, Monks F, Mungroo S, Nikoletopoulou C, Pearce L, Sara X, Shahid A, Suresh G, Wilcha R, Atiyah A, Davies E, Dermanis A, Gibbons H, Hyde A, Lawson A, Lee C, Leung-Tack M, Li Saw Hee J, Mostafa O, Nair D, Pattani N, Plumbley-Jones J, Pufal K, Ramesh P, Sanghera J, Saram S, Scadding S, See S, Stringer H, Torrance A, Vardon H, Wyn-Griffiths F, Brew A, Kaur G, Soni D, Tickle A, Akbar Z, Appleyard T, Figg K, Jayawardena P, Johnson A, Kamran Siddiqui Z, Lacy-Colson J, Oatham R, Rowlands B, Sludden E, Turnbull C, Allin D, Ansar Z, Azeez Z, Dale VH, Garg J, Horner A, Jones S, Knight S, McGregor C, McKenna J, McLelland T, Packham-Smith A, Rowsell K, Spector-Hill I, Adeniken E, Baker J, Bartlett M, Chikomba L, Connell B, Deekonda P, Dhar M, Elmansouri A, Gamage K, Goodhew R, Hanna P, Knight J, Luca A, Maasoumi N, Mahamoud F, Manji S, Marwaha PK, Mason F, Oluboyede A, Pigott L, Razaq AM, Richardson M, Saddaoui I, Wijeyendram P, Yau S, Atkins W, Liang K, Miles N, Praveen B, Ashai S, Braganza J, Common J, Cundy A, Davies R, Guthrie J, Handa I, Iqbal M, Ismail R, Jones C, Jones I, Lee KS, Levene A, Okocha M, Olivier J, Smith A, Subramaniam E, Tandle S, Wang A, Watson A, Wilson C, Chan XHF, Khoo E, Montgomery C, Norris M, Pugalenthi PP, Common T, Cook E, Mistry H, Shinmar HS, Agarwal G, Bandyopadhyay S, Brazier B, Carroll L, Goede A, Harbourne A, Lakhani A, Lami M, Larwood J, Martin J, Merchant J, Pattenden S, Pradhan A, Raafat N, Rothwell E, Shammoon Y, Sudarshan R, Vickers E, Wingfield L, Ashworth I, Azizi S, Bhate R, Chowdhury T, Christou A, Davies L, Dwaraknath M, Farah Y, Garner J, Gureviciute E, Hart E, Jain A, Javid S, Kankam HK, Kaur Toor P, Kaz R, Kermali M, Khan I, Mattson A, McManus A, Murphy M, Nair K, Ngemoh D, Norton E, Olabiran A, Parry L, Payne T, Pillai K, Price S, Punjabi K, Raghunathan A, Ramwell A, Raza M, Ritehnia J, Simpson G, Smith W, Sodeinde S, Studd L, Subramaniam M, Thomas J, Towey S, Tsang E, Tuteja D, Vasani J, Vio M, Badran A, Adams J, Anthony Wilkinson J, Asvandi S, Austin T, Bald A, Bix E, Carrick M, Chander B, Chowdhury S, Cooper Drake B, Crosbie S, D Portela S, Francis D, Gallagher C, Gillespie R, Gravett H, Gupta P, Ilyas C, James G, Johny J, Jones A, Kinder F, MacLeod C, Macrow C, Maqsood-Shah A, Mather J, McCann L, McMahon R, Mitham E, Mohamed M, Munton E, Nightingale K, O'Neill K, Onyemuchara I, Senior R, Shanahan A, Sherlock J, Spyridoulias A, Stavrou C, Stokes D, Tamang R, Taylor E, Trafford C, Uden C, Waddington C, Yassin D, Zaman M, Bangi S, Cheng T, Chew D, Hussain N, Imani-Masouleh S, Mahasivam G, McKnight G, Ng HL, Ota HC, Pasha T, Ravindran W, Shah K, Vishnu K S, Zaman S, Carr W, Cope S, Eagles EJ, Howarth-Maddison M, Li CY, Reed J, Ridge A, Stubbs T, Teasdaled D, Umar R, Worthington J, Dhebri A, Kalenderov R, Alattas A, Arain Z, Bhudia R, Chia D, Daniel S, Dar T, Garland H, Girish M, Hampson A, Kyriacou H, Lehovsky K, Mullins W, Omorphos N, Vasdev N, Venkatesh A, Waldock W, Bhandari A, Brown G, Choa G, Eichenauer CE, Ezennia K, Kidwai Z, Lloyd-Thomas A, Macaskill Stewart A, Massardi C, Sinclair E, Skajaa N, Smith M, Tan I, Afsheen N, Anuar A, Azam Z, Bhatia P, Davies-kelly N, Dickinson S, Elkawafi M, Ganapathy M, Gupta S, Khoury EG, Licudi D, Mehta V, Neequaye S, Nita G, Tay VL, Zhao S, Botsa E, Cuthbert H, Elliott J, Furlepa M, Lehmann J, Mangtani A, Narayan A, Nazarian S, Parmar C, Shah D, Shaw C, Zhao Z, Beck C, Caldwell S, Clements JM, French B, Kenny R, Kirk S, Lindsay J, McClung A, McLaughlin N, Watson S, Whiteside E, Alyacoubi S, Arumugam V, Beg R, Dawas K, Garg S, Lloyd ER, Mahfouz Y, Manobharath N, Moonesinghe R, Morka N, Patel K, Prashar J, Yip S, Adeeko ES, Ajekigbe F, Bhat A, Evans C, Farrugia A, Gurung C, Long T, Malik B, Manirajan S, Newport D, Rayer J, Ridha A, Ross E, Saran T, Sinker A, Waruingi D, Allen R, Al Sadek Y, Alves do Canto Brum H, Asharaf H, Ashman M, Balakumar V, Barrington J, Baskaran R, Berry A, Bhachoo H, Bilal A, Boaden L, Chia WL, Covell G, Crook D, Dadnam F, Davis L, De Berker H, Doyle C, Fox C, Gruffydd-Davies M, Hafouda Y, Hill A, Hubbard E, Hunter A, Inpadhas V, Jamshaid M, Jandu G, Jeyanthi M, Jones T, Kantor C, Kwak SY, Malik N, Matt R, McNulty P, Miles C, Mohomed A, Myat P, Niharika J, Nixon A, O'Reilly D, Parmar K, Pengelly S, Price L, Ramsden M, Turnor R, Wales E, Waring H, Wu M, Yang T, Ye TTS, Zander A, Zeicu C, Bellam S, Francombe J, Kawamoto N, Rahman MR, Sathyanarayana A, Tang HT, Cheung J, Hollingshead J, Page V, Sugarman J, Wong E, Chiong J, Fung E, Kan SY, Kiang J, Kok J, Krahelski O, Liew MY, Lyell B, Sharif Z, Speake D, Alim L, Amakye NY, Chandrasekaran J, Chandratreya N, Drake J, Owoso T, Thu YM, Abou El Ela Bourquin B, Alberts J, Chapman D, Rehnnuma N, Ainsworth K, Carpenter H, Emmanuel T, Fisher T, Gabrel M, Guan Z, Hollows S, Hotouras A, Ip Fung Chun N, Jaffer S, Kallikas G, Kennedy N, Lewinsohn B, Liu FY, Mohammed S, Rutherfurd A, Situ T, Stammer A, Taylor F, Thin N, Urgesi E, Zhang N, Ahmad MA, Bishop A, Bowes A, Dixit A, Glasson R, Hatta S, Hatt K, Larcombe S, Preece J, Riordan E, Fegredo D, Haq MZ, Li C, McCann G, Stewart D, Baraza W, Bhullar D, Burt G, Coyle J, Deans J, Devine A, Hird R, Ikotun O, Manchip G, Ross C, Storey L, Tan WWL, Tse C, Warner C, Whitehead M, Wu F, Court EL, Crisp E, Huttman M, Mayes F, Robertson H, Rosen H, Sandberg C, Smith H, Al Bakry M, Ashwell W, Bajaj S, Bandyopadhyay D, Browlee O, Burway S, Chand CP, Elsayeh K, Elsharkawi A, Evans E, Ferrin S, Fort-Schaale A, Iacob M, I K, Impelliziere Licastro G, Mankoo AS, Olaniyan T, Otun J, Pereira R, Reddy R, Saeed D, Simmonds O, Singhal G, Tron K, Wickstone C, Williams R, Bradshaw E, De Kock Jewell V, Houlden C, Knight C, Metezai H, Mirza-Davies A, Seymour Z, Spink D, Wischhusen S. Evaluation of prognostic risk models for postoperative pulmonary complications in adult patients undergoing major abdominal surgery: a systematic review and international external validation cohort study. Lancet Digit Health 2022; 4:e520-e531. [PMID: 35750401 DOI: 10.1016/s2589-7500(22)00069-3] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2021] [Revised: 01/07/2022] [Accepted: 04/06/2022] [Indexed: 06/15/2023]
Abstract
BACKGROUND Stratifying risk of postoperative pulmonary complications after major abdominal surgery allows clinicians to modify risk through targeted interventions and enhanced monitoring. In this study, we aimed to identify and validate prognostic models against a new consensus definition of postoperative pulmonary complications. METHODS We did a systematic review and international external validation cohort study. The systematic review was done in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We searched MEDLINE and Embase on March 1, 2020, for articles published in English that reported on risk prediction models for postoperative pulmonary complications following abdominal surgery. External validation of existing models was done within a prospective international cohort study of adult patients (≥18 years) undergoing major abdominal surgery. Data were collected between Jan 1, 2019, and April 30, 2019, in the UK, Ireland, and Australia. Discriminative ability and prognostic accuracy summary statistics were compared between models for the 30-day postoperative pulmonary complication rate as defined by the Standardised Endpoints in Perioperative Medicine Core Outcome Measures in Perioperative and Anaesthetic Care (StEP-COMPAC). Model performance was compared using the area under the receiver operating characteristic curve (AUROCC). FINDINGS In total, we identified 2903 records from our literature search; of which, 2514 (86·6%) unique records were screened, 121 (4·8%) of 2514 full texts were assessed for eligibility, and 29 unique prognostic models were identified. Nine (31·0%) of 29 models had score development reported only, 19 (65·5%) had undergone internal validation, and only four (13·8%) had been externally validated. Data to validate six eligible models were collected in the international external validation cohort study. Data from 11 591 patients were available, with an overall postoperative pulmonary complication rate of 7·8% (n=903). None of the six models showed good discrimination (defined as AUROCC ≥0·70) for identifying postoperative pulmonary complications, with the Assess Respiratory Risk in Surgical Patients in Catalonia score showing the best discrimination (AUROCC 0·700 [95% CI 0·683-0·717]). INTERPRETATION In the pre-COVID-19 pandemic data, variability in the risk of pulmonary complications (StEP-COMPAC definition) following major abdominal surgery was poorly described by existing prognostication tools. To improve surgical safety during the COVID-19 pandemic recovery and beyond, novel risk stratification tools are required. FUNDING British Journal of Surgery Society.
Collapse
|
45
|
Alunno A, Carubbi F, Mariani FM, Rossi M, Santilli J, Ferri C. AB0524 RELATIONSHIP BETWEEN SERUM URIC ACID, CARDIOVASCULAR RISK AND INFLAMMATORY STATUS IN PRIMARY SJÖGREN’S SYNDROME. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.3603] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BackgroundAn unhealthy diet, with or without impaired renal urate excretion, is the most frequent cause of hyperuricemia. Despite its pivotal role in the pathogenesis of gout, the clinical relevance of serum uric acid (SUA) levels goes well beyond the simple association with gout and/or nephrolithiasis. Several studies pointed to hyperuricemia as cardiovascular (CV) risk factor in the general population therefore, the 2018 guidelines of the European Society of Cardiology and the European Society of Hypertension included the assessment of uricemia among the screening tests to be performed in hypertensive patients. Furthermore, in view of the association between hyperuricemia and mortality (both CV and all-cause) and CV events, it is conceivable that cardiovascular damage begins with much lower levels of uricemia. In this context, the first results of the URRAH (Uric Acid Right for Heart Health) study identified a uricemia threshold value of 4.7 mg/dL for all-cause mortality and 5.6 mg/dL for CV mortality1.ObjectivesSince patients with primary Sjögren’s syndrome (pSS) have a higher risk of CV events compared to the general population, we aimed to explore how uricemia correlates with other CV risk factors and previous CV events in patients with pSS and without gout.MethodsA cross sectional study was conducted recruiting consecutive patients with pSS without history of gout. SUA was measured upon recruitment alongside the assessment of disease activity (EULAR Sjögren’s syndrome disease activity index, ESSDAI and ClinESSDAI), patient reported symptoms (EULAR Sjögren’s syndrome patient reported symptoms, ESSPRI), CV risk factors including hypertension and diabetes among others, and previous CV events. Dietary habits were also explored with various food frequency questionnaires.ResultsOne hundred and three patients with pSS were enrolled. SUA levels ranged between 2.9 and 6.8 mg/dl and, according to the cut-off values of the URRAH study, 16 (16%) patients had SUA levels >4.7 mg/dL while 5 (5%) had SUA levels >5.6 mg/dL. Patients with SUA levels >4.7 mg/dL were more likely males (20% vs 3%) with a higher number of CV risk factors compared to patients with SUA levels <4.7mg/dL. No differences were observed regarding dietary habits across groups. Disease activity assessed with both ESSDAI and ClinESSDAI was significantly higher in patients with SUA levels >4.7 mg/dL compared to patients with SUA levels <4.7 (9.3 vs 6.3 p= 0.04 and 9.0 vs 6.0 p=0.03). Conversely, patient reported symptoms (total ESSPRI and individual VAS scales for total dryness, xerostomia, xerophtalmia, pain and fatigue) did not differ across groups. Logistic regression analysis confirmed the association of SUA values >4.7 mg/dL and a higher number of CV risk factors (OR 2.8; 95% CI=1.2-6.5; p=0.016).ConclusionAccumulating evidence highlights the emerging role of hyperuricemia as an independent CV risk factor, but no data are available in pSS patients. This is the first study demonstrating that SUA levels >4.7 mg/dL correlate with both a higher number of CV risk factors and a higher disease activity in pSS patients. Large interventional studies are needed to clarify the possible benefits of urate-lowering treatments in pSS patients.References[1]Virdis A et al. Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years. Hypertension 2020;75(2):302-308Disclosure of InterestsNone declared
Collapse
|
46
|
Alunno A, Carubbi F, Mariani FM, Rossi M, Sipari P, Grassi D, Ferri C. POS0723 DIETARY HABITS AND THE IMPACT ON CLINICAL FEATURES IN PRIMARY SJOGREN’S SYNDROME. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.46] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BackgroundIn recent years, increasing evidence on the role of diet on chronic conditions, including cardiovascular diseases (CV) and rheumatic and musculoskeletal diseases (RMDs) has accrued. Most studies exploring the possible role of nutrients and dietary patterns on both the risk to develop RMDs in the general population and the natural history of the disease in patients with established RMDs pertain to rheumatoid arthritis. Data in patients with established primary Sjogren’s syndrome (pSS) is lacking.ObjectivesTo explore dietary habits and their relationship with metabolic and inflammatory features in a cohort of patients with established pSS.MethodsConsecutive patients with pSS were recruited and dietary habits over the previous 12 months were explored. Adherence to the Mediterranean Diet was assessed with the 14-item PREvencion con DIeta MEDiterranea’ (PREDIMED) tool and the 28-item Mediterranean Lifestyle (MEDLIFE) index. Adherence to the Dietary Approaches to Stop Hypertension (DASH) was estimated using a score based on 8 food items. Tea/herbal tea and coffee intake were also explored and clinical/serological records were retrospectively collected.ResultsWe enrolled 105 patients with pSS (95% females) with a mean age of 59 years. According to the PREDIMED score 32 (31%) patients had a good adherence to the Mediterranean Diet, 64 (61%) a medium adherence and only 9 (8%) a poor adherence. According to the DASH score, 74 (71%) patients had low adherence and 31 (29%) had high adherence. When dividing patients according to the extent of adherence to either of the dietary patterns and correlating the diet adherence scores to disease specific variables some associations emerged. The PREDIMED score was inversely correlated with disease activity, as measured by the EULAR Sjögren’s syndrome disease activity index (ESSDAI) (Spearman’s rho=-0.27, p= 0.009) and ClinESSDAI (Spearman’s rho=-0.26, p=0.01) revealing that a higher adherence to the Mediterranean Diet was associated with lower disease activity. With regard to the MEDLIFE, the total of blocks 1 and 2, that are related to Mediterranean foods and dietary habits, did not correlate with the total of block 3 (related to other healthy habits such as physical activity), meaning that the patients adhering the most to the Mediterranean Diet not necessarily had an overall healthy lifestyle. Adherence to DASH was not associated with disease activity. With regard to individual nutrients, fish consumption was associated with a lower prevalence of hypertension as observed in the general population. Higher intake of red meat was associated with higher values of self-reported pain (Spearman’s rho=-0.3; p=0.01) while high wholegrain intake was associated with a lower number of coexisting CV risk factors (OR=0.7; 95% CI=0.52-0.97; p=0.03).ConclusionAdherence to the Mediterranean Diet, with particular attention to high intake of fish and wholegrains and low intake of red meat, may be beneficial on various domains in pSS, such as the CV system and the inflammatory environment, and as such should be recommended to patients with this disease.Disclosure of InterestsNone declared
Collapse
|
47
|
Hatziagorou E, Orenti A, Naehrlich L, Rossi M, Mei-Zahav M, van Rens J, Zolin A, Carr S, Burgel PR, Daneau G, Storms V, Lammertyn E, Lindblad A, Macek M, Jung A. WS08.01 The changing epidemiology of cystic fibrosis in Europe from 2010 to 2019: data from the European Cystic Fibrosis Society Patient Registry. J Cyst Fibros 2022. [DOI: 10.1016/s1569-1993(22)00195-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
48
|
Castelo-Branco L, Tsourti Z, Gennatas S, Rogado J, Sekacheva M, Viñal D, Lee R, Croitoru A, Vitorino M, Khallaf S, Šušnjar S, Soewoto W, Cardeña A, Djerouni M, Rossi M, Alonso-Gordoa T, Ngelangel C, Whisenant JG, Choueiri TK, Dimopoulou G, Pradervand S, Arnold D, Harrington K, Michielin O, Dafni U, Pentheroudakis G, Peters S, Romano E. COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE). ESMO Open 2022; 7:100499. [PMID: 35644101 PMCID: PMC9080222 DOI: 10.1016/j.esmoop.2022.100499] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2022] [Revised: 04/22/2022] [Accepted: 04/23/2022] [Indexed: 12/19/2022] Open
Abstract
BACKGROUND ESMO COVID-19 and CAncer REgistry (ESMO-CoCARE) is an international collaborative registry-based, cohort study gathering real-world data from Europe, Asia/Oceania and Africa on the natural history, management and outcomes of patients with cancer infected with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). PATIENTS AND METHODS ESMO-CoCARE captures information on patients with solid/haematological malignancies, diagnosed with coronavirus disease 2019 (COVID-19). Data collected since June 2020 include demographics, comorbidities, laboratory measurements, cancer characteristics, COVID-19 clinical features, management and outcome. Parameters influencing COVID-19 severity/recovery were investigated as well as factors associated with overall survival (OS) upon SARS-CoV-2 infection. RESULTS This analysis includes 1626 patients from 20 countries (87% from 24 European, 7% from 5 North African, 6% from 8 Asian/Oceanian centres), with COVID-19 diagnosis from January 2020 to May 2021. Median age was 64 years, with 52% of female, 57% of cancer stage III/IV and 65% receiving active cancer treatment. Nearly 64% patients required hospitalization due to COVID-19 diagnosis, with 11% receiving intensive care. In multivariable analysis, male sex, older age, Eastern Cooperative Oncology Group (ECOG) performance status ≥2, body mass index (BMI) <25 kg/m2, presence of comorbidities, symptomatic disease, as well as haematological malignancies, active/progressive cancer, neutrophil-to-lymphocyte ratio (NLR) ≥6 and OnCovid Inflammatory Score ≤40 were associated with COVID-19 severity (i.e. severe/moderate disease requiring hospitalization). About 98% of patients with mild COVID-19 recovered, as opposed to 71% with severe/moderate disease. Advanced cancer stage was an additional adverse prognostic factor for recovery. At data cut-off, and with median follow-up of 3 months, the COVID-19-related death rate was 24.5% (297/1212), with 380 deaths recorded in total. Almost all factors associated with COVID-19 severity, except for BMI and NLR, were also predictive of inferior OS, along with smoking and non-Asian ethnicity. CONCLUSIONS Selected patient and cancer characteristics related to sex, ethnicity, poor fitness, comorbidities, inflammation and active malignancy predict for severe/moderate disease and adverse outcomes from COVID-19 in patients with cancer.
Collapse
Affiliation(s)
- L Castelo-Branco
- Scientific and Medical Division, ESMO (European Society for Medical Oncology), Lugano, Switzerland; NOVA National School of Public Health, NOVA University, Lisbon, Portugal
| | - Z Tsourti
- Frontier Science Foundation-Hellas, Athens, Greece
| | - S Gennatas
- Medical Oncology Department, The Royal Marsden Hospital - NHS Foundation Trust, London, UK
| | - J Rogado
- Medical Oncology Department, Hospital Universitario Infanta Leonor, Madrid, Spain
| | - M Sekacheva
- World-Class Research Center 'Digital Biodesign and Personalized Healthcare', Sechenov First Moscow State Medical University, Moscow, Russia
| | - D Viñal
- Medical Oncology Department, Hospital Universitario La Paz, Madrid, Spain
| | - R Lee
- Medical Oncology Department, The University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK
| | - A Croitoru
- Medical Oncology Department, Fundeni Clinical Institute, Bucharest, Romania
| | - M Vitorino
- Servico Oncologia, Hospital Prof. Dr Fernando Fonseca EPE (Hospital Amadora/Sintra), Amadora, Portugal
| | - S Khallaf
- Medical Oncology Department, South Egypt Cancer Institute (SECI), Assiut University, Assiut, Egypt
| | - S Šušnjar
- Department of Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia
| | - W Soewoto
- Department of Surgery, Oncology Division, Sebelas Maret University, Surakarta, Indonesia
| | - A Cardeña
- Medical Oncology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain
| | - M Djerouni
- Oncology Department, Dr Saadane Hospital, Biskra, Algeria
| | - M Rossi
- Oncology Deparment, ASO 'SS. Antonio, Biagio e Cesare Arrigo', Alessandria, Italy
| | - T Alonso-Gordoa
- Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain
| | - C Ngelangel
- Asian Cancer Institute - Asian Hospital and Medical Center, Metro Manila, the Philippines
| | - J G Whisenant
- Vanderbilt University Medical Center, Nashville, USA
| | - T K Choueiri
- The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, USA; Harvard Medical School, Boston, USA
| | - G Dimopoulou
- Frontier Science Foundation-Hellas, Athens, Greece
| | - S Pradervand
- Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland
| | - D Arnold
- Oncology, Haematology, Palliative Care Department, Asklepios Klinik Altona - Asklepios Kliniken, Hamburg, Germany
| | - K Harrington
- Division of Radiotherapy and Imaging, The Royal Marsden/The Institute of Cancer Research NIHR Biomedical Research Centre, London, UK
| | - O Michielin
- Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland
| | - U Dafni
- Laboratory of Biostatistics, School of Health Sciences, National and Kapodistrian University of Athens, Athens Frontier Science Foundation-Hellas, Athens, Greece
| | - G Pentheroudakis
- Scientific and Medical Division, ESMO (European Society for Medical Oncology), Lugano, Switzerland
| | - S Peters
- Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland
| | - E Romano
- Center for Cancer Immunotherapy, Department of Oncology, PSL Research University, Institut Curie, Paris, France.
| |
Collapse
|
49
|
Litman Y, Pós ES, Box CL, Martinazzo R, Maurer RJ, Rossi M. Dissipative tunneling rates through the incorporation of first-principles electronic friction in instanton rate theory. II. Benchmarks and applications. J Chem Phys 2022; 156:194107. [PMID: 35597654 DOI: 10.1063/5.0088400] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
In Paper I [Litman et al., J. Chem. Phys. (in press) (2022)], we presented the ring-polymer instanton with explicit friction (RPI-EF) method and showed how it can be connected to the ab initio electronic friction formalism. This framework allows for the calculation of tunneling reaction rates that incorporate the quantum nature of the nuclei and certain types of non-adiabatic effects (NAEs) present in metals. In this paper, we analyze the performance of RPI-EF on model potentials and apply it to realistic systems. For a 1D double-well model, we benchmark the method against numerically exact results obtained from multi-layer multi-configuration time-dependent Hartree calculations. We demonstrate that RPI-EF is accurate for medium and high friction strengths and less accurate for extremely low friction values. We also show quantitatively how the inclusion of NAEs lowers the crossover temperature into the deep tunneling regime, reduces the tunneling rates, and, in certain regimes, steers the quantum dynamics by modifying the tunneling pathways. As a showcase of the efficiency of this method, we present a study of hydrogen and deuterium hopping between neighboring interstitial sites in selected bulk metals. The results show that multidimensional vibrational coupling and nuclear quantum effects have a larger impact than NAEs on the tunneling rates of diffusion in metals. Together with Paper I [Litman et al., J. Chem. Phys. (in press) (2022)], these results advance the calculations of dissipative tunneling rates from first principles.
Collapse
Affiliation(s)
- Y Litman
- MPI for the Structure and Dynamics of Matter, Luruper Chaussee 149, 22761 Hamburg, Germany
| | - E S Pós
- MPI for the Structure and Dynamics of Matter, Luruper Chaussee 149, 22761 Hamburg, Germany
| | - C L Box
- Department of Chemistry, University of Warwick, Coventry CV4 7AL, United Kingdom
| | - R Martinazzo
- Department of Chemistry, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy
| | - R J Maurer
- Department of Chemistry, University of Warwick, Coventry CV4 7AL, United Kingdom
| | - M Rossi
- MPI for the Structure and Dynamics of Matter, Luruper Chaussee 149, 22761 Hamburg, Germany
| |
Collapse
|
50
|
Litman Y, Pós ES, Box CL, Martinazzo R, Maurer RJ, Rossi M. Dissipative tunneling rates through the incorporation of first-principles electronic friction in instanton rate theory. I. Theory. J Chem Phys 2022; 156:194106. [PMID: 35597633 DOI: 10.1063/5.0088399] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Reactions involving adsorbates on metallic surfaces and impurities in bulk metals are ubiquitous in a wide range of technological applications. The theoretical modeling of such reactions presents a formidable challenge for theory because nuclear quantum effects (NQEs) can play a prominent role and the coupling of the atomic motion with the electrons in the metal gives rise to important non-adiabatic effects (NAEs) that alter atomic dynamics. In this work, we derive a theoretical framework that captures both NQEs and NAEs and, due to its high efficiency, can be applied to first-principles calculations of reaction rates in high-dimensional realistic systems. More specifically, we develop a method that we coin ring polymer instanton with explicit friction (RPI-EF), starting from the ring polymer instanton formalism applied to a system-bath model. We derive general equations that incorporate the spatial and frequency dependence of the friction tensor and then combine this method with the ab initio electronic friction formalism for the calculation of thermal reaction rates. We show that the connection between RPI-EF and the form of the electronic friction tensor presented in this work does not require any further approximations, and it is expected to be valid as long as the approximations of both underlying theories remain valid.
Collapse
Affiliation(s)
- Y Litman
- MPI for the Structure and Dynamics of Matter, Luruper Chaussee 149, 22761 Hamburg, Germany
| | - E S Pós
- MPI for the Structure and Dynamics of Matter, Luruper Chaussee 149, 22761 Hamburg, Germany
| | - C L Box
- Department of Chemistry, University of Warwick, Coventry CV4 7AL, United Kingdom
| | - R Martinazzo
- Department of Chemistry, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy
| | - R J Maurer
- Department of Chemistry, University of Warwick, Coventry CV4 7AL, United Kingdom
| | - M Rossi
- MPI for the Structure and Dynamics of Matter, Luruper Chaussee 149, 22761 Hamburg, Germany
| |
Collapse
|